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Abstract 
Shigella species cause bacillary dysentery, especially among young individuals. 
Shigellae target the human colon for invasion; however, the initial adhesion mechanism is 
poorly understood.  The Shigella surface localised protein IcsA, in addition to its role in 
actin-based motility (ABM) intracellularly, acts as a host cell adhesin through unknown 
mechanism(s). In this thesis, the role of IcsA in cell adherence was confirmed by using 
purified IcsA53-740 protein to show blocking of Shigella adherence and direct binding to host 
cells. A specific region (residues 138 to 148) in IcsA’s functional domain was found to be 
required for the IcsA mediated adherence, but not for polar localisation and actin-based 
motility. The purified mutant protein IcsA53-740(Δ138-148) was found to no longer block S. 
flexneri adherence and had reduced ability to interact with host molecules. Additionally, S. 
flexneri expressing IcsAΔ138-148 was found with significant defect in both cell adhesion and 
invasion. This may provide useful information for designing therapeutics for Shigella 
infection. The conformational change of IcsA’s functional domain which is associated with 
its adhesin activity was also explored. Through limited proteolysis assay, it was found that 
the IcsAΔ138-148 was unable to adapt the conformation associated with the hyper-adherent 
phenotype. The purified IcsA passenger domain was found to have an intramolecular 
interaction which might be a consequence of IcsA’s conformational change. Identification 
of HeLa cell receptors for IcsA was also attempted. Mass spec data found that non-muscle 
myosin heavy chain IIA and IIB might be the potential host binding partners for IcsA. Using 
a myosin IIA deficient cell line COS-7, S. flexneri was still found to be hyper-adherent, and 
the use of the anti-myosin IIA antibody also failed to reduce Shigella adherence. Far Western 
blotting indicated that myosin IIA is the only one of several IcsA interacting molecule. The 
DOC induced hyper-adherence of S. flexneri was also characterised. It was found that DOC 
triggers the release of IpaD into culture supernatant and promotes the IcsA self-association 
activity that might be responsible for the IcsA-dependent biofilm formation. Overall, this 
work provides further clues and expands our understanding of the adhesin function of IcsA, 
the potential molecular mechanism of IcsA’s conformational change, and the potential 
receptor for the Shigella adhesion mediated by IcsA.  
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underlying meaning of the work. Chapter 7 draws conclusions of the outcomes and 
significance of this study, and points out the future research directions.  
  





×g times g force 
°C Celsius degree 
aa  amino acid 
ABM actin-based motility 
Amp ampicillin  
Arp2/3 actin related protein 2/3 
BAM barrel assembly machinery 
bp base pairs 
BSA bovine serum albumin 
Cml chloramphenicol 
co-IP co-immunoprecipitation 
C-terminal carboxyl terminal 
DMEM Dulbecco's modified eagle medium 
DNA deoxyribonucleic acid 




EDTA ethylene diamine tetra-acetic acid 
FAE follicular associated epithelium 
FCS fetal calf serum 
FLAG DYKDDDK peptide sequence 
FRT FLP recognition target 
GST glutathione S-transferase 
h; min; s hour(s); minute(s); second(s) 
His6 histamine×6 tag 
hNE human neutrophil elastase 
i insertion site 
IFN-γ gamma interferon 
IL interleukin 
IM inner membrane 
Ipa Invasion plasmid antigens 
IPTG isopropyl-β-D-thiogalactopyranoside 
Kan kanamycin 
kb kilobase pairs 
kDa kiloDaltons 
L litres 
LB Lysogeny Broth 
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LPS lipopolysaccharide 
M; mM molar; millimolar 
mA milli-amps 
mAb monoclonal antibody 
M-cell membranous epithelial cells 
MEM modified eagles medium 
mg; ml; mm milligram(s); millilitre(s); millimetre(s) 
MQ MilliQ 
MW molecular weight 
MWCO molecular weight cut off 
Ni nickel 
N-terminal amino terminal 
N-WASP neural Wiskott-Aldrich syndrome protein 
Oag O-antigen 
OD600 optical density of 600 nm 
OM outer membrane 
pAbs polyclonal antibodies 
PBS phosphate buffered saline 
PCR polymerase chain reaction 





RBS ribosomal binding site 
Rha  rhamnose 
RT room temperature 
S/N; Sup supernatant 
SDS sodium dodecyl sulphate 
SDS-PAGE SDS polyacrylamide gel electrophoresis 
SEM standard error mean 
Sm streptomycin 
Sp spectinomycin 
ss signal sequence 
T3SS type three secretion system 
TBE tris-borate-EDTA 
TBS tris buffered saline 
TCA trichloroacetic acid 
Tet tetracycline 
Tris tris (hydroxymethyl) aminomethane 
U units 
Und-PP undecaprenyl pyrophosphate 
UV ultraviolet 
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V volt(s) 
v/v volume per volume 
VP virulence plasmid 
w/v weight per volume 
WCL whole cell lysate 
WM whole membrane 




μg; μl; μM microgram(s); microliter(s); micromolar(s) 
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Chapter 1: Introduction 
1.1. Shigella 
Shigella are the causative agents for bacterial dysentery or shigellosis in 
humans worldwide. This disease often manifests with symptoms including severe abdominal 
pain, fever, bloody and mucoid stools and watery diarrhea that results from intestinal 
dysfunction (Butler et al., 1986). Due to the low infectious dose of  Shigella, which is as few 
as 10 organisms (Bennish, 1991), they are relatively easy to transmit either person to person 
or directly via contaminated food and water. Shigella alone accounted for over 200,000 
deaths in 2016 and was the second leading cause of diarrheal mortality (Khalil et al., 2018). 
Although shigellosis is typically mild and self-limited for older adults, in children under 5 
years of age (Kotloff et al., 2013) and malnourished and immunocompromised people, 
infections can be more frequent and severe, such as in the case of HIV-coinfection (Lam & 
Bunce, 2015). 
Shigella are Gram-negative, non-motile bacteria belonging to the family of 
Enterobacteriacae and are genetically related to enteroinvasive E. coli (EIEC) (Van den Beld 
& Reubsaet, 2012, Zuo et al., 2013, Ud-Din & Wahid, 2014). This genus comprises four 
species (serogroups), namely S. dysenteriae (A), S. flexneri (B), S. boydii (C) and S. sonnei 
(D) (Niyogi, 2005). These four species can be further divided into serotypes according to 
their lipopolysaccharides (LPS) structure (Levine et al., 2007). In Shigella species, virulence 
is conferred by multiple factors encoded by a ~200 kb virulence plasmid (VP), which is 
essential for infection initiation and invasion (Sansonetti, 2001, Schroeder & Hilbi, 2008).  
S. flexneri 2a is the most frequently isolated serotype among all the Shigella 
species worldwide (Levine et al., 2007). However, it is being replaced by S. sonnei in many 
western countries (Holt et al., 2013, Qiu et al., 2015). The current treatment for shigellosis 
relies on rehydration therapy and antibiotics, however multiple antibiotic resistance has 
emerged in Shigella species (Barry et al., 2013, Khaghani et al., 2014, Qu et al., 2014, Cui 
et al., 2015), making the development of an effective vaccine more important. Despite many 
vaccine candidates being under assessment to different degrees (Mani et al., 2016), there is 
no vaccine available to protect from infection. Due to the serotype-specific immunity 
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(DeLaine et al., 2016) acquired after Shigella infection (Rasolofo-Razanamparany et al., 
2001),  vaccines that are made using a single attenuated live strain only protect from 
homologous Shigella serotypes (Ferreccio et al., 1991). Together with the issue of side 
effects, low efficacy, and lack of suitable animal models, this has made vaccine development 
problematic. To design novel treatments and preventions of Shigella infection, it is crucial 
to understand the nature of Shigella pathogenesis. 
1.2. Pathogenesis 
Humans (Speelman et al., 1984, Anand et al., 1986) and rhesus monkeys 
(Good et al., 1969) are the only two natural reservoirs of Shigella. In studies on human 
patients (Speelman et al., 1984, Anand et al., 1986) and healthy volunteers (Levine et al., 
1973), lesions were found exclusively in the colon with the increased severity towards the 
distal direction and the most severe damage in the rectosigmoid area (Speelman et al., 1984). 
Shigella infection lesions found in these studies were: cell infiltration of the mucosa area by 
lymphocytes, disorganisation of crypts, goblet cell depletion, micro-ulcers and flattened 
surfaces in epithelial layers (Levine et al., 1973, Anand et al., 1986, Mathan & Mathan, 
1986). These features are similar to those described in Shigella infections in monkeys 
(Formal et al., 1966, Takeuchi et al., 1975, Takeuchi, 1982) where lesions were reported in 
the colon while not in the small intestine. It was also found that apart from the mucosal 
invasions found in colon which result in dysentery, the small intestine, specifically jejunum, 
was also impaired resulting in diarrhea symptoms but with little or no invasion (Rout et al., 
1975). This impaired secretion by the jejunum is due to the release of ShET enterotoxins by 
Shigella in the small intestine (Levine et al., 2007). Little has been known for the species 
specificity of Shigella, yet as Shigella preferably invade the colon rather than the small 
intestine, it is therefore important to distinguish the differences between the colon and the 
small intestine (Figure 1.1). 
4 | P a g e  
 
 
Figure 1.1. Atonamy of intestinal mucosa 
Small intestine and colon have distinct structures. In the small intestine, epithelial cells 
derived from stem cells in crypts and migrate upwards to form villi (Potten & Loeffler, 1990, 
Barker et al., 2007), which increase the surface area of intestine. These stem cells also give 
rise to Paneth cells (Cheng et al., 1969) that secrete antimicrobial proteins and are located at 
bottom of crypts; goblet cells (Merzel & Leblond, 1969, Cairnie, 1970) that produce mucins 
to form mucus, separating the epithelial cells from commensal bacteria presented in gut 
lumen; and enteroendocrine cells which function in hormone secretion (Gunawardene et al., 
2011). Under the epithelial layers, there are lymphoid follicles of gut-associated lymphoid 
tissues (GALT) including Peyer’s patches and isolated lymphoid follicles. M cells are found 
predominantly in dome-associated crypts in Peyer’s patches (Gebert et al., 1999). M cells 
are highly specialised for antigen and pathogenic microorganism sampling, and have unique 
morphological features with reduced glycocalyx and microvilli on the surface (Mabbott et 
al., 2013). In the colon, epithelial cells derived from stem cells from crypts does not form 
villi, thus have a relatively flat surface compared to the small intestine. Paneth cells are rare 
and goblet cells are relatively more abundant. M cells can be identified in colonic patches 
(Fujimura et al., 1992) which is the Peyer’s patches equivalent GALT in the colon. 
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1.2.1 Acid resistance 
One of the reasons why the infectious dosage of Shigella is low might be due 
to its high acid resistance. It has been known that Shigella can survive in acid conditions (pH 
2.5) for more than 2 hours independent to the large virulence plasmid (Gorden & Small, 
1993). However, it is interesting that as reported, Shigella surviving acid challenge were 
unable to invade epithelial cells, yet the ability can be restored by growing at neutral pH for 
4 hours (Gorden & Small, 1993). Moreover, the virulence plasmid, which is required for 
invasion, actually reduces the ability to survive in acid environments (Niu et al., 2017). It 
can be speculated that Shigella might have different repertoires to deal with different 
environmental conditions. Indeed, it was found that Shigella required the alternative Sigma 
factor RpoS for its acid resistance (Small et al., 1994). Further research revealed that certain 
genes, gadC and hdeAB, that contribute to the acid resistance were regulated by RpoS under 
acidic conditions (Waterman & Small, 1996). GadC is an antiporter that belongs to the 
glutamate-dependent acid resistance system (Jennison & Verma, 2007), and HdeA, HdeB, 
HdeC and HdeD are periplasmic chaperones and major acid resistance proteins (Foster, 
2004). Moreover, it has also been found that an RNA binding protein Hfq coordinates the 
expression of acid resistance genes including hdeA, hdeB, hdeD, gadA and gadB, and T3SS 
genes in response to the acid environment (Yang et al., 2015). Apart from the regulatory 
pathways that Shigella use to survive the acid environments, the surface component 
lipopolysaccharides (LPS) is also implicated in the acid resistance (Martinic et al., 2011), 
particularly the polymerised sugar components. 
1.2.2 Mucus layer penetration 
To establish shigellosis and causes tissue damage, Shigella needs to firstly 
gain access to colonic epithelial cells, however Shigella would initially encounter the mucus 
layer which is a host innate defense system. The mucus layer consists of mucins, which are 
glycoproteins produced and secreted by goblet cells. The mucus layer in colon can be 
separated into outer layer and inner layer. The outer layer is softer and associated with 
commensal bacteria, and can be easily removed by intestinal movement, whereas the inner 
layer is thicker and free of bacteria (McGuckin et al., 2011). The mucus layer also contains 
antimicrobial peptides, defensins and cathelicidins produced and secreted by enterocytes 
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(McGuckin et al., 2011). Mover, mucins are also indispensable for the epithelial 
inflammation response triggered by the Shigella infection (Nutten et al., 2002). 
Shigella does not have flagella, hence it has limited motility in the gut lumen, 
and it lacks classic adhesins which would aid colonization. To date little has been known in 
regard to how Shigella deal with the mucus layer. However, several studies have implicated 
the potential strategies that Shigella might exploit to colonize and penetrate the mucus layer. 
It has been reported that the serine protease Pic expressed by Shigella and enteroaggregative 
E.coli (EAEC) was able to bind to mucin substrates (Gutierrez-Jimenez et al., 2008). 
Moreover, by using polarized human intestinal cells, Shigella was also found to manipulate 
the expression, secretion and post-translation modification of mucins, which forms a gel-like 
matrix and favors the bacteria entry to the epithelial cells (Sperandio et al., 2013). The 
binding of the mucin to Shigella might be specific as Shigella only recognizes few hosts. 
Indeed, mucus composition in different species is different (Podolsky et al., 1986). It has 
been found that certain serotypes of Shigella strains can be agglutinated by Guinea pig mucus, 
and their invasion to HeLa cells can also be inhibited by the mucus from Guinea pigs, while 
not by monkey mucus (Dinari et al., 1986). It can be speculated that a specific interaction 
between Shigella and human mucins exist, which facilitates the colonization and subsequent 
bacterial penetration of the mucus layers. Indeed, the adherence of Shigella to Guinea pig 
mucus can be inhibited by either carbohydrates or Shigella LPS (Izhar et al., 1982), which 
indicated a carbohydrate interactions between the pathogen and hosts. However, in humans, 
it has been reported that Shigella dysenteriae adheres to colonic mucin rather small intestinal 
mucin (Sudha et al., 2001), and that adherence cannot be inhibited by monosaccharides from 
mucins, suggesting that the potential receptors might be a glycoprotein. It still needs 
intensive studies to elucidate the mechanism that Shigella uses to adhere and across the 
mucus barrier. 
1.2.3 Epithelial layer invasion 
After Shigella bacteria cross the mucus barrier, it has to invade the epithelial 
cells in order to replicate and exert its virulence in the host, causing subsequent inflammatory 
responses and devastating tissue damage. However, the lining of the epithelial cells consist 
of polarized enterocytes that have microvilli structures facing the lumen and are sealed by 
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tight junctions, making it hard for Shigella to colonise and penetrate. Therefore, 
understanding the strategies Shigella exploit to cross this barrier may have important clinical 
value in understanding how to combat the disease.  
1.2.3.1 M cell entry pathway 
Due to ethical and financial consideration, it is difficult to study the early 
pathogenesis of shigellosis in humans at a cellular and molecular level. However, with 
several established animal models and in vitro human cancer cell lines, knowledge of 
Shigella infection, especially of the host immune response and inflammatory process respect, 
is partially elucidated. In the rabbit ligated ileal loop model, Shigellae takes advantage of M 
cells found within follicle-associated epithelium (FAE) in Peyer’s patches (Bernardini et al., 
1989, Wassef et al., 1989, Sansonetti et al., 1996) to penetrate epithelial layers (Figure 1.2, 
A). In the murine macrophage cell line (Zychlinsky et al., 1992), rabbit ligated ileal loop 
model (Zychlinsky et al., 1996) and human ex vivo cells (Senerovic et al., 2012), Shigella 
induces pyroptosis of macrophages after having been engulfed. Using in vitro cultured cells, 
Shigella was found to be able to lyse the phagocytic vacuoles with the aid of the type three 
secretion system (T3SS) (High et al., 1992, Du et al., 2016). Upon pyroptosis, inflammatory 
IL-1β and IL18 are released to the submucosa when studied in the mouse lung infection 
model (Sansonetti et al., 2000). This also leads to the release of Shigella bacteria into the 
lamina propria which gain access to the basolateral side of epithelial cells, where they can 
invade. In addition, using in vitro human cell lines (Philpott et al., 2000, Girardin et al., 2001) 
and mouse models (Singer & Sansonetti, 2004), LPS and peptidoglycan presented by 
internalised Shigella can activate host cell nuclear factor-κB (NF-κB), which then activates 
the transcription of IL-8. The release of cytokines IL1β, IL18 and IL8 results in amplified 
inflammatory response and massive tissue destruction. 
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Figure 1.2. Models for Shigella penetration of the epithelial barrier. 
The colonic epithelium layer is a single layer of polarized epithelial cells with apical and 
basolateral surfaces. Tight junctions are intracellular structures which form a barrier to 
control intracellular diffusion of components between epithelial cell’s apical and basolateral 
membrane domains (Shin et al., 2006). (A) Shigella penetrate the epithelial barrier by M 
cells. This is based on the rabbit small intestine model, and in vitro cell line models 
(Schroeder & Hilbi, 2008), (i) Shigella utilise M cells to penetrate epithelial barrier. (ii) 
Shigella are delivered into residential macrophages via transcytosis. (iii) Shigella escape by 
inducing pyroptosis of macrophages. (iv) Shigella are able to invade epithelium cells from 
the basolateral side, aided by its T3SS. (v) Shigella can spread to adjacent cells via actin 
based motility. (vi) The death of macrophages and infection of epithelium cells results in the 
release of cytokines, amplifying inflammatory reactions. (B) Shigella penetrate the epithelial 
barrier by the para-cellular space. (vii) Shigella triggers PMN cells to disrupt tight junctions 
between epithelial cells and use the para-cellular space to penetrate the epithelial barrier. 
(viii) Shigella actively disrupts tight junction between epithelial cells to gain access to the 
mucosa. (ix) Shigella was found targeting upper third of the colonic crypts, however the cell 
type(s) is unknown. 
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1.2.3.2 Paracellular entry pathway 
While Wassef et al. (1989) have reported the initial entry of Shigella to 
mucosa is through M cells, this is not entirely convincing because the discovery of this 
mechanism used a rabbit small intestine model, while the actual infection site in humans is 
in the colon. Shigella do not require Peyer’s patches and M cells to establish infections in 
both mouse-human intestinal xenograft (Zhang et al., 2001) and in the ex vivo human colon 
model (Coron et al., 2009). To date, there is no M cell-entry mechanism reported in humans 
nor in rhesus monkeys studies, and whether M cells in human colonic patches (Fujimura et 
al., 1992) have the same function as in rabbit small intestines and whether they can be utilised 
by Shigella remains unknown.  However, Shigella may have other entry sites. According to 
Mounier et al. (1992), Shigella was imaged binding to intercellular junctions of host cells 
and inefficient in invading polarised Caco-2 cells (human colonic cancer cell line) from the 
apical side compared that from the basolateral side. Histological studies on patient rectal 
biopsies frequently identified bacteria in para-cellular spaces (Mathan & Mathan, 1986). 
These results suggest that Shigella can gain access to mucosa through a para-cellular pathway. 
Using an in vitro human colonic cancer cell line (T84 cells), Perdomo et al. (1994a) 
demonstrated that Shigella on the apical side of monolayer is able to promote PMN cells 
migrating from basolateral side towards apical side and disrupt the barrier formed by the 
polarised monolayer (Figure 1.2, B-vii). In addition, in a rabbit model, Sansonetti et al. (1999) 
demonstrated that in the presence of IL8 which was released by epithelial cells, PMN cells 
were recruited to disrupt the epithelial barrier, though the exact mechanism is still 
controversial (McCormick et al., 1998). One possible pathway showed by Sakaguchi et al. 
(2002) is that Shigella has the ability to interact with and penetrate the tight junctional seal 
to gain access to the basolateral side where it invades T84 monolayer cells (Figure 1.2, B-
viii). In addition, Shigella flexneri disrupts the tight junction of Caco-2 cell monolayers 
independent of pro-inflammatory IL-8 (Fiorentino et al., 2014). These results indicate that 
Shigella can penetrate the epithelial layers by the disruption of the tight junctions, yet the 
exact mechanism also remains unknown. 
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1.2.3.3 Apical infection pathway 
Apart from the para-cellular pathway, internalisation of Shigella is also 
observed when adding bacteria apically to Caco-2 cell lines (Wells et al., 1998, Mathias et 
al., 2013, Longet et al., 2014), suggesting an alternative route to penetrate epithelial layers. 
However, it worth mentioning that in these experiments, bacteria were either incubated with 
Caco-2 cells overnight where a transepithelial electrical resistance (TEER, which represents 
the integrity of cell monolayer) drop was observed (Mathias et al., 2013, Longet et al., 2014), 
or centrifuged to promote the contact of bacteria and cells (Wells et al., 1998). Therefore, it 
is still unknown whether Shigella can directly infect and enter epithelial cells apically. More 
studies on apical infection are needed to confirm this pathway. 
Recently, Shigella were found targeting crypts in both the Guinea pig colon 
and human ex vivo specimens by bioimage analysis (Arena et al., 2015), which is consistent 
with the observations in patient biopsy where damage was found predominantly in the upper 
third of crypts (Figure 1.2, B-ix) (Mathan & Mathan, 1986). Colonic crypts have epithelial 
stem cells that can proliferate and differentiate to different cell types, such as epithelial cells, 
enteroendocrine cells and goblet cells, all of which are important in maintaining the colonic 
health (Abdul Khalek et al., 2010). Moreover, the upper third of crypts might have M cells 
that are derived from the follicle-associated epithelial cells before they migrate and mature 
in lymphoid follicles. As reported by Tahoun et al. (2012), M cells can be derived from 
follicle-associated epithelial cells upon the contact with pathogen. However, the targeted cell 
type in colonic crypts and the mechanism of cell targeting in humans by Shigella are 
completely unexplored.  
1.3. Shigella pathogenesis models 
1.3.1 Immortal cell lines 
The majority of research on the interactions between Shigella and host have 
relied on immortal cell lines such as HeLa (human cervix epithelial cells), Intestine-407 
(human embryonic intestinal cells contaminated with HeLa cells), T84 (human colonic 
epithelial cells), HT-29 (human colonic epithelial cells) and Caco-2 (human colonic 
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epithelial cells). Using these cell lines, studies were able to demonstrate the successful 
adherence and invasion, therefore they have become useful tools to investigate Shigella 
virulence factors at the cellular and molecular level. HeLa cells and Intestine-407 cells are 
useful for assessing invasion ability, and cell to cell spread of Shigella by plaque formation, 
as well as the adherent characteristics of different Shigella strains (Koestler et al., 2018b). 
Caco-2 and T84, as they are derived from human colonic tissue and can form polarized 
colonic epithelial cells, are useful in assessing the efficiency of Shigella invasion and 
adhesion from different sides (Mounier et al., 1992), i.e. apical and basolateral side (Figure 
1.3). It is also helpful in investigating the host pathogen interactions at the molecular level. 
Using T84 cells, it was found that Shigella was able to manipulate the expression of tight 
junction proteins via dephosphorylation independent to their invasion machinery (Sakaguchi 
et al., 2002).  Further research on this demonstrated that Shigella secrete serine protease A 
(SepA) to disrupt the tight junctions by causing a decrease in active LIM kinase 1, a negative 
regulator of cofilin which leads to the remodeling of actin and the opening of tight junctions 
(Maldonado-Contreras et al., 2017). 
Although these cells are derived from human source, they have altered 
physiology and expression profile compared to their normal human counterparts, therefore 
they do not fully represent the intestinal epithelial cells. Besides, as they are all single cell 
type, they lack the complexity which a multicellular system can provide, hence they have 
limited ability to represent the disease progression and unable to elucidate the initially 
infected cell type. Moreover, when using these cells, it often requires either long infection 
time with large number of bacteria or centrifugation to promote contact between bacteria and 
host cells. Furthermore, Caco-2 and HT-29 cells have multiple cell subtypes (Lievin-Le Moal 
& Servin, 2013) which is likely to give variable results. 
1.3.2 Animal models 
When trying to understand the initial infection process of shigellosis and the 
cell type that Shigella utilizes for its entry, as well as establishing a model for the assessment 
of Shigella vaccine candidates, animal models are often exploited (Table 1.1).  
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Figure 1.3. Polarised epithelial infection and adherence system. 
Tissue cultured polarised epithelial cell system for the investigation of Shigella adherence 
and infection from apical (left) and basolateral (right) sides. Colonic immortal cells grow on 
the surface of the transwell which hold a 0.4 µm (basolateral) or 0.2 µm (apical) microporous 
membrane and sit in the 24-well plate. Depend on the side they grow, they can expose either 
apical or basolateral side to the bacteria which can be added into the transwell. The 
confluence of the cell layer is measured by the transepithelial electrical resistance (TEER). 
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Table 1.1. Summary of Shigella animal models. 
Animal models References 
Rabbits  
Ligated ileal loop model (Arm et al., 1965, Wassef et al., 1989) 
Cecal ligation model (Rabbani et al., 1995) 
Oral infection model (Etheridge et al., 1996) 
Guinea pigs  
Oral infection model (Formal et al., 1958) 
Sereny test model (Sereny, 1959, Sansonetti et al., 1983) 
Intrarectal infection model (Shim et al., 2007) 
Cecal ligation model (Barman et al., 2011) 
Mice  
Intranasally infection model (Voino-Yasenetsky & Voino-Yasenetskaya, 1962, Mallett et al., 
1993) 
New-born mouse intragastrical infection model (Fernandez et al., 2003, Fernandez et al., 2008) 
Intraperitoneal infection model (Yang et al., 2014) 
Human intestinal xenograft model 
Antibiotic treated oral infection model 
(Seydel et al., 1997) 
(Medeiros et al., 2019) 
Other models  
Monkey model (Kent et al., 1967, Takeuchi et al., 1968, Rout et al., 1975, 
Takeuchi et al., 1975, Takeuchi, 1982, Formal et al., 1984, Oaks 
et al., 1986, Karnell et al., 1993, Gardner & Luciw, 2008, Shipley 
et al., 2010, Gregory et al., 2014, Islam et al., 2014) 
Pig model (Maurelli et al., 1998) 
Chicken model (Shi et al., 2014) 
C. elegans model (Burton et al., 2006, George et al., 2014) 
Zebrafish model (Mostowy et al., 2013) 
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1.3.2.1 Rabbit models 
The most successful model that demonstrated the potential pathogenesis of 
Shigella is the ligated rabbit ileal loop model (Arm et al., 1965), by which it was found that 
M cells are the entry site of Shigella (Wassef et al., 1989). However, in this study, ileal loop 
was used instead of the large intestine section, which is the natural infection site in humans. 
Besides, large number of bacteria were inoculated and made contact directly to Peyer’s 
Patch-rich sections, and both pathogenic and non-pathogenic strains were taken up by M 
cells, which may not truly represent the natural disease progression. Although rabbit can be 
infected in the colon, it again requires the administration of large amount of bacteria and the 
manipulations of the intestines, where bacteria was directly injected into the proximal colon 
after been ligated to the distal cecum (Rabbani et al., 1995). Rabbits can be orally infected 
with Shigella, yet it required starving and preconditioning of the animal (Etheridge et al., 
1996). More importantly, although the histological analysis of the lesion was the same as 
that in other hosts, the primary infection site is restrained in the ileum, suggesting an intrinsic 
difference to its natural host, humans. 
1.3.2.2 Guinea pig models 
The Guinea pig is one of the oldest animal models used in obtaining 
knowledge about Shigella pathogenesis. By starving and preconditioning of the animal, 
orally administrated Shigella successfully caused disease symptoms and tissue destruction 
in guinea pigs (Formal et al., 1958). Similar to shigellosis in the humans, lesions were 
restrained in the colon rather the small intestine, yet it was not as diffused as observed in 
patients. Guinea pig models seems to be superior in studying Shigella adherence, as it was 
found to be the most efficient host for bacteria to adhere among rats, rabbits and hamsters 
(Izhar et al., 1982). In addition, the adherence of Shigella in the colon was found significantly 
higher than that in the small intestine, with increasing adherence rate towards the distal end, 
which closely correlated to the observations in humans where lesions were predominantly 
found in the colon with the increasing severity towards the distal end of the colon (Formal et 
al., 1958). Another widely used purpose of the Guinea pig is to assess the virulence of 
Shigella strains, known as the Sereny test (Sereny, 1959), where Shigella strains were 
inoculated into Guinea pig eyes, and the conjunctivitis and keratitis was observed in animals 
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infected with virulent strains (Sansonetti et al., 1983). In addition, through intrarectal 
administration of Shigella strains, Guinea pigs can be infected and not only displayed the 
symptoms of weight loss, fever, severe damage to the colonic mucosa as observed in humans, 
but also the inflammatory response was similar to shigellosis (Shim et al., 2007). Further 
analysis in this model revealed the colonic crypts are the favored entry site for Shigella 
(Arena et al., 2015). Again, this model bypasses the proximal colon, which is the targeted 
site by Shigella in humans. In another Guinea pig model, Shigella was administrated in the 
proximal colon after the ileocecal junction was tied, which also produced acute inflammatory 
response and colonic tissue damage (Barman et al., 2011). However, this model failed to 
develop severe diarrhea and the severity of the disease was mitigated after 3 to 4 days. 
Although these Guinea pig models closely resemble the pathogenesis of shigellosis, they 
either involve animal starvation or preconditioning, which could potentially alter the normal 
intestinal flora and contributing to the observed results. 
1.3.2.3 Mouse models 
One of the early developed mouse models was the mouse pneumonia model, 
where Shigella was inoculated intranasally to determine bacterial virulence (Voino-
Yasenetsky & Voino-Yasenetskaya, 1962, Mallett et al., 1993), but this model was only 
useful in assessing the virulence of the attenuated live Shigella vaccines and exploring the 
inflammatory responses, hence it had limited relevance in terms of exploring pathogenesis. 
Adult mice cannot easily be orally, intragastrically or intrarectally infected by Shigella. The 
possible explanation of the difficulty in establishing shigellosis in adult mice might be the 
proportion of polymorphonuclear neutrophils (PMNs) in mouse blood is far less than that of 
in humans, representing 10-25% and 50-70% respectively (Mestas & Hughes, 2004), as 
PMNs play an important role during Shigella infection. Besides, mice do not express IL-8 
which recruits PMNs (Singer & Sansonetti, 2004), which was thought to be responsible for 
the massive inflammatory response and the disruption of epithelial barrier, dampening the 
tissue destruction in humans. Because of this, the newborn mouse was exploited as a model 
(Fernandez et al., 2003), where Shigella was administrated intragastrically, and was able to 
elicit an acute immune response. However, the tissue damage described in the literature was 
restrained in the small intestine. It is still unknown why newborn mice can be easily infected 
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by Shigella, yet one might speculate that the immaturity of the newborn mice might affect 
the ability to control the inflammatory response (Liechty et al., 1993). Moreover, as the 
newborn mice infected by Shigella developed small intestine lesions similar to human 
colonic lesions, it is reasonable to investigate the transcriptomic differences in mice growing 
for different days. Indeed, expression of certain genes specific for Paneth cells accounts for 
the limited disease progressing in adult mice, suggesting the importance of Paneth cells in 
combating shigellosis in humans (Fernandez et al., 2008). Nevertheless, it has been reported 
recently that mice can be orally infected with Shigella flexneri 2a after the treatment of 
antibiotics (Medeiros et al., 2019), with the infection found in the colon and been promoted 
by the zinc deficiency. In addition, by intraperitoneal injection of Shigella flexneri 2a, adult 
mice were found having bacillary dysentery, with observations of invasion and colonization 
of the bacterial pathogen in the colon (Yang et al., 2014). Another mouse model that was 
developed is the mouse-human intestinal xenograft model (Seydel et al., 1997), where human 
colonic tissue was grafted into the subscapular region of mice to assess the immune response 
elicited by Shigella infection (Zhang et al., 2001). This model has limitations in investigation 
the dissemination of the bacteria, yet demonstrated the ability of Shigella to invade human 
colonic tissue in the absence of M cells. 
1.3.2.4 Other animal models 
Since primates were reported naturally infected with Shigella (Banish et al., 
1993), it has been recognized as a natural host and used to examined the tissue lesions at a 
morphological and histological level, or used to assess vaccine candidates (Labrec et al., 
1964, Kent et al., 1967, Takeuchi et al., 1968, Rout et al., 1975, Takeuchi, 1982, Formal et 
al., 1984, Karnell et al., 1993, Shipley et al., 2010, Gregory et al., 2014). In these models, 
Shigella were experimentally administrated via oral route or intragastric route (Islam et al., 
2014). The symptoms, immune responses and tissue damages closely resemble the human 
shigellosis, but it is costly and strictly restrained by ethics regulation. 
Pigs have also been experimentally infected with Shigella via the oral route 
(Maurelli et al., 1998). However, they failed to elicit an inflammating response and failed to 
penetrate colonic cells. Therefore, it has little value in investigating the pathogenesis of 
Shigella.  
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Chickens have been reported with shigellosis, with the symptoms of bloody 
and mucoid diarrhea. Because of this, chickens were intraperitoneally injected with Shigella 
isolated from human, and invasion were observed in intestinal mucosa. However, bacteria 
internalization was only observed in the jejunum and ileum, rather in the duodenum, cecum, 
or rectum (Shi et al., 2014), suggesting that chickens are not appropriate to represent 
shigellosis in humans. 
Caenorhabditis elegans were also exploited as a Shigella infection model 
(Burton et al., 2006). The research into the interactions between Caenorhabditis elegans and 
the pathogen revealed that Shigella was able to induce a cytopathological changes in the host 
and disrupt the host iron homeostasis, making the host more susceptible to the infection 
(George et al., 2014). Through proteomic analysis, a Shigella periplasmic enzyme, AnsB, 
which has been reported to be immunogenic, was found to contribute to bacterial 
adherence.(Jennison et al., 2006). 
Apart from chickens, pigs and worms, infection of zebrafish have also been 
used as a model to study the host-pathogen interactions (Mostowy et al., 2013), but this 
model is not suitable for investigation of the pathogenicity of Shigella, rather it provided 
information in host innate immune response after the infection. 
Humans and monkeys are the only natural reservoir for Shigella, while 
rabbits, guinea pig, mice, and other animals are non-susceptible to the natural infections. To 
study the pathogenesis in these animal models requires a variety of manipulation including 
starvation, administration of antimicrobial reagents, toxic reagents, acid neutralization 
treatments and even opiates. Some are even involve surgery to bypass the small intestine, or 
infection directly from distal end of the colon. These heavy manipulations on animal subjects 
would alter the natural microflora and represent artificial infection cases, which has 
limitations in deciphering the pathogenesis as occurs in the naturally susceptible hosts. 
1.3.3 Human biopsies and organoids model 
As far as the host specificity of shigellosis is concerned, experimental 
material from humans seems to be more suitable for the study of the pathogenesis. Human 
ex vivo colon specimens were used to examine the primary infection site targeted by Shigella 
18 | P a g e  
 
(Coron et al., 2009, Arena et al., 2015), where specimens were taken from the patients 
undergoing surgery, and immediately infected by Shigella, flowed by immunohistochemical 
analysis. Although it might be helpful in gaining the understanding of how human colonic 
cells react to the infection of Shigella in the cellular and molecular level, it is limited in 
explaining the process of spread of bacteria and the immune response elicited by the infection, 
as they lack of an underlining tissue and blood circulation which also contributes to the 
disease progression.  
A recently developed human model is human intestinal enteroids, being 
theoretically advantageous in investigating Shigella invasion processes. These enteroids are 
derived from LGR5+ stem cells, which are originally isolated from human colonic crypts 
and subsequently differentiated to different enterocytes including epithelial cells, goblet cells, 
Paneth cells and enteroendocrine cells (Barker et al., 2007, Wells & Spence, 2014, Bartfeld 
& Clevers, 2015, VanDussen et al., 2015). They have been used to investigate the 
interactions between human tissues and a variety of bacteria including: Salmonella (Zhang 
et al., 2014, Forbester et al., 2015, Wilson et al., 2015), Helicobacter (McCracken et al., 
2014, Bartfeld et al., 2015), and recently, Shigella (Koestler et al., 2019, Ranganathan et al., 
2019). In Shigella infection, it was found that Shigella was able to invade more efficiently 
from the basolateral side of the epithelial cells compared to that of from the apical side 
(Koestler et al., 2019, Ranganathan et al., 2019), consistent to that reported from the tissue 
cultured cells (Mounier et al., 1992). When enteroids were made to differentiate to M cells, 
apical infection of Shigella was increased by 10-fold, suggesting that M cells does contribute 
to the uptake of pathogen and facilitate Shigella across the epithelial barrier (Ranganathan et 
al., 2019). However, it can still be argued that M cells are not as abundant in the colon as in 
the small intestine (Bowcutt et al., 2014), and the fact that Shigella is unable to invade the 
small intestinal epithelial suggesting that M cells might not be the primary targeted site for 
the entry. Enteroids also have limitations in capturing the interactions between the pathogen 
and immune system, gut fluid and flora. Therefore, enteroids have limitations with respects 
to deciphering aspects of pathogenesis.  
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1.4. Shigella cell adhesion 
For pathogenesis, adhesion of bacteria to host cells is crucial for establishing 
early infection, allowing bacteria to contact with specific host cells and initiate subsequent 
infection. A variety of bacterial adhesins have been identified and reviewed (Chahales & 
Thanassi, 2015), including pili, curli, and some autotransporters such as Ag43, FdeC and 
pertactin. It is still unclear as to what molecular and mechanism Shigella utilises to adhere 
to the host cells and to initiate infection, as until recently there are no well characterised 
adhesins in Shigella. However, several host molecules and bacterial surface molecules were 
recently reported to promote adhesion of Shigella bacteria to host cells. 
1.4.1 Host molecules enhanced adherence. 
It has been reported that neutrophils are required for effective Shigella 
invasion of epithelial cells (Perdomo et al., 1994a), and are recruited early in infection 
(Perdomo et al., 1994b). Further studies found that these recruited neutrophils can 
degranulate and release antimicrobial proteins which were then exploited by Shigella to 
enhance their adherence and invasion to epithelial cells, by potentially binding to the 
bacterial surface (Eilers et al., 2010). Recently, human enteric α-defensin 5 (HD5) that is 
secreted by intestinal Paneth cells was found to promote Shigella adherence and invasion in 
a variety of in vivo models including the Guinea pig Sereny test model, the Guinea pig 
intrarectal infection model and a mouse ligated ileal and colonic model (Xu et al., 2018). 
HD5 was also found binding to Shigella surface molecules to mediate the adherence and 
invasion to epithelial cells in vitro (Xu et al., 2018). However, the exact mechanism of this 
remains unknown. 
1.4.2 LPS 
One of the bacterial surface molecules found to promote adhesion is 
lipopolysaccharide (LPS), which is an important bacterial virulence factor (Trent et al., 2006), 
and is known to be involved in the adherence of many bacteria (Jacques, 1996). Fully 
assembled LPS can be divided into three units: 1) an outer membrane embedded Lipid A, 2) 
a core sugar component, and 3) a repeated O-antigen glycan subunit of various lengths. 
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Shigella that are devoid of O-antigen units are called rough LPS strains, while those with the 
presence of O-antigen units, are called smooth LPS strains (Figure 1.4). 
The diversity of the O-antigen also plays a role in Shigella virulence and host 
immune avoidance. It has been reported that the glucosylated O-antigen on LPS might adapt 
a helical structure compared with the unglucosylated LPS, making the LPS molecules shorter, 
and hence allowing more exposure of the T3SS (West et al., 2005). Moreover, LPS has been 
implicated in pathogen-host interactions in many bacterial species, and been reviewed by 
Jacques (1996).  In Shigella, it has been found that isogenic LPS preparation inhibits the 
adherence of bacteria to Guinea pig intestinal cells (Izhar et al., 1982) and human cancer 
cells (Day et al., 2015). This inhibition can also be achieved by glycans from human cells 
(Day et al., 2015). Moreover, LPS-specific secretory IgA (Boullier et al., 2009) and anti-O 
antigen antibody (Chowers et al., 2007) can reduce invasion and Shigella induced 
inflammatory reactions. Recently, purified polysaccharides of Shigella showed specific 
binding to human small intestinal sections and glycan arrays, and can inhibit adherence to 
T84 cells (Day et al., 2015). Collectively, these studies indicate a role of LPS O-antigen in 
adherence of Shigella to host cells. 
1.4.3 The SSO1327 multivalent adhesion molecule 
Recently, through sequence comparison, a putative protein SSO1327 (around 
120 kDa) encoded by the chromosome near the ipaH pathogenicity island was found in 
Shigella sonnei as an ortholog of the well characterized multivalent adhesion molecules in 
V. parahaemolyticus (VP1611) (Mahmoud et al., 2016). This protein has been predicted with 
seven mammalian cell entry domains and can be also found in S. boydii (SB01249), 
S. flexneri (SF1391) and S. dysenteriae (SDY1985) although in most S. flexneri, it encodes 
for a truncated protein. Mutations in this protein in Shigella sonnei lead to decreased 
adherence and invasion in the Galleria mellonella larvae infection model, demonstrating a 
role of SSO1327 in contributing to Shigella adhesion. However the effect of its other 
othologs in other Shigella species needs to be investigated as well. 
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Figure 1.4. Schematic representation of Shigella LPS structure. 
The matured LPS molecules (shown as of Shigella flexneri 2a) can be separated into three 
parts including lipid A, core sugar (inner and outer core), and the O-antigen repeating units. 
LPS having the full length O-antigen repeating units is called smooth LPS, while the LPS 
devoid of O-antigen is called rough LPS. GlcN: glucosamine; Kdo: 3-deoxy-D-mannooct-2-
ulosonic acid; Hep: L-glycero-D-manno-heptose phosphate; PEtN: O-phosphoryl-
ethanolamine; Gla: D-galactose; Glc: D-glucose; GlcNAc: N-acetyl-D-glucosamine; Rha: L-
rhamnose. 
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1.4.4 Type III secretion system (T3SS) 
Another surface component that has been found essential to establish early 
infection is the type III secretion system (T3SS). The T3SS exists in a wide range of Gram-
negative bacterial pathogens and symbionts, and is comprised of more than 20 proteins, 
which form the entire T3SS apparatus across the bacterial inner and outer membrane, namely 
the injectisome (Deng et al., 2017). The injectisome can be divided into three parts according 
to their cellular locations, which are 1) the peripheral cytoplasmic components including the 
ATPase complex and the cytoplasmic ring (C ring), which are responsible for protein 
secretion, sorting and unfolding; 2) the basal body consisted of proteins that are highly 
oligomerized spanning across the inner and outer membrane, through which the effector 
proteins are secreted; and 3) the extracellular components including the hollow needle and 
the tip complex, which is responsible for the delivery of effector proteins to the host 
cytoplasm. Proteins involved in the assembly of the T3SS and their function were reviewed 
and summarized by (Deng et al., 2017).  In Shigella, this system is encoded by the ipa-mxi-
spa locus of the large virulence plasmid (VP).  
1.4.4.1 Membrane targeting of T3SS 
The T3SS extracellular needle contains IpaB, IpaC and IpaD (Veenendaal et 
al., 2007). Specifically, IpaB and IpaC are hydrophobic proteins and were thought to be 
assembled onto the needle with the help of IpaD, and are inserted into host cell membranes 
to form a channel for delivery of effector proteins (Blocker et al., 1999, Veenendaal et al., 
2007). These effector proteins are involved in the subversion of host cell processes to 
facilitate Shigella invasion, and their functions are reviewed by Belotserkovsky and 
Sansonetti (2018). It has been shown that IpaB, IpaC and IpaD proteins can interact with 
host receptor α5β1 integrin (Watarai et al., 1996), and IpaB interacts with CD44 (Skoudy et 
al., 2000, Lafont et al., 2002) and host cell membrane component cholesterol (Hayward et 
al., 2005), initiating the invasion process to host cells. However, these two host membrane 
receptors are thought to be located at the basolateral surface of the polarized epithelial cells 
(Neame & Isacke, 1993, Lee & Streuli, 2014), and those Ipa proteins are not directly 
contributing to the cell adhesion (Menard et al., 1993), questioning their role in the initial 
adherence of Shigella to the apical surface of the host lumen. Nevertheless, the apical 
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infection of the intestinal epithelial layers could be attributed to the interaction between host 
filopodia and T3SS (Carayol & Nhieu, 2013). Recently, Shigella effector protein IpaA was 
found binding to host focal adhesion protein talin to stabilize the adhesion of Shigella to host 
cell filopodia and facilitates the capture of the bacteria (Valencia-Gallardo et al., 2019). IpaA 
proteins has previously been reported binding to another focal adhesion protein vinculin 
(Tran Van Nhieu et al., 1997, Bourdet-Sicard et al., 1999), through which it increased the 
association between vinculin and F-actin and subsequently depolymerized the actin filaments. 
Clearly, it suggests that IpaA contributes to the filopodial capture of Shigella by host cells, 
yet prior to this, it requires the activation of T3SS and close contact between the pathogen 
and host cells. 
1.4.4.2 T3SS as a host sensing system 
T3SS is thought to react to the environmental stimuli, specifically, the gut 
environment, to modulate cell surface components and trigger increased adherence and 
invasion. Indeed, when switched from anaerobic environment to the epithelial barrier where 
O2 can be detected, the expression of T3SS regulators was changed in Shigella to activate 
the T3SS, allowing efficient invasion (Marteyn et al., 2010). Shigella also regulates its 
virulence in response to conditions such as temperature (Maurelli et al., 1984) and osmolarity 
(Bernardini et al., 1990). Studies comparing the difference in expression of Shigella proteins 
between intracellular and extracellular also revealed some changes in the expression and the 
secretion of T3SS effector proteins (Headley & Payne, 1990, Pieper et al., 2013). This further 
suggests that Shigella has evolved into a well host adapted pathogen that can utilize a 
sophisticated system to sense the host environment facilitating its colonization and invasion. 
1.4.4.3 T3SS activation by bile 
The natural infectious dose of Shigella in humans is as low as 10 organisms 
(Bennish, 1991), in contrast, infection of the tissue culture cells requires a large number of 
organisms and often involves spinoculation (Koestler et al., 2018b). One might speculate 
that it might be that in the gut environment, there are factors that can stimulate the bacteria 
towards their virulence activated form which is more efficient in adherence and invasion. 
One factor that Shigella would encounter in human gut is bile salt. Bile salt has been reported 
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as a signaling trigger to regulate the expression of virulence factors during the infection in 
other bacterial species including Salmonella typhimurium (Prouty & Gunn, 2000, Prouty et 
al., 2004) and Vibrio (Gupta & Chowdhury, 1997, Schuhmacher & Klose, 1999, Krukonis 
& DiRita, 2003), and was reviewed by Begley et al. (2005). In a Shigella study, a bile salt 
deoxycholate (DOC), among other related compounds, were reported to significantly 
increase the ability of Shigella adhesion and invasion of tissue culture cells (Pope et al., 
1995). DOC is a secondary bile acid which is mainly produced by microbial reactions in the 
human large intestine (Ridlon et al., 2006). This coincide with the observations that Shigella 
preferably invade colon. In addition, DOC does not directly enhance the Shigella adhesion 
and invasion, it requires bacterial growth (Pope et al., 1995). Therefore, it can be speculated 
that DOC might act as a stimulus that activates a signal transduction cascade that leads to the 
expression of virulence factors, priming for cell invasion. This may also partially explain the 
observations in the patients with shigellosis, where severity of tissue damage increases 
towards the distal colon (Speelman et al., 1984). When bacteria travel along the colon 
towards the distal end, they are continuously exposed to DOC, which would allow them to 
produce and secrete effectors such as Ipa proteins and surface localize adhesins for more 
efficient cell adhesion and invasion when they reach the rectum. 
1.4.4.4 DOC induced adhesins 
As DOC plays such an important role in activating Shigella adherence, one 
might hypothesize that adhesins might be involved in this. Indeed, it has been demonstrated 
that the T3SS is indirectly required for the DOC enhanced attachment (Faherty et al., 2012), 
and analysis of the change of global expression of Shigella proteins at the transcriptional 
level in the presence of DOC revealed two potential adhesins, OspE1 and OspE2 proteins. 
The expression of OspE1 and OspE2 was induced by DOC, and which was subsequently 
secreted by T3SS and localized on the bacterial membrane (Faherty et al., 2012) (Figure 1.5). 
Clearly, these data suggest that DOC acts on T3SS to activate an unknown signal 
transduction cascade to modulate the expression of virulence factors. 
To date, little has been known for this signal transduction process, yet the 
fact that the exposure of bacteria to DOC leads to an increased secretion of effector proteins 
into bacterial culture supernatant gives a clue. The secretion of effector proteins is through  
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Figure 1.5. Deoxycholate induced Shigella adherence. 
In the human gut, Shigella encounters bile salt DOC. i) DOC binds to the protein IpaD which 
reside on the needle tip of the T3SS. ii) This binding leads to the activation of T3SS. 
Activated T3SS then undergo iii) an unknown transduction, which leads to iv) the increased 
expression of adhesins OspE1/2, and v) their subsequent secretion via T3SS. The secreted 
OspE1/2 then vi) bind back to the surface of Shigella and function as adhesins to mediate the 
adherence of Shigella to gut epithelial cells.  
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the induction of the T3SS (Menard et al., 1994), particularly the needle-resident proteins 
IpaB and IpaD. IpaD is thought to be located at the needle tip of T3SS and prevents leakage 
and secretion of effectors through the T3SS (Roehrich et al., 2013). While the initial 
localization of IpaB is controversial, some conclude that it is absent from the needle tip and 
can be recruited upon contact between DOC and bacteria surface (Olive et al., 2007, Stensrud 
et al., 2008), whereas others claimed that IpaB is a part of needle complex residing at the 
needle tip (Veenendaal et al., 2007, Cheung et al., 2015, Murillo et al., 2016). Nevertheless, 
it has been reported that DOC can directly bind to IpaD, causing a conformational change to 
the protein that subsequently leads to the activation of T3SS (Stensrud et al., 2008, Barta et 
al., 2012). When the flexible region that is responsible for the conformational change was 
mutated, Shigella no longer had an increased adherence, presumably due to the inability to 
respond to the binding of DOC (Bernard et al., 2017), by potentially affecting the interaction 
with IpaB (Kaur et al., 2016). 
How exactly the initial contact between IpaD and DOC, and the subsequent 
altered interaction between IpaD and IpaB which then leads to an increased bacterial 
adhesion and invasion remains to be investigated. As IpaB and IpaD were thought to be 
important in regulating the activity of T3SS, by knocking out ipaB or ipaD, S. flexneri was 
found to be hyper-adherent to host cells (Menard et al., 1993). Surprisingly, under this 
simulated activation event (Brotcke-Zumsteg et al., 2014), the surface presented 
autotransporter IcsA was found to play a crucial role in the hyper-adherence phenotype, 
which uncovered a long missing Shigella adhesin. 
1.5. IcsA protein 
Intra-/inter-cellular spread protein A (IcsA) or large virulence plasmid 
encoded virulence protein G (VirG) was first found in S. flexneri, where a Tn5 insertion in 
the large virulence plasmid made the mutant avirulent, and while maintaining the ability to 
invade the host cell, it was unable to escape the initial infected cells and spread intercellularly 
(Makino et al., 1986). Mutations in icsA also lead to attenuated virulence in both animal and 
human studies (Sansonetti et al., 1991, Kotloff et al., 1996), demonstrating the indispensable 
role of IcsA in Shigella pathogenesis.  
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1.5.1 The biosynthesis of IcsA 
IcsA contains an N-terminal domain (IcsA1-52), which is responsible for its 
secretion; a passenger domain (IcsA53-740, or IcsAα), which is responsible for its biological 
function; a β-barrel domain (IcsA813-1102 or IcsAβ), which is a pore forming structure inserted 
in the outer membrane and is responsible in the translocation of the passenger; and an 
unstructured linker region (IcsA741-812) that connects the passenger with β-barrel (Figure 1.6). 
The maturation of IcsA starts with the translocation of the nascent peptides across the inner 
membrane via Sec machinery. IcsA then exists in the periplasmic compartment and this 
transit state is stabilized by periplasmic folding factors DegP, SkP and SurA (Purdy et al., 
2007). The β-barrel domain of IcsA is then thought to be assembled by a complex known as 
the β-barrel assembly machinery (BAM) complex (Hagan et al., 2011), which folds the IcsA 
β-barrel domain into the outer membrane and transports the passenger domain across the 
outer membrane. The maturated IcsA passenger protein can either remain on the surface of 
the bacteria or be cleaved off by a specific serine protease IcsP (SopA), which cleaves IcsAα 
on lateral region of the bacteria (Shere et al., 1997, Tran et al., 2013). IcsA requires other 
membrane proteins for its proper localization on outer membrane, as deletion of the 
cytoplasmic membrane protein insertase YidC abolished the proper IcsA localization (Gray 
et al., 2014). Recently, it has been found that the intracellular expression of IcsA is depend 
on the presence of formate (Koestler et al., 2018a), which is a byproduct produced by 
metabolizing host cytosolic carbon. 
1.5.2 The polar distribution of IcsA 
IcsA preferably displayed at the old pole of the bacterium (Charles et al., 
2001). Mutagenesis studies suggested a region within IcsA played an important role in this 
polar distribution (IcsA506-620) (Doyle et al., 2015a). Apart from IcsA itself, it has been 
reported that the periplasmic region of FtsQ and RpoS are also involved in the IcsA polar 
distribution (Fixen et al., 2012), yet the fundamental mechanism remains to be discovered. 
Recently, it has been found that IcsA can interact with cardiolipin, which is preferably 
located at the bacteria pole due to its biochemical characteristics (Rossi et al., 2017). 
Although it provided a model that by interacting with cardiolipin, IcsA is directed to the pole 
of the bacteria, it did not satisfactorily explain the unipolar distribution of IcsA, specifically,  
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Figure 1.6. Structure of IcsA protein. 
A) Schematic structure of IcsA protein and its primary features. IcsA protein comprises an 
N-terminal signal sequence (SS, white, IcsA1-52) for its secretion, a passenger domain (blue, 
IcsA53-740) for its function, a β-barrel domain (green, IcsA812-1102) for passenger translocation, 
and a linker region (grey, IcsA741-812) that connects passenger to barrel. The mature IcsA 
beyond the bacterial surface is cleaved by IcsP at IcsA758 (dark arrow). At the C terminus 
end of the passenger, there is a polar targeting region (PT, orange, IcsA506-736) that 
responsible for IcsA asymmetric distribution. Interacting regions (IR) of passenger to N-
WASP protein (purple, IcsA185-312, IcsA330-382, and IcsA508-730). IcsA320-433 (yellow) is 
targeted by host cell autophagy protein Atg5, and masked by IcsB. The putative 
autochaperone (pink, IcsA534-735) (May et al., 2012) and passenger-associated transport 
repeat (PATR, light blue, IcsA526-557) (Doyle et al., 2015b) were conserved structures in ATs 
and identified in IcsA passenger. The stable core (light yellow, IcsA591-740) of passenger was 
crystallised and the 3D structure is available (Kuhnel & Diezmann, 2011). B) I-TASSER 
predicted IcsA passenger structure and predicted β-barrel structure. 
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the localization on the old pole rather the septum forming pole. This polar distribution is 
further maintained by the asymmetrically distributed IcsP, which cleaves IcsA passenger off 
the bacterial surface on the septum forming pole (Tran et al., 2013). However, IcsP does not 
determine the polarity of IcsA, as knocking out IcsP did not abolish the polarity of IcsA 
completely (Tran et al., 2015).  
1.5.3 Actin based motility 
The polar distribution of IcsA results in the accumulation of F-actin at the 
pole of the bacterium, which is essential in performing actin based motility (ABM) 
(Bernardini et al., 1989). IcsA is essential and sufficient for ABM in that mutations in icsA 
mutants did not develop comet tails; E. coli expressing IcsA were able to form actin tails and 
demonstrate ABM; and inert particles coated with IcsA demonstrated ABM (Goldberg & 
Theriot, 1995). The ABM is achieved by the binding of three interacting regions (IRI, IRII 
and IRIII) on IcsA passenger to Neural Wiskott-Aldrich syndrome protein (N-WASP), which 
in turn recruits Arp2/3 complex, resulting in the polymerization of actin in the host cell 
cytosol (Suzuki & Sasakawa, 1998, Egile et al., 1999, Teh & Morona, 2013). The efficient 
spread of Shigella in the epithelial lining was reported through targeting a tricellular junction 
protein, tricellulin, and was aided by phosphoinositide 3-kinase, clathrin, Epsin-1 and 
Dynamin-2 (Fukumatsu et al., 2012, Lum & Morona, 2014a). 
Apart from IcsA itself, other molecules are also involved in the intercellular 
spread process. It has been known that Shigella have dysregulated LPS chain length will 
affect the spread of bacterial between host cell, and it was through a masking effect on IcsA 
(Morona et al., 2003). Deletion of a periplasmic protein, Apyrase or PhoN2, which is located 
at the same pole to IcsA (Scribano et al., 2014), resulted in Shigella generating smaller 
plaques in cell monolayers (Santapaola et al., 2006), while deletion of an outer membrane 
protein OmpA made Shigella unable to generating plaques (Ambrosi et al., 2012). In both 
cases, IcsA expression is not altered and can form actin comet tails, yet the distribution of 
IcsA is affected. Further research on PhoN2 failed to show interaction between the PhoN2 
and IcsA, but revealed an interaction between PhoN2 and OmpA (Scribano et al., 2014, 
Scribano et al., 2016). However, to date, it is still unknown how these proteins are implicated 
in affecting the function of IcsA.  
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1.5.4 IcsA is a target of autophagy 
While IcsA does not require the T3SS to be secreted onto the surface of the bacteria, it is 
masked by a T3SS secreted effector protein IcsB binding to an area of passenger domain 
(IcsA320-433) (Kayath et al., 2010), and this region is otherwise important in binding to an 
autophagic response system protein Atg5 (Ogawa et al., 2005), resulting in the escape of 
intracellular Shigella from autophagy. This indicates the interaction between T3SS and IcsA, 
demonstrating a potential regulation of IcsA activity by the T3SS. 
1.5.5 The autotransporters 
Sequence analysis of the mutations revealed that IcsA has the characteristics 
of an autotransporter (Lett et al., 1989). IcsA is classified as a type Va autotransporter, and 
belongs to the AIDA autotransporter family. Members of this family including some well 
characterised autotransporters AIDA-1 (Benz & Schmidt, 1992), Ag43 (Henderson & Owen, 
1999), TibA (Lindenthal & Elsinghorst, 1999), which all play important roles in bacterial 
adherence.  
Type Va autotransporters are proteins with a conserved β-barrel structure that 
inserts into the outer membrane and a passenger domain, which is secreted to the surface of 
the bacteria and determines the function of the protein (Leyton et al., 2012). Pertactin, which 
functions as an adhesin mediating the interactions of Bordetella pertussis to human 
respiratory epithelial cells, is the first autotransporter for which the structure of the passenger 
domain was solved (Emsley et al., 1996). Following which, the structure of Antigen 43 
(Ag43) (Heras et al., 2014), which is responsible for the biofilm formation of uropathogenic 
E. coli; Hbp (Otto et al., 2005), which is a heme binding protein from pathogenic E. coli; Pet 
(Domingo Meza-Aguilar et al., 2014), which is a cytoskeleton-altering toxin from 
pathogenic E. coli; TibA (Lu et al., 2014), which mediates the adherence of enterotoxigenic 
E. coli to a variety of human cells; VacA (Gangwer et al., 2007), which is a toxin from 
Helicobacter pylori; IgA1 protease (Johnson et al., 2009), which is a protease from 
Haemophilus influenzae and is responsible for the degradation of immunoglobulin A1; and 
Hap (Meng et al., 2011), which is an adhesin from Haemophilus influenzae; were all solved. 
Although the passenger domains of these proteins are different in their sequences and 
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functions, they adapt similar structures, which is characterized as extended triangular β-
helices formed by multiple β-sheets. While the full-length structure of IcsA passenger 
domain remains to be solved, structures of several regions have been solved (IcsA591-740 and 
IcsA419-758). Similar to the above autotransporters, IcsA passenger domain also folds into a 
prism-like 3D structure (Figure 1.7) (Kuhnel & Diezmann, 2011, Leupold et al., 2017). The 
overall architecture of the protein adapts an L shape (Mauricio et al., 2017), similar to the 
structure of Ag43 (Heras et al., 2014), which was reported to have a self-association ability. 
IcsA has also been found to have self-association ability (May et al., 2012), although the 
exact outcomes of this self-association has not yet been fully elucidated. 
1.5.6 IcsA is recognized as an adhesin 
Despite IcsA being known to be important in both ABM and inducing host 
autophagy process in the absence of IcsB, it has been found to act as an adhesin. Brotcke-
Zumsteg et al. (2014) reported that S. flexneri lacking IpaB and IpaD hyper-adhere to the 
host cells via their pole, indicating a potential role of IcsA in this process, since IcsA has a 
polar localisation. Indeed, deleting IcsA in these mutant stains abolished polar adhesion and 
reduced adherence to host cells. This decreased adhesion was also observed by Mahmoud et 
al. (2016) using an icsA knockout Shigella sonnei. IcsA is also involved in the human enteric 
α-defensin 5 enhanced Shigella adherence and invasion (Xu et al., 2018). Moreover, IcsA 
was able to promote adhesion of an E. coli B strain, and the protease cleavage pattern of IcsA 
in adhesive and non-adhesive strains was different (Brotcke-Zumsteg et al., 2014). Random 
insertions (May & Morona, 2008) (5 aa) on two sites (i148 and i386) of IcsA passenger 
abolished the hyper-adherence phenotype in S. flexneri ΔipaB and S. flexneri ΔipaD. Hence 
these studies suggested that IcsA functions as an adhesin in a certain conformation, and 
several amino acids or regions might act in adherence in a cooperative manner. Using a 
limited proteolysis assay, IcsA was found to have different conformations in the hyper-
adherent strains compared to the wild type Shigella, and this conformational change seems 
to be related to the increased adherence, since it can be observed when expressing IcsA in E. 
coli. This implies that in Shigella, IcsA adherence activity is tightly regulated by a factor, 
since Shigella lacking the T3SS components do not have an IcsA-dependent hyper-adherence, 
while in E. coli, IcsA can promote adherence by itself. In addition, the bile salt sodium  
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Figure 1.7. Autotransporters with solved structures 
Ribbon representation of solved autotransporter structures including Pertactin (B. pertussis, 
1DAB), Ag43 (E. coli, 4KH3), Hap (H. influenzae, 3SYJ), VacA (H. pylori, 2QV3), Pet (E. 
coli, 4OM9), TibA (E. coli, 4Q1Q), Hbp (E. coli, 1WXR), IgA1 (H. influenzae, 3H09), 
partial IcsA passenger domain IcsA419-758 (Shigella, 5KE1). All the structures were acquired 
from the protein database (PDB) with their file number shown in the bracket. 
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deoxycholate (DOC) was also found to induce a hyper-adherence phenotype in S. flexneri in 
both an IcsA- and T3SS-dependent manner (Brotcke-Zumsteg et al., 2014). Though the exact 
mechanism of DOC, IpaB and IpaD deficiency induced hyper-adherence in S. flexneri is 
unknown, IcsA was found essential and sufficient to promote the adhesion to host cells. 
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1.6. Research Plan  
As described above, understanding how Shigella initially attaches to host 
cells which leads to subsequent colonization and invasion is a key step in understanding 
Shigella pathogenesis. Therefore, investigating the mechanism of IcsA-dependent adhesion 
(Brotcke-Zumsteg et al., 2014) will expand our knowledge of shigellosis, and contribute to 
therapeutic intervention and strategies. 
This leads to the question as to what parts of IcsA are functioning in adhesion 
to host cells, what host cell type of IcsA is targeting, and what is the cellular receptor(s) of 
IcsA. Moreover, as IcsA completely conserved in all Shigella species, and immunogenic in 
Shigella infected patients (Oaks et al., 1986), it is therefore important to investigate its 
adhesion function as this will contribute to understanding early steps in pathogenesis of the 
whole genus. 
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1.7. Aims/Objectives of the project 
1.7.1 Aim 1: To investigate the regions in IcsA involved in the adherence 
⚫ To construct the hyper-adherent stains S. flexneri 2a ΔipaD and S. flexneri 2a 
ΔipaDΔicsA, and to examine their ability in adherence 
⚫ To demonstrate the interactions between IcsA and host cell surface 
⚫ To screen the regions which are essential for IcsA adherence with an IcsA insertion 
mutant library 
⚫ To purify IcsA passenger in a stable and soluble form 
⚫ To investigate the molecular basis of IcsA adherence regions 
1.7.2 Aim 2: To investigate the conformations of IcsA involved in the 
adherence 
⚫ To purify IcsA passenger in a native form 
⚫ To investigate the role of the IcsA adhesin region in the adhesin associated conformation 
1.7.3 Aim 3: To identify the cellular targets and receptors for IcsA. 
⚫ To identify the receptors for IcsA on HeLa cells 
⚫ To validate the interactions between the putative receptor(s) and IcsA passenger protein 
1.7.4 Aim 4: To characterise IcsA in the hyper-adherence phenotype induced 
by DOC 
⚫ To investigate how IpaD and IcsA was affected in the DOC treated S. flexneri  
⚫ To investigate the conformations of IcsA in the DOC induced hyper-adherent S. flexneri 
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Chapter 2: Methods and Materials 
2.1. Bacterial strains and plasmids maintenance 
2.1.1 Bacteria strains 
Bacteria strains involved in this work are listed in Appendix A: Bacterial 
strains, and all the strains were stored at -80 °C in storage media (Section 2.1.3.3). Whenever 
required, bacteria were streaked out on a solid medium plate with appropriate selection 
additives. 
2.1.2 Plasmids 
Plasmids used in this work were listed in Appendix B: Plasmids. Unless 
specified, all the plasmids were maintained in E. coli DH5α. 
2.1.3 Bacterial growth media 
2.1.3.1 Solidified growth media 
Strains were grown on Tryptic Soy (TS) agar [15 g/L agar (Becton, 
Dickinson and Co.; BD), 30 g/L TSB soybean-casein digest (BD)], or on Lysogeny broth 
(LB) (Bertani, 2004) agar [10 g/L tryptone (BD), 5 g/L yeast extract (BD), 5 g/L NaCl, 15 
g/L agar]. 
2.1.3.2 Liquid growth media 
Strains were streaked out on solidified media and a single colony was picked 
to inoculate an LB broth [10 g/L tryptone (BD), 5 g/L yeast extract (BD), 5 g/L NaCl]. 
Bacterial growth phase was measured by optical absorbance at 600 nm (OD600), where the 
reading of 0.4-0.8 was considered as bacteria growing at mid- exponential phase.  
2.1.3.3 Storage media 
Strains grown on solidified media were recovered and resuspended in 1 mL 
storage media [10 g/L peptone (BD), 30% (v/v) glycerol] and immediately stored at -80 °C. 
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2.2. Mammalian cell lines and culture conditions 
2.2.1 Mammalian cell lines 
Cell lines used in this thesis were HeLa cells (human cervical epithelial 
adenocarcinoma cells, ATCC CRM-CCL-2), and COS-7 cells (grivet kidney fibroblast cells, 
ATCC CRL-1651).  
2.2.2 Cell line culture conditions and maintenance 
All cells were maintained in the medium recommended by the manufacture; 
(Eagle's Minimum Essential Medium (MEM) for HeLa cells, Dulbecco's modified Eagle's 
medium (DMEM) for COS-7 cells and supplemented with 5% (v/v) fetal calf serum (FCS), 
4 mM glutamine, 100 U/mL penicillin and 100 U/mL streptomycin. All the cells were 
cultured at 37 °C with 5% carbon dioxide (CO2). 
When growing in 75 cm2 culture flask and reaching over 80% confluence, 
cells were washed with phosphate-buffered saline (PBS) to remove all traces of serum that 
contains trypsin inhibitor and then dispersed by adding 2 to 3 mL of 0.25% (w/v) Trypsin-
0.53 mM ethylenediaminetetraacetic acid (EDTA) solution and incubating at 37 °C for 10 
min. Trypsinised cells were then resuspended in culture medium and subcultured into 75 cm2 
culture flask with appropriate subculture ratio (1:10 for both HeLa and COS-7 cells). 
2.2.3 Cell line storage 
Cells were stored in corresponding medium supplemented with 5% (v/v) 
dimethyl sulfoxide (DMSO) at -80 °C or in liquid nitrogen. 
2.3. Antibodies and antibiotics 
2.3.1 Antibodies and antisera 
Antibodies used in this thesis were rabbit anti-IcsA polyclonal antibodies 
(pAbs), in-house made, (Van Den Bosch et al., 1997), mouse anti-His6 monoclonal antibody 
(mAb, Genscript), mouse anti-DYKDDDDK (anti-FLAG) mAb (Genscript), rabbit anti-
Myosin IIA pAbs (Sigma), rabbit anti-Myosin IIB pAbs (Sigma), mouse anti-IpaD pAbs 
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(gifted by Prof. Nikolai Petrovsky, Flinders University). For Western immunoblotting, horse 
radish peroxidase (HRP) conjugated goat anti-rabbit or goat anti-mouse secondary antibodies 
(KPL) were used. For immunofluorescence microscopy, donkey anti-mouse AlexaFluor 488 
or donkey anti-rabbit AlexaFluor 488 secondary antibodies (Life Technologies) were used. 
2.3.2 Antibiotics and additives 
For selection and plasmid maintenance, antibiotics were added to bacterial 
growth medium as appropriate: ampicillin at 100 µg/mL, kanamycin at 50 µg/mL, 
tetracycline at 10 µg/mL, chloramphenicol at 25 µg/mL, gentamycin at 40 µg/mL, and 
spectinomycin at 100 µg/mL. For screening virulence plasmid carrying Shigella strains, 
Congo red (Sigma) dye was supplemented to TS agar at the concentration of 0.01% (w/v). 
Shigella strains harboring virulence plasmid will develop red colonies at 37 °C as the result 
of binding of Congo red dye to the hydrophobic virulence factors encoded by the virulence 
plasmid. For blue-white colony screening with strains harboring pGEM-T Easy (Promega) 
plasmid, LB agar were supplemented with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and 20 µg/mL 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal). When 
expressing protein controlled by a PBAD promoter, glucose at 0.2% (w/v) was added to 
suppress expression and L-arabinose at 0.2% (v/w) was added to induce expression. 
2.4. DNA technique 
2.4.1 DNA preparation 
2.4.1.1 Chromosomal DNA extraction 
For bacterial chromosomal DNA extraction, bacteria were cultured in 10 mL 
LB broth for 16 h, harvested by centrifugation (4500×g, 7 min) and resuspended in 3 mL 
0.85% (w/v) saline by vortexing. Proteins were removed by mixing with 3 mL Tris-
equilibrated phenol (pH 7.5) followed by centrifugation (4500×g, 7 min). The aqueous layer 
containing DNA was then collected and DNA was precipitated by adding 3 mL of cold 100% 
isopropanol and incubated at -20 °C. The precipitated DNA was then collected and washed 
with 70% (v/v) ethanol and dissolved in Milli-Q (MQ) water, and stored at -20 °C. 
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2.4.1.2 Plasmid Isolation 
Plasmid DNA was isolated from bacterial cultures (LB, 10 mL) grown for 
16 h using QIAprep Spin Miniprep kit (Qiagen) as per manufacture’s protocol. All plasmids 
were eluted in MQ water and stored at -20 °C. 
2.4.1.3 Crude bacterial DNA preparation 
When used for colony PCR screening purposes, bacterial DNA sample were 
prepared by resuspending single colonies of bacteria in 100 µL of MQ water and heated at 
100 °C for 5 min. Crude bacterial DNA preparation were then obtained by centrifugation 
(16,250×g, 1 min). 
2.4.1.4 DNA fragment purification 
For DNA fragments amplified by polymerase chain reaction (PCR) or 
generated by restriction endonuclease enzyme digestion, purification was performed by 
using the GFX PCR DNA and Gel Band Purification Kit (GE Healthcare) as per 
manufacture’s protocol. All DNA was eluted in MQ water and stored at -20 °C. 
For DNA fragments amplified by PCR and used for in vivo genetic 
engineering, PCR products were precipitated by adding NaCl to a final concentration of 0.5 
M and ethanol to a final concentration of 75% (v/v), followed by an incubation on ice for 20 
min. The DNA fragments were then recovered by centrifugation (16,100 ×g), washed with 
75% (v/v) ethanol, and air dried at room temperature. The fragments were then solubilised 
in 50 µL of MQ water and kept on ice before use. 
2.4.1.5 Oligonucleotides 
All oligonucleotides [Appendix C: Oligonucleotides] were ordered from 
Integrated DNA Technologies (IDT), resuspended in MQ water at the concentration of 100 
µM for storage at -20 °C, and further diluted in MQ to 10 µM before use in PCR at 0.5-2 
µM. 
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2.4.1.6 DNA quantitation 
DNA was quantified using a NanoDrop 2000c Spectrophotometer (Thermo 
Scientific) by measuring the absorption at 260 nm. A ratio of the absorbance at 260 nm to 
the absorbance at 280 nm (A260/280) around 1.8 was considered as a pure DNA preparation. 
2.4.1.7 DNA sequencing 
Sample was prepared by adding oligonucleotides at the final concentration 
of 0.8 µM to 600-1500 ng of purified DNA template to a total volume of 12 µL. The samples 
were sequenced by the Australia Genome Research Facility (AGRF) sequencing service. 
2.4.2 DNA manipulation 
2.4.2.1 Restriction endonuclease digestion 
DNA was digested using appropriate restriction endonucleases purchased 
from New England Biolabs (NEB) and used per manufacture’s protocol with supplied buffer. 
Following digestion, enzymes were heat inactivated where possible or otherwise removed 
by using the GFX PCR DNA and Gel Band Purification Kit (GE Healthcare). 
2.4.2.2 DNA phosphorylation 
To prepare the PCR amplified DNA for ligation, DNA fragments were 5’ 
phosphorylated using T4 polynucleotide kinase (PNK, NEB), according to manufacturer’s 
protocol.  
2.4.2.3 DNA ligation 
Ligation of linear DNA fragments was performed using T4 DNA ligase 
(NEB) according to supplier’s protocol. Samples were incubated at 16 °C for 2 h or at 4 °C 
overnight to maximise the yield of product. 
For ligating fragments into pGEMT-Easy, fragments were polyadenylated 
according to manufactures’ protocol (Promega), and ligated into pGEMT-Easy as above. 
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2.4.2.4 Polymerase chain reaction (PCR) 
PCR reactions were prepared according to supplier’s protocol (NEB). 
Deoxynucleic triphosphates (dNTPs) were purchased from Sigma. All the reactions were 
conducted in an Eppendorf Mastercycler Gradient thermocycler. The reaction conditions 
were as per supplier’s (NEB) recommendations. Primer annealing temperature was 
calculated using the Tm Calculator tool supplied by NEB (https://tmcalculator.neb.com), 
where primer’s Tm exceeding 72 °C, the annealing step was skipped, and two-step PCR 
reaction were performed instead. 
For screening purposes, Taq polymerase (NEB) was used to amplify DNA 
fragments with appropriate oligonucleotides. For cloning purposes, Q5 high fidelity 
polymerase (NEB) was used instead. 
2.4.2.5 Electrophoretic separation of DNA and visualization 
For DNA size analysis and fragments separation, DNA sample was mixed 
with DNA loading dye [1 mg/mL bromophenol blue, 20% (v/v) glycerol, 0.1 mg/mL RNase] 
at the ratio of 1:9. Samples were separated with 1, 1.5 or 2% (w/v) agarose TBE [70 mM 
Tris, 20 mM boric acid, 1 mM EDTA] gel containing RedSafe nucleic staining solution 
(iNtRON Biotechnology) at 20,000× dilution. Size marker used were SPP1 phage DNA 
digested by EcoRI and made in house (sizes (kb): 8.51, 7.35, 6.11, 4.84, 3.59, 2.81, 1.95, 
1.86, 1.51, 1.39, 1.16, 0.98, 0.72, 0.48, 0.36, and 0.09). Gels were electrophoresed at 120V 
for 30 min and visualised using a GelDoc XR system (Biorad). 
2.4.3 Inverse PCR deletion, addition and substitution 
For in-frame deletion of protein coding regions within plasmids, 
oligonucleotide primers were designed to target the adjacent sequences of the region to be 
deleted in opposite direction. The entire plasmid was PCR amplified (Section 2.4.2.4), 
phosphorylated (Section 2.4.2.2) and ligated (Section 2.4.2.3). 
For in-frame addition or substitution, primers were designed to target the 
adjacent sequences of the desired region in opposite direction, and the sequences encoding 
the addition or substitution were incorporated at the 5’ end of each primer. The entire plasmid 
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was PCR amplified (Section 2.4.2.4), phosphorylated (Section 2.4.2.2) and ligated (Section 
2.4.2.3). 
2.4.4 PCR coupled with Restriction enzyme cloning 
For generating expression constructs, the protein coding sequence was PCR 
amplified (Section 2.4.2.4) using oligonucleotides flanked with appropriate restriction 
enzyme recognition sequences and 5 random nucleotides overhang at 5’ end for efficient 
binding of restriction endonuclease enzymes. Amplicons were then digested with appropriate 
restriction endonuclease enzymes (Section 2.4.2.1) and ligated (Section 2.4.2.3) to the Multi-
cloning site (MCS) of the plasmid vector digested with the same enzymes. 
2.4.5 Overlap extension PCR 
For in-frame addition of affinity tags, a pair of hybrid oligonucleotide 
primers were designed containing complementary sequence to both the desired insert and the 
adjacent sequences to the target site. These primers were used to PCR amplify (Section 
2.4.2.4) fragments containing full insert flanked with over 50 base pairs (bp) sequences 
homologous to the adjacent region of the targeted site. The fragment was then used as a 
mega-primer to perform a secondary PCR (Section 2.4.2.4) with the target plasmid to 
generate a nicked hybrid vector. The parental plasmid was eliminated by DpnI treatment 
(Section 2.4.2.1), leaving the final construct ready for transformation. 
2.4.6 Site-directed mutagenesis with degenerated primers 
Random single amino acid substitutions were performed using the 
QuickChange Lighting Site-directed Mutagenesis kit (Aglient Technologies) according to 
manufacturer’s protocol. Primers were designed using the primer design tool supplied by the 
manufacturer (https://www.genomics.agilent.com/primerDesignProgram.jsp). 
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2.5. Gene cloning 
2.5.1 Bacterial competent cells preparation 
2.5.1.1 Chemical competent cells  
Bacterial cells from 16 h incubation at 37 °C with aeration were diluted 1 in 
20 in 10 mL broth and incubated at 37 °C to an OD600 of 0.5. Bacterial cells were then 
collected by centrifugation (4,500 ×g, 4 °C, 7 min) and sequentially washed by precooled 
0.1 M MgCl2, 0.1 M CaCl2. Bacterial cells were then resuspended in 0.1 M CaCl2 solution 
containing 15% (v/v) glycerol, and stored at -80 °C. 
2.5.1.2 Super competent Shigella bacterial cells 
For smooth Shigella strains and strains used for recovering constructs that 
were of low yield, and to ensure a high transformation efficiency, bacterial strains were 
prepared differently (Inoue et al., 1990). Briefly, bacteria were grown overnight at 37 °C for 
approximately 8 h to reach stationary growth phase, and then were diluted in 250 mL of SOB 
medium [20 g/L tryptone [BD], 5 g/L yeast extract [BD] and 0.5 g/L NaCl, 2.5 mM KCl, 10 
mM MgCl2, pH 7.0] in different ratios; 1:10, 1:20 and 1:50. Cultures were then incubated at 
18 °C for 16 h with vigorous shaking (250-300 rpm). The bacterial culture that has the OD600 
reading closest to but under 0.55 were then continued to grow to OD600 reading of 0.55. 
Bacterial cells were then collected by centrifugation (4,500 ×g, 4 °C, 10 min), and washed 
with 80 mL of precooled transformation buffer [55 mM MnCl2, 15 mM CaCl2, 250 mM KCl, 
10 mM PIPES, pH 6.7], followed by centrifugation as above. The bacterial pellet was then 
resuspended in 20 mL of ice cold transformation buffer, and 1.5 mL of DMSO was added 
and 100 µL aliquots were stored at -80 °C. 
2.5.1.3 Electrocompetent cells 
Bacterial cell culture (10 mL) grown to an OD600 of 0.5 after subcultured 
from an 16 h culture were collected by centrifugation (4,500 ×g, 4 °C, 7 min), washed twice 
with 10 mL ice cold MQ water, and resuspended in 200 µL of 10% (v/v) glycerol, and stored 
at -80 °C. 
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2.5.2 Transformation 
2.5.2.1 Heat shock 
Chemical competent cells (100 µL) thawed on ice were mixed with 2-10 µL 
of purified DNA and left on ice for 20 min. Bacterial cells were then heat shocked at 37 °C 
for 3 min or 42 °C for 90 s, and immediately return on ice for another 5 min. The mixture 
was then supplemented with 900 µL of SOC medium [SOB with 20 mM glucose] and 
incubated at 37 °C (or 30 °C if harboring a temperature sensitive plasmid) for 30-90 min 
before spreading on LB agar selection plates. Plates were then incubated at appropriate 
temperature for 16 h to recover transformants. 
2.5.2.2 Electroporation 
Electrocompetent bacterial cells (100 µL) thawed on ice were mixed with 2-
10 µL of purified DNA in a sterile electroporation cuvette (0.2 cm gap, BioRad) and 
incubated on ice for 5 min. Bacterial cells were then electroporated (BioRad Gene Pulser, 
2.5 kV, 25 µF, Capacitance extender 960 µF, Pulse Controller 200 Ω) and supplemented with 
900 µL SOC medium. The mixture was incubated at 37 °C (or 30 °C if harboring a 
temperature sensitive plasmid for 30-90 min) before spreading on LB agar selection plates. 
Plates were then incubated at the appropriate temperature for 16 h to recover transformants. 
2.6. In vivo genetic engineering 
Bacterial in vivo genetic engineering was performed using the λ Red 
mutagenesis as described by (Datsenko & Wanner, 2000). Briefly, primers were designed to 
PCR amplify the frt-kan-frt cassette from pKD13 or pKD4 plasmid with 50 bp nucleotides 
homologous to the adjacent region of the target gene. Ten PCR reactions were combined and 
the amplicons were purified and eluted to a total volume of 50 µL (Section 2.4.1.4). The 
parental plasmid was eliminated by DpnI digestion (Section 2.4.2.1). Strains to be mutated 
harbouring a plasmid pKD46 were grown at 30 °C in the presence of 0.2% (v/v) arabinose 
and made electrocompetent. The purified PCR amplicon was then electroporated into 100 
µL of the competent cells. The transformants that grew at 37 °C were then patched onto LB 
agar containing ampicillin and appropriate antibiotics, respectively, to confirm the loss of 
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pKD46 and the incorporation of the resistance cassette. The successful replacement of target 
gene with the resistance gene cassette was then confirmed by PCR.  In order to avoid any 
polar effect, a plasmid, pCP20, carrying yeast FLP recombinase recognising frt sequences 
was then electroporated in the mutant. Transformants were recovered by using LB agar 
containing ampicillin and grown at 30 °C. Colonies were picked and inoculated in 10 mL 
LB broth grown at 30 °C for 16 h and incubated at 42 °C for another 3 h. Cultures were 
diluted and spread on an LB agar plate and incubated at 37 °C for 16 h. The loss of pCP20 
and the resistance gene cassette was then confirmed by patching colonies onto LB agar with 
or without chloramphenicol antibiotics. Mutants were confirmed by PCR (Section 2.4.2.4) 
with the appropriate primers and DNA sequencing (Section 2.4.1.7). 
2.7. Protein techniques 
2.7.1 Bacterial whole cell sample preparation 
Bacterial whole cell lysates were prepared by collecting 5×108 cells grown 
at mid-exponential phase (OD600 of 0.4-0.8) by centrifugation (16,250 ×g, 1 min). The pellet 
was then resuspended in 100 µL of 2× SDS-PAGE buffer [80 mM Tris, 2% (w/v) SDS, 10% 
(v/v) glycerol, 0.0006% (w/v) bromophenol blue, 0.1 M DTT] (Lugtenberg et al., 1975) and 
heated at 100 °C for 5-10 min. 
2.7.2 TCA precipitation of secreted protein samples 
When analysing protein secreted by bacterial strains, bacteria were grown for 
18 h in 10 mL LB broth, and the culture supernatant was recovered by centrifugation (16,250 
×g, 5 min, 4 °C), followed by filtration through a membrane (0.45 µm pore size) to exclude 
bacterial cells. The filtered culture supernatant was then cooled on ice and protein was 
precipitated by adding 10% (v/v) Trichloroacetic acid (TCA) and incubation on ice for 20 
min. Protein was then collected by centrifugation (16,250 ×g, 5 min, 4 °C), washed twice by 
500 µL of ice cold acetone and centrifuged as above. The protein pellet was then air dried 
and resuspended in 2× SDS-PAGE buffer and heated at 100 °C for 5-10 min. 
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For protein filaments secreted by S. flexneri ΔipaD, filaments were washed 
three times with 1 mL of PBS and dissolved in 500 µL of 2× SDS-PAGE buffer and heated 
at 100 °C for 5-10 min. 
2.7.3 IcsA protein purification 
2.7.3.1 IcsA protein purification from inclusion bodies (IB) 
For IcsA passenger purification from IB, an 18 h cultured E. coli TOP10 
[pMDBAD::his12×-IcsA
53-740] was inoculated 1 in 1000 into  8 L of auto-induction Terrific 
Broth medium [22 g/L Bacto Tryptone (BD), 11 g/L Bacto yeast extract (BD), 2.94 g/L 
NH4Cl, 2.2 mM MgSO4, 5.5% (v/v) glycerol, 1.157 g/L KH2PO4, 6.27 g/L K2HPO4] 
containing a mixture of glucose and arabinose in the ratio of 0.1%:0.3% (w/v) and incubated 
at 37 °C 18 h with aeration (200 rpm). Bacterial cells were harvested by centrifugation 
(10,000 ×g, 10 min) and lysed by cell disruptor (30 kpsi, Constant Cell Disruption System, 
Constant System Ltd) in 250 mL of TN buffer [50 mM Tris pH 7.0, 150 mM NaCl] 
containing four EDTA-free protease inhibitor tablets (Roche). The IBs were recovered by 
centrifugation of the cell lysate (20,000 ×g, 10 min), and pre-cleaned by 120 mL of detergent 
wash buffer [50 mM Tris, 1M NaCl, 2% (v/v) Triton X-100, 4 mM DDM and 2% (w/v) DOC, 
pH 8.0] to exclude membranes fractions. IcsA passenger protein from IB was then washed 
twice with 120 mL of TN buffer, and solubilised in 50 mL of protein solubilisation buffer [8 
M urea, 50 mM NaCl, 50 mM Tris, 10 mM imidazole, pH 8.0], followed by centrifugation 
(185,000 ×g, 1 h). Solubilised IcsA passenger protein was loaded on a 5 mL His-trap column 
(GE healthcare, #17524801), washed and eluted by increasing concentration (10 mM to 500 
mM in 45 mL) of imidazole by using an ÄKTAprime plus (GE healthcare). 
2.7.3.2 Supernatant secreted IcsA protein purification 
For secreted IcsA passenger purification, an 18 h cultured E. coli C43(DE3) 
[pCDF-Duet::IcsA54::FLAG×3-IcsP] (JQRM115) was subcultured 1 in 20 into 6 L of LB broth 
supplemented with 1 mM IPTG, and incubated at 30 °C for 16 h. The bacterial culture was 
then collected by centrifugation (10,000 ×g, 10 min, 4 °C) and filtered by a Nalgene Rapid-
Flow Filter (0.2 µm asymmetric Polyethersulfone (aPES) membrane, Thermo Fisher 
Scientific). Proteins in the filtered culture supernatant were then concentrated and exchanged 
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into 50 mL of TBS buffer [50 mM Tris, 150 mM NaCl, pH 7.5] using a Vivaflow 200 (30,000 
MWCO PES membrane, Sartorius). Concentrated protein was then loaded onto a TBS pre-
equilibrated polypropylene column (Thermo Scientific) prepacked with 2 mL of anti-
DYKDDDDK G1 affinity resin (GenScript, #L00432). The column was washed by TBS 
three times, and protein was then eluted in 10 mL of acidic elution buffer [0.1 M glycine, pH 
3.0]. The pH of eluates was then adjusted to 7.0 by Tris buffer (1 M Tris, pH 9.0). Protein 
was then concentrated into 1 mL by Vivaspin 6 column (10 kDa MWCO, GE healthcare, 
#14VS0608) via centrifugation (4,000×g, 10 min, 4 °C). 
2.7.4 Protein purification by size exclusion chromatography (SEC) 
Proteins purified by affinity purification were further cleaned by SEC on a 
SuperdexTM 200 increase column 10/300 GL (GE Healthcare, #28990944) using an ÄTKA 
pure system (GE Healthcare). Elution fractions were concentrated using Vivaspin 6 (10 kDa 
molecular weight cut off, MWCO, GE Healthcare). Gel filtration markers Kit (29 kDa, 66 
kDa, 150 kDa, 200 kDa, 443 kDa, 669 kDa and 2000 kDa; Sigma, #SLBN3608V) were used 
to calculate the apparent molecular size of purified proteins. 
2.7.5 Protein dialysis 
Protein was loaded and sealed in a buffer pre-equilibrated dialysis tube 
(CelluSep T4, MWCO 12-14 kDa, CelluSep, #1430-25) and incubated in 4 L of desired 
dialysis buffer for at least 18 h with stirring (150 rpm) at room temperature or 4 °C.  
2.7.6 Affinity purification of anti-IcsA pAbs 
Rabbit anti-IcsA pAbs were purified from antisera acquired as described in 
Van Den Bosch et al. (1997). Briefly, purified IcsA proteins were separated by a self-cast 
SDS-PAGE gel and transferred onto a nitrocellulose membrane (BioRad, #1620112). 
Membrane that contains IcsA protein was then excised and blocked with 10 mL of 5% (w/v) 
skim milk in PBS for 20 min. Membrane was then washed with 10 mL of PBS and incubated 
with 10 mL of 10% (v/v) rabbit antisera in PBS for 4 h. Non-specifically bound antibodies 
were then washed off by 10 mL of PBS. Anti-IcsA pAbs were then eluted from the membrane 
using 700 µL 0.2 M glycine pH 2.0. The eluate was then dialysed against PBS (Section 2.7.5) 
for 18 h at 4 °C and 700 µL 100% glycerol were added and stored at -20 °C. 
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2.7.7 Protein quantification 
Protein preparations were quantified by performing a protein assay using 
bicinchoninic acid as per manufacture’s protocol (Pierce BCA protein assay kit, Thermo 
Scientific). Optical absorption was taken by a microplate Spectrophotometer (PowerWave 
XS2, BioTek). 
For quantitation of pure protein at high concentration (>200 µg/mL), protein 
sample was quantified using a NanoDrop 1000 Spectrophotometer (ThermoFisher 
Scientific). Protein concentration was then calculated using a protein concentration 
calculator tool (AAT Bioquest®, https://www.aatbio.com/tools/calculate-protein-
concentration) based on the absorbance reading at 280 nm and the calculated protein 
extinction coefficient. 
2.7.8 Chemical crosslinking 
2.7.8.1 In vivo chemical crosslinking of IcsA 
In vivo chemical crosslinking of IcsA was done as described by May et al. 
(2012). Briefly, Shigella grown to mid-exponential phase (OD600 of 0.4-0.6) were collected 
(1109 cells), washed with PBS three times and resuspended in 1 mL crosslinking buffer [0.2 
mM DSP (Sigma, #D3669) in PBS, pH 7.0] and incubated at room temperature for 1 h. The 
reaction was quenched by 20 mM Tris pH 7.0 and incubated for another 15 min. Bacteria 
were then harvested via centrifugation (16,000 g, 1 min) and resuspended in 1 mL 
sonication buffer [PBS, 1 mM PMSF] and sonicated (Sonifier 450, Branson) on ice at the 
output power 4 for four 40% cycles with the microtip. The sonicate was centrifuged (4,000×g, 
10 min, 4°C) to exclude unbroken cells. The isolated sonicate was then ultracentrifuged 
(108,000 ×g, 30 min, 4°C, Beckman OptimaTM MAX-XP Ultracentrifuge) and the resulting 
pellet was resuspended in 2 PAGE buffer [4% (w/v) SDS, 20% (v/v) glycerol, 0.01% (w/v) 
bromophenol blue and 100 mM Tris HCl]. Alternatively, SDS-PAGE samples were reduced 
by adding 10 mM DTT. 
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2.7.8.2 Chemical crosslinking of purified IcsA 
 Purified IcsA passenger protein (0.38 mg/mL) was dialysed against PBS 
(Section 2.7.5) for 18 h at 4°C. DSP (50 mM) was then added to the dialysed protein to a 
final concentration of 0.1 mM, 1 mM and 10 mM respectively and incubated for 30 min at 
room temperature. Protein samples were then resuspended in 2 PAGE buffer. 
2.7.9 Protein electrophoresis 
2.7.9.1 SDS-polyacrylamide gel electrophoresis (PAGE) 
For protein separation by molecular weight, protein containing sample 
resuspended in an equal volume of 2 SDS-PAGE sample buffer [4% (w/v) SDS, 20% (v/v) 
glycerol, 200 mM DTT, 0.01% (w/v) bromophenol blue and 100 mM Tris HCl] was heated 
at 100 °C for 5-10 min and loaded on self-cast SDS-PAGE gel [375 mM Tris pH 8.5, 0.1% 
(w/v) SDS, 0.05% (w/v) ammonium persulfate (APS) 0.05% (v/v) 
Tetramethylethylenediamine (TEMED, Sigma), 7.5-20% acrylamide/bis (BioRad)] using 
Mini-Protean system III (BioRad). For high resolution separation, protein sample was loaded 
on a pre-cast 4-12% gradient SDS-PAGE (Thermo Scientific) or an AnykDa gel (BioRad, 
#4569033). Running buffer consist of 25 mM Tris pH 8.3, 200 mM glycine, and 0.1% (w/v) 
SDS. Gels were electrophoresed at 100-200 V for 1 h. Seeblue Plus2 molecular marker (198 
kDa, 98 kDa, 62 kDa, 49 kDa, 38 kDa, 28 kDa, 17 kDa, 14 kDa, 6 kDa and 3 kDa; Invitrogen, 
#LC5925), Novex Sharp pre-stained protein standard marker (260 kDa, 160 kDa, 110 kDa, 
80 kDa, 60 kDa, 50 kDa, 40 kDa, 30 kDa, 20 kDa, 15 kDa, 10 kDa and 3.5 kDa; Invitrogen, 
#LC5800), or BenchMarkTM pre-strained protein ladder marker (190 kDa, 120 kDa, 85 kDa, 
60 kDa, 50 kDa, 40 kDa, 25 kDa, 20 kDa, 15 kDa, and 10 kDa; Invitrogen, #10748010) were 
used to determine the molecular size of proteins. 
2.7.9.2 Native-PAGE 
 For analysing the oligomeric states of the purified IcsA proteins, proteins 
were resuspended in Native sample buffer 2× [62.5 mM Tris-HCl pH 6.8, 25% (v/v) glycerol, 
1% (w/v) bromophenol blue] at the ratio of 1:1, and directly loaded onto a self-cast Native 
gel [315 mM Tris-HCl pH 8.5, 0.1% (w/v) APS, 6-15% acrylamide/bis] without prior heating. 
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Running buffer consist of 25 mM Tris-HCl pH 8.5, and 192 mM glycine. Gels were 
electrophoresed at 200 V for 0.5-1 h at 4 °C. NativeMark Unstained (1236 kDa, 1048 kDa, 
720 kDa, 480 kDa, 242 kDa, 146 kDa, 66 kDa and 20 kDa; Invitrogen, #LC0725) was used 
to estimate the molecular size of proteins. 
2.7.10 Protein visualisation by staining 
2.7.10.1 Coomassie Blue staining 
Proteins separated by electrophoresis were stained with Coomassie blue 
staining solution [0.01% (w/v) Coomassie blue G250 (Sigma), 10% (v/v) acetic acid, 50% 
(v/v) methanol] at room temperature with shaking overnight. Gels were destained with 
repeated washes of destain solution [10% (v/v) acetic acid, 50% (v/v) methanol].  Images 
was acquired by an electronic scanner (HP). 
2.7.10.2 Colloidal Blue Staining 
For proteins that were either at low concentration or for the proteins 
recovered by immunoprecipitation for mass spectrometry analysis, gels were stained with 
Colloidal Blue Staining Kit (ThermoFisher Scientific) as per manufacture’s protocol. 
2.7.11 Western Immunoblotting 
2.7.11.1 Western transfer 
Proteins separated by electrophoresis were transferred to nitrocellulose 
membrane (NitroBind, pure nitrocellulose, 0.45 µm, GR Water & Process Technologies) 
using Trans-Blot® TurboTM transfer system (BioRad) with Trans-Blot Turbo transfer buffer 
(BioRad, # 1704271). For proteins that are large in size (>150 kDa), transfer was done by 
using Trans-Blot Electrophoretic Transfer Cells (BioRad) at 400 mA for 1 h with an ice block 
in the transfer buffer [25 mM Tris-HCl, 200 mM glycine, 5% (v/v) methanol].  
2.7.11.2 Ponceau S staining 
For proteins that had been transferred to a nitrocellulose membrane, Ponceau 
S staining was performed by incubating the membrane with 5 mL of ponceau S staining 
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solution (0.1% (w/v) Ponceau S (Sigma), 5% (v/v) glacial acetic acid) for 1 min and rinsing 
with MQ water.  
2.7.11.3 Western immunoblotting 
The membrane was blocked with TTBS buffer [16 mM Tris-HCl, 120 mM 
NaCl, 0.05% (v/v) Tween-20 (Sigma)] with 5% (w/v) of skim milk for 1 h before incubation 
with primary antibodies (Section 2.3.1) in TTBS with 5% (w/v) of skim milk for 18 h. The 
membrane was then washed with TTBS three times (5 min each) and incubated with HPR 
conjugated secondary antibodies (Section 2.3.1) in TTBS with 5% (w/v) of skim milk for 2 
h. The membrane was then washed three times with TTBS and once with TBS [16 mM Tris-
HCl, 120 mM NaCl], followed by the incubation with Chemiluminescent substrate (Sigma, 
# WBKLS0500) for 5 min. Imaged were then acquired by using a BioRad GelDoc XR+. 
2.7.11.4 Colony immunoblotting 
Screening for either the successful generation of expression constructs or the 
addition of affinity tags was performed as follow. Colonies that recovered from 
transformation were picked and patched directly onto a nitrocellulose membrane. The 
membrane was then blocked with 5% (w/v) BSA in PBS for 20 min at room temperature. 
Membrane was then sequentially incubated with 10% (w/v) SDS; 0.5 M NaOH, 1.5 M NaCl; 
0.5 M Tris pH 7.5, 1.5 M NaCl, and 2×SSC buffer [0.3 M NaCl, 0.03 M sodium citrate, pH 
7.0] for 5 min each. The membrane was then re-blocked with 5% BSA in PBS for 20 min 
and was subjected to Western immunoblotting (Section 2.7.11.3). 
2.7.11.5 Far Western immunoblotting 
For far Western immunoblotting, the membrane on which proteins were 
transferred was blocked by 5% (w/v) skim milk in TTBS buffer and incubated with 0.28 nM 
IcsA passenger protein in 1 mL of TTBS with 5% (w/v) skim milk for 18 h at 4 °C. 
Membrane was then washed with TBS three times and interaction between IcsA passenger 
protein and host cell proteins was detected with the anti-IcsA antibody (1:1000) (Section 
2.7.11.3). 
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2.7.12 Protein refolding buffer screening and refolding by dialysis 
Purified IcsA passenger protein (~2 mg/mL) (Section 2.7.3.1) was diluted 
1:20 into 200 μL base buffer (50 mM NaCl, 50 mM Tris, pH 8) with different screening 
ingredients and/or conditions including 10% (v/v) glycerol, 1.5 M NaCl, 1% (v/v) NP-40, 
0.5 M urea, 10 mM DTT, 1% (w/v) glycine, 100 mM MgCl2 or 50 mM Tris, pH 7.0. The 
mixtures were incubated 16 h at 4 °C, and ultracentrifuged (108,000 ×g, 30 min, 4°C, 
Beckman OptimaTM MAX-XP Ultracentrifuge) to separate the insoluble and soluble 
fractions. Both insoluble and soluble fractions were electrophoresed into a 12% SDS-PAGE 
gel (Section 2.7.9.1), transferred onto nitrocellulose membrane (Section 2.7.11.1), and 
stained with Ponceau S (Section 2.7.11.2). Conditions that yielded the least aggregation were 
then used for refolding by dialysis (Section 2.7.5). 
2.7.13 Proteolysis assays 
Proteolysis assays were done as described by May and Morona (2008) with 
modifications. Basically, a 500 µL of refolded IcsA passenger protein (1.35 mg/mL) was 
incubated with human neutrophil elastase (hNE) (0.33 µM) (Elastin Products Company) for 
up to 2 h at 37 °C. Aliquots (50 µL) were taken at different time points (0 min, 5 min, 10 
min, 15 min, 30 min, 45 min, 60 min, and 90 min) and immediately mixed with an equal 
volume of 2× SDS-PAGE buffer and heated at 100 °C for 10 min, and then analysed by a 
12% SDS-PAGE (Section 2.7.9.1) and stained with Coomassie Blue G250 (Section 2.7.10.1). 
For hNE accessibility of IcsA, S. flexneri grown to the mid-exponential phase 
were collected (1109 cells) and washed with 1 mL of PBS three times. Bacteria were then 
resuspended into 500 µL of PBS and incubated with hNE (0.33 µM) (Elastin Products 
Company) for up to 90 min. Aliquots (50 µL) were taken at different time points (0 min, 5 
min, 10 min, 15 min, 30 min, 45 min, 60 min, and 90 min) and immediately resuspended 
with equal volume of 2× SDS-PAGE buffer and heated at 100 °C for 10 min. Alternatively, 
Aliquots (50 µL) taken at different time points were separated into whole cell fraction and 
digestion supernatant via centrifugation (13,200×g, 1 min, 4 °C). Samples were then mixed 
with 50 µL of 2× SDS-PAGE buffer and heated at 100 °C for 10 min. 
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For hNE digestions performed on the growth inhibited S. flexneri. Bacteria 
grown to the mid-exponential phase (OD600 of 0.4-0.6) were centrifuged (13,200 ×g, 1 min 
25 °C) and resuspended in 10 mL LB broth with 25 µg/mL of chloramphenicol and incubated 
for 30 min at 37 °C, and the inhibition of the bacterial growth was confirmed by reading the 
OD600. DOC at 2.5 mM was then added and the bacterial cultures were then incubated at 
37 °C for another 2 h before being digested with hNE (0.33 µM) in the presence of 
chloramphenicol. 
2.7.14 Mammalian cell line whole cell sample preparation 
Mammalian cells that were grown to confluence on a 100 mm dish were 
recovered either by cell scraper or trypsin digestion (Section 2.2.2), and washed with PBS 
followed by centrifugation (4,000 ×g, 5 min, 4 °C). Pellets were lysed using 1 mL of RIPA 
buffer [25 mM Tris-HCl, 150 mM NaCl, 1% (v/v) NP-40, 0.5% (w/v) deoxycholate, 0.1% 
(w/v) SDS, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 µg/mL 
leupeptin] supplemented with 1 mg/mL of DNase I (Sigma) as described previously (Suzuki 
et al., 1998). Lysates were then ultracentrifuged (108,000 ×g, 30 min, 4°C, Beckman 
OptimaTM MAX-XP Ultracentrifuge) and mixed with the same volume of sample buffer, 
incubated at 95 °C for 10 min before electrophoresing into 4-12% gradient SDS-PAGE gel 
(ThermoFisher Scientific, #NP0322PK2) and then transferring onto a nitrocellulose 
membrane (Section 2.7.11.1) for subsequent analysis. 
2.7.15 Fractionation of HeLa cells and sample preparation 
Cell fractionation was done as described by Laarmann and Schmidt (2003). 
Briefly, HeLa cells grown to confluence on a 100 mm dish were into 10 mL of PBS 
containing 1 mM Pefabloc® (Sigma, #PEFBSC-RO) and 10 µg/mL leupeptin (Sigma, 
#L2884) and sonicated (Sonifier 450, Branson) on ice at the output power 4 for four 40% 
cycles with the microtip. The unbroken cells were excluded from the sonicate via 
centrifugation (4,000×g, 10 min, 4°C). The isolated sonicate was then ultracentrifuged 
(108,000 ×g, 30 min, 4°C, Beckman OptimaTM MAX-XP Ultracentrifuge). Supernatant was 
isolated as cytosolic fraction and the pellet was then washed with 1 mL of PBS before being 
resuspended in 1 mL buffer containing 0.1 M Na2CO3/1 M NaCl (pH 11) and incubated on 
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ice for 30 min. The solubilised membrane was then ultracentrifuged (108,000 ×g, 30 min, 
4°C, Beckman OptimaTM MAX-XP Ultracentrifuge), and resulting a membrane associated 
fraction in the supernatant and the integral membrane fraction in the pellet. The pellet was 
then washed using 1 mL of 2% (w/v) CHAPS in sonication buffer and ultracentrifuged again 
(108,000 ×g, 30 min, 4°C), resulting in the detergent resistant integral membrane fraction in 
the pellet. All fractions were solubilised in 2 SDS-PAGE sample buffer and incubated at 
95 °C for 10 min before electrophoresing into 4-12% gradient SDS-PAGE (Section 2.7.9.1) 
and transferred onto a nitrocellulose membrane (Section 2.7.11.1).    
2.7.16 Protein fluorescent probe generation 
One hundred µL of purified IcsA passenger protein (28 µM) (Section 2.7.3.1) 
and BSA protein (28 µM) (Sigma) were incubated with DyLight 594 Maleimide (50 µM) 
(ThermoFisher) for 18 h at room temperature. Excessive dye was quenched by reacting with 
β-mercaptoethanol (2-ME) (1 mM), and subsequently dialysed against 4 L determined 
dialysis buffer (Section 2.7.12) to remove 2-ME. Successful labelling was visualised in SDS-
PAGE (Section 2.7.9.1) via imaging with a BioRad GelDoc XR+. 
2.7.17 Immunoprecipitation (IP) of IcsA 
For immunoprecipitation (IP) by IcsA passenger protein, HeLa cells grown 
confluent on four 100 mm culture dishes were recovered by cell scraper and washed with 10 
mL of PBS. Cells were then lysed in 1 mL of cell solubilization buffer [50 mM sodium 
phosphate, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% (v/v) glycerol, 0.025% 
(w/v) NaN3 (Sigma), 10 µg/mL leupeptin (Sigma), 1 µ/mL aprotinin (Sigma), 1 mM Pefabloc 
(Sigma), 0.125 U/mL α2-macroglobulin (Roche), 2% (w/v) CHAPS (Roche)] and incubated 
for 30 min at 4 °C with rotation. Unlysed cells were then spun down (4,000 ×g, 4 °C, 10 min) 
and the lysate was then split into two samples (600 µL each). The lysate was then precleaned 
with 30 µL protein A resin (Genscript, #L00210) by incubation for 30 min at 4 °C with 
rotation. Both samples were then adjusted to 1.2 mL with TSA buffer [50 mM Tris-HCl pH 
7.4, 100 mM NaCl, 0.02% (w/v) NaN3], 20 µL of IcsA passenger protein (28 µM) was then 
added to the lysate and incubated for 2 h at 4 °C with rotation. For mock pull down, 20 µL 
protein refolding buffer was added and incubated in the same way. To pull down IcsA-target 
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protein complexes, 20 µL of anti-IcsA antibody or anti-His6 antibody and 40 µL of protein 
A resin were added to both IcsA and mock pull down reactions and incubated for another 2 
h at 4 °C with rotation. Resins were then recovered by centrifugation (1,000 ×g, 4 °C, 1 min), 
and washed sequentially by 1 mL TSA buffer; TSA buffer containing 0.1% (w/v) CHAPS; 
TSA buffer containing 0.1% (v/v) CHAPS and 250 mM NaCl; and finally TSA buffer again. 
Protein A resins were then mixed with 30 µL of SDS-PAGE sample buffer and heated at 
100 °C for 5 min before loading onto a 4-12% SDS-PAGE gel. 
2.7.18 Protein pull down assay 
2.7.18.1 N-WASP pull down of IcsA 
For N-WASP pull down experiments, approximately 60 µg mini-N-WASP-
GST protein purified as described previously (Papayannopoulos et al., 2005) was mixed with 
either 12.5 µg IcsA53-740 or IcsAΔ138-148, and incubated with 200 μl glutathione SepharoseTM 
4B (GE Healthcare, # 17075601) resin overnight at 4 °C. For mock pull down, approximately 
60 µg GST protein was mixed with 12.5 µg IcsA53-740 and processed as above. Resins were 
washed sequentially with PBS; PBS containing 1 mM DTT; PBS containing 0.1% (v/v) NP-
40; and PBS for three times each. Protein was eluted in 50 µL PBS containing 20 mM 
reduced glutathione (Sigma). Samples were solubilised in SDS-PAGE sample buffer and 
subjected to SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 2.7.11.3). 
2.7.18.2 IcsA pull down N-WASP 
For IcsA pull down N-WASP experiments, approximately 60 µg mini-N-
WASP-his protein purified as described previously (Papayannopoulos et al., 2005) was 
mixed with either 38 µg IcsA , and incubated with 100 µL of anti-DYKDDDDK G1 affinity 
resin (GenScript, #L00432) resin overnight at 4 °C. For mock pull down, 60 µg mini-N-
WASP-his protein was mixed with 100 µL of anti-DYKDDDDK G1 affinity resin and 
processed as above. Resins were washed 5 times with 1 mL TBS and beads were resuspended 
in 50 µL of 2 SDS-PAGE buffer and heated to 100 °C. Samples were then subjected to 
SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 2.7.11.3). 
57 | P a g e  
 
2.7.19 Mass spectrometry (MS) 
2.7.19.1 MS for IcsA-interacting protein identification 
For IcsA receptor identification via mass spectrometry, samples from IP 
(Section 2.7.17) were separated by SDS-PAGE (Section 2.7.9.1) and stained by Colloidal 
Blue (Section 2.7.10.2). Unique proteins from the IcsA pull down sample compared to mock 
pull down, and having the same apparent molecular weight that been visualised in far 
Western immunoblotting, were excised and sent for protein identification via liquid 
chromatography electrospray ionization tandem mass spectrometry (Nano-LC-ESI-MS/MS, 
Adelaide Proteomics Centre). The same mass position regions in the mock pull down sample 
were also excised and analysed in the same way to determine background protein 
contamination. Unique peptides identified from IcsA pull down was then searched against 
the non-redundant human Uniport database to identify IcsA interacting proteins. 
2.7.20 IcsA structure prediction 
The predicted IcsA structure was acquired by using an online protein 
prediction tool Iterative Threading ASSEmbly Refinement (I-TASSER) (Zhang, 2008). 
2.8. LPS methods 
2.8.1 LPS sample preparation  
Bacteria strains grown 18 h at 37 °C were subcultured 1:20 in LB broth and 
incubated at 37 °C for another 4 h with shaking (200 rpm). Bacteria cells were then collected 
(1×109 cells) by centrifugation (16,250 ×g, 1 min) and resuspended in 50 µL of LPS lysing 
buffer [2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 4% (v/v) 2-ME, 10% (v/v) glycerol, 
0.66 M Tris-HCl, pH 7.6]. After an incubation at 100 °C for 5-10 min, 10 µL of proteinase 
K (2.5 mg/mL) was added and samples were then incubated at 56 °C for 4 h allowing 
complete digestion of proteins. Samples were then stored at -20 °C. 
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2.8.2 Silver staining of LPS 
2.8.2.1 LPS SDS-PAGE 
For separation of LPS molecules in samples, samples were diluted 1:4 in LPS 
lysis buffer and heated at 100 °C for 5 min before loading onto a self-cast SDS-PAGE gels 
(Section 2.7.9.1) except all solutions were made in MQ water. LPS were then 
electrophoresed at 12 mA for 16 h. 
2.8.2.2 LPS silver staining 
For LPS silver staining, PAGE gels were fixed in fixing solution [5% (v/v) 
glacial acetic acid, 40% (v/v) ethanol] for 2.5 h, oxidized for 5 min with oxidizing solution 
[5% (v/v) glacial acetic acid, 40% (v/v) ethanol, 0.7% (w/v) periodic acid], washed 4 times 
with MQ water for 15 min each, stained for 10 min with staining solution [1.33% (v/v) 
NH3OH, 0.08% (w/v) NaOH, 0.67% (w/v) AgNO3] and washed 5 times with MQ water as 
above. Staining was developed in pre-warmed (42 °C) developing solution [0.005% (w/v) 
citric acid, 0.037% (v/v) formaldehyde], and stopped by using stropping solution [4% (v/v) 
glacial acetic acid]. The image was then acquired using an electronic scanner (HP). 
2.8.3 LPS depletion and regeneration 
LPS depletion and regeneration were done as described previously (Teh et 
al., 2012). Briefly, Shigella bacteria grown for 16 h were subcultured 1 in 20 into 10 mL of 
LB and grown to an OD600 of 0.5 at 37 °C before further dilution 1:20 into 10 mL of LB in 
the presence of 3 μg/ml polymyxin B nonapeptide (PBMN, Sigma) and 5 μg/ml tunicamycin  
(Sigma), and incubated for another 3 h at 37 °C to deplete the LPS O antigen. Bacterial 
cultures were then centrifuged (4,000g, 10 min), washed twice with 10 mL of fresh LB to 
remove PMBN and tunicamycin, and further diluted 1:20 into 10 mL of LB for another 3 h 
incubation at 37 °C to regenerate LPS O antigen. Shigella bacteria with either depleted LPS 
O antigen or regenerated LPS O antigen were prepared into LPS sample (Section 2.8.1) and 
analysed via LPS SDS-PAGE (Section 2.8.2.1) and LPS silver staining (Section 2.8.2.2) or 
subjected to proteolysis assays (Section 2.7.13).  
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2.9. Tissue culture techniques 
2.9.1 Bacterial adherence assay  
Bacterial adherence assays were performed as described by Brotcke-
Zumsteg et al. (2014) with modifications. Briefly, HeLa cells and COS-7 cells seeded at 4.5 
×105/well a day before the assay and grown to confluence in 24-well plates, were washed 
with 1 mL of PBS three times, replenished with 200 µL of culture medium devoid of 
antibiotics. S. flexneri 2a strains grown to the mid-exponential phase were collected (4.5×108 
cells), washed with 1 mL of PBS three times, and replenished with 1 mL of culture medium 
devoid of antibiotics. A 100 µL of bacteria suspension was then added onto monolayers to 
reach the multiplicity of infection (MOI) of 100:1. The 24-well plates were centrifuged (500 
×g, 5 min) and incubated for 15 min. Unbound Shigella bacteria were removed by washing 
three times with 1 mL of PBS, and monolayers were lysed using 500 µL of 0.1% (v/v) Triton 
X-100 at 37 °C for 10 min. A 20 µL of monolayer lysate containing Shigella bacteria were 
then used to prepare serial dilution in 200 µL each to up to 10-4 in triplicate, and a 20 µL of 
each dilution triplicate were doted on an agar plate containing appropriate antibiotics. Plates 
were then incubated at 37 °C for 16 h, and the average number of the colonies from dilution 
triplicate was used. 
2.9.2 Bacterial adherence blocking assay 
2.9.2.1 Adherence blocking assays using purified IcsA 
HeLa cells seeded at 4.5×105/well a day before assay and grown to 
confluence in 24-well plates were washed by 1 mL of PBS three times, then replenished with 
200 µL of culture medium devoid of antibiotics. A 100 µL of IcsA passenger protein at 
different concentrations (2.5 µM, 1.25 µM, 250 nM and 25 nM), along with 100 µL of culture 
medium washed S. flexneri 2a strains (Section 2.9.1) were added onto monolayers at the 
multiplicity of infection (MOI) of 100:1. A 100 µL of protein dialysis buffer (Section 2.7.12) 
with or without BSA protein at the concentration of 2.5 µM were used as controls. Samples 
were then subjected to bacterial adherence assays (Section 2.9.1). 
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2.9.2.2 Adherence blocking assays using antibodies 
HeLa cells seeded at 4.5×105/well a day before assay and grown to confluence in 24-
well plates were washed by 1 mL of PBS three times, then replenished with 200 µL of culture 
medium devoid of antibiotics. Bacteria were washed with 1 mL PBS and replenished in 900  
µL of culture medium, mixed with 100 µL of rabbit anti-IcsA pAbs (3.125 µg/mL and 0.3125 
µg/mL in PBS), mouse anti-Myosin II-A antibodies (15 µg/mL, 1.5 µg/mL and 0.15 µg/mL 
in PBS), mouse anti-Myosin II-B antibodies (15 µg/mL, 1.5 µg/mL and 0.15 µg/mL in PBS) 
or rabbit pre-immune serum (concentration of IgG 100 μg/mL), and incubated for 15 min at 
room temperature. A mixture of 100 µL of bacteria with antibodies were then added onto 
cell monolayers at the MOI of 100 and incubated for another 15 min at 37 °C with 5% CO2
 
to allow bacteria passive settling. Samples were then subjected to bacterial adherence assays 
(Section 2.9.1) 
2.9.3 Invasion assay 
Bacterial invasion assays were performed as described by Brotcke-Zumsteg et al. 
(2014) with modifications. Briefly, HeLa cells seeded at 4.5 ×105/well a day before the assay 
and grown to confluence in 24-well plates, were washed with 1 mL of PBS three times, 
replenished with 200 µL of culture medium devoid of antibiotics. Shigella grown to an OD600 
of 0.4-0.6 in the presence of DOC (2.5 mM) were collected (4.5×108 cells), washed with 1 
mL of PBS three times, and replenished with 1 mL of culture medium devoid of antibiotics. 
A 100 µL of bacteria suspension was then added onto monolayers to reach the multiplicity 
of infection (MOI) of 100:1, and the 24-well plates were incubated at 37 °C. Gentamycin (40 
μg/mL) was added after 45 min post infection and HeLa monolayers were incubated for 
another 45 min. The monolayers were then washed three times with 1 mL of PBS, and were 
lysed using 500 µL of 0.1% (v/v) Triton X-100 at 37 °C for 10 min. The intracellular Shigella 
bacteria were enumerated by serial dilution plating onto LB agar (Section 2.9.1). 
2.9.4 Statistical analysis 
The statistical analysis on Shigella adherence and invasion assays was performed 
using GraphPad Prism 8.0.0. Data were normalised against the relevant controls and 
significance was calculated using either a student t test or one-way ANOVA followed by 
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Dunnett’s multiple comparisons test against the controls based on at least two independent 
experiments.  
2.9.5 Plaque assay 
Bacterial plaque formation assay was done as described previously (Tran et 
al., 2015). In general, HeLa cells or COS-7 cells seeded at 2×106 cells/well a day before 
assay and grown to confluence in 6-well plates were washed by 2 mL of PBS three times. S. 
flexneri 2a strains grown to the mid-exponential phase were collected (6×108 cells), washed 
with 1 mL of PBS three times, and replenished with 1 mL of culture medium devoid of 
antibiotics. Washed bacteria were then diluted 1 in 1000 in PBS, and a 250 µL of the diluted 
bacteria preparation was added onto each monolayer, and incubated in MEM at 37 °C with 
5% CO2. After 90 min post-infection, a 5 mL of first overlay (5% (v/v) FCS, 0.5% (w/v) 
agarose, 20 µg/mL Gentamicin, in DMEM) was added and incubated at 37 °C with 5% CO2. 
After 48 h post-infection, a 5 mL of a second overlay (5% (v/v) FCS, 20 µg/mL Gentamicin, 
0.5% (w/v) agarose, 3 mg/mL, 0.1% (w/v) Neutral Red (Gibco BRL) in DMEM) was added 
and plaque formation was observed 6–8 h later. Plaque size was measured using MetaMorph 
V7.5. 
2.10. Microscopy techniques 
2.10.1 Fluorescence Microscopy 
2.10.1.1 Staining with fluorescent IcsA protein probe 
To visualise the binding of IcsA to host cell surfaces, confluent HeLa 
monolayers grown on glass slides in 24-well plates were fixed with 200 µL of 3.7% (v/v) 
formaldehyde in PBS. Monolayers were then washed with 1 mL of PBS, quenched with 200 
µL of 50 mM NH4Cl for 10 min, washed with 1 mL of PBS, and incubated with 50 µL of 
IcsA-Dylight 594 (2.8 µM) or BSA-Dylight 594 (2.8 µM) probes in PBS containing 10% 
(v/v) FCS for 2 h at room temperature. Monolayers were then washed with 1 mL of PBS, 
permeabilised with 100 µL of 0.1% (v/v) Triton X-100 in PBS. The cytoskeleton was stained 
by 50 µL of AlexaFluor 488 phalloidin (Invitrogen) diluted to 1:100 in PBS containing 10 % 
(v/v) FCS, and DNA was stained using 50 µL of 10 μg/mL DAPI for 1 min, and washed 1 
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mL of PBS again. Samples were then mounted with 6 µL of 20% Mowiol 4–88 (Calbiochem), 
4 mg/mL p-phenylenediamine, and visualised by an Olympus IX-70 microscope driven by 
MetaMorph software (Version 7.5) using a 100 oil immersion objective, or an Olympus 
confocal laser scanning microscope FV3000 driven by FV31S-SW Fluoview software 
(V2.3.1.163) with a 100 oil immersion objective. 
2.10.1.2 Immunofluorescence (IF) staining of bacterial surface 
antigen 
For surface immunostaining of the bacterial strains, bacteria were grown to 
mid-exponential phase (OD600 of 0.5) and collected (10
8 cells) by centrifugation (16,250 ×g, 
1 min). Cells were then washed with 1 mL of PBS once and fixed in 1 mL of 3.7% (v/v) 
formaldehyde solution in PBS at room temperature for 20 min. Fixed cells were then washed 
twice with 1 mL of PBS and resuspended in 100 µL of PBS. Fixed bacteria (5 µL) were then 
centrifuged (500 ×g, 5 min) onto 10 mm round cover slips (in 24-well plate) precoated with 
200 µL of 10% (v/v) poly-L-lysine (Sigma). 
Bacteria were then incubated with 50 µL of appropriate primary antibodies 
at appropriate concentration (generally 1:100) in PBS containing 10% (v/v) FCS for 2 h at 
room temperature. Bacteria were then washed twice with 1 mL of PBS and incubated with 
50 µL of AlexaFluor 488 conjugated secondary antibody in PBS containing 10% (v/v) FCS. 
Coverslips were then washed with 1 mL of PBS twice and mounted on microscope slides 
(Section 2.10.1.1). Images were acquired using an Olympus IX-70 microscope driven by 
Metamorph software (Version 7.5) using a 100 oil immersion objective. 
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3.2. Article abstract 
Shigella species cause bacillary dysentery, especially among young 
individuals. Shigellae target the human colon for invasion; however, the initial adhesion 
mechanism is poorly understood. The Shigella surface protein IcsA, in addition to its role in 
actin-based motility, acts as a host cell adhesin through unknown mechanism(s). Here we 
confirmed the role of IcsA in cell adhesion and defined the region required for IcsA adhesin 
activity. Purified IcsA passenger domain was able block S. flexneri adherence and was also 
used as a molecular probe that recognised multiple components from host cells. The region 
within IcsA’s functional passenger domain (aa 138-148) was identified by mutagenesis. 
Upon the deletion of this region, the purified IcsAΔ138-148 was found to no longer block S. 
flexneri adherence and had reduced ability to interact with host molecules. Furthermore, S. 
flexneri expressing IcsAΔ138-148 was found to be significantly defective in both cell adherence 
and invasion. Taken together, our data identify an adherence region within the IcsA 
functional domain and provides useful information for designing therapeutics for Shigella 
infection. 
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3.3. Article introduction 
Shigellae are Gram-negative bacteria that cause severe bloody diarrhoea in 
humans (Speelman et al., 1984) and rhesus monkeys (Good et al., 1969). Shigellosis is life 
threating to children under 4 years of age (Kotloff et al., 2018) and is a growing health 
problem in developed countries due to decreased susceptibility to antibiotics (Kozyreva et 
al., 2016). Shigella spp. are primate specific pathogens that target the colon (Speelman et al., 
1984, Anand et al., 1986) and it has been demonstrated in the rabbit ligated ileum model 
(Wassef et al., 1989), and in vitro colonoids (Ranganathan et al., 2019), that Shigella can be 
taken up by M cells. However, Shigella has been reported to target the human colonic crypts 
where M cells were not present (Arena et al., 2015), strongly indicating that an alternative 
route of entry exists. Indeed, the mechanisms by which Shigella species initially adhere to 
host cells, a prerequisite for subsequent invasion and establishing infection, remains poorly 
understood. 
 A role in host cell adhesion has been recently revealed for the essential 
surface displayed virulence factor IcsA (Brotcke-Zumsteg et al., 2014). IcsA is 100% 
conserved in Shigella species and is a member of the secreted autotransporter (AT) 
superfamily. IcsA contains a signal sequence (aa 1-52) at its N-terminus for secretion across 
the inner membrane; a passenger domain (aa 53-740) which confers its function;  a β-barrel 
domain (aa 813-1102) which is responsible for passenger domain translocation across the 
outer membrane; and an unstructured linker region (aa 741-812) that connects the passenger 
with the β-barrel. IcsA also belongs to the AIDA subfamily with members that are well 
characterised adhesins, such as AIDA-I and Ag43, both of which are known to have β-helix 
passenger structures (Emsley et al., 1996, Charbonneau et al., 2009, Heras et al., 2014). The 
IcsA passenger also possesses these β-helix structures (Kuhnel & Diezmann, 2011, Doyle et 
al., 2015a, Doyle et al., 2015b, Leupold et al., 2017). IcsA has been well studied with respect 
to its function in actin based motility (ABM) (Goldberg et al., 1993, Goldberg & Theriot, 
1995), where polarly distributed IcsA recruits host N-WASP protein (Suzuki & Sasakawa, 
1998, Suzuki et al., 2002, Teh & Morona, 2013), resulting in the subsequent polymerisation 
of host cell actin at one pole of the bacterium to facilitate bacterial inter- and intracellular 
motility (Egile et al., 1999). Recently, IcsA has been found contributing to S. flexneri biofilm 
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formation in the presence of bile salt deoxycholate (DOC) by promoting cell-to-cell contact 
and aggregative bacterial growth (Koseoglu et al., 2019). Besides ABM and biofilm 
formation, however, knockouts of the type 3 secretion tip complex proteins IpaD or IpaB in 
Shigella flexneri result in polar adhesion to host cells in an IcsA-dependent manner (Brotcke-
Zumsteg et al., 2014). IcsA was also found to contribute to DOC induced hyper-adherence, 
and expressing IcsA in E. coli  promotes adherence to host cells, confirming that IcsA is 
sufficient to promote bacterial adherence (Brotcke-Zumsteg et al., 2014). While IcsA’s 
expression level and cellular distribution is not altered in the hyper-adherent Shigella 
compared to the wild type strain, data suggest that the conformation of IcsA is different in 
hyper-adherent strains (Brotcke-Zumsteg et al., 2014). 
In this study, the direct role of IcsA in Shigella-host-cell adherence was 
demonstrated via adherence inhibition with purified IcsA passenger domain, and adherence 
blocking with anti-IcsA antibodies. Fluorescently labelled IcsA passenger was also able to 
bind to host cell surfaces. Indirect probing with purified IcsA passenger protein recognised 
several host molecules through far Western blotting. Through screening of an IcsA 5 aa 
insertion library (May & Morona, 2008), the region responsible for adhesin activity was 
identified and characterised. 
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3.4. Article materials and methods 
3.4.1 Ethics statement 
The anti-GST antibody and anti-IcsA antibody were produced under the 
National Health and Medical Research Council (NHMRC) Australian Code of Practice for 
the Care and Use of Animals for Scientific Purposes, and was approved by the University of 
Adelaide Animal Ethics Committee (S-2012-90). Bacterial adherence and invasion assays 
were performed under the National Statement of Ethical Conduct in Human Research 2018, 
and was approved by Human Research Ethics Committee (HREC H-2016-091). 
3.4.2 Bacterial strains and tissue culture 
The bacterial strains used in this study are listed in S1 Table. For adherence 
assays, bacterial strains were streaked onto Tryptic Soy Agar with 0.2% (w/v) Congo Red, 
and after incubation at 37 °C overnight, red colonies were selected and incubated in 
Lysogeny broth (LB) overnight with appropriate antibiotics (tetracycline, 10 μg ml−1; 
kanamycin, 50 μg ml−1; chloramphenicol, 25 μg ml−1 and ampicillin, 100 μg ml−1). For all 
assays, overnight bacterial cultures were subcultured (1:20) in the presence or absence of 2.5 
mM sodium deoxycholate and grown to a mid-exponential phase (OD600 reading of 0.6-0.8) 
before use. 
HeLa cells were maintained and grown in minimal essential medium (MEM) 
supplemented with L-glutamine, 10% (v/v) fetal calf serum (FCS), and 
penicillin/streptomycin. Cell cultures were maintained at 37 °C with 5% CO2 for growth. 
The day prior to the bacterial adherence assay and invasion assay, or for microscopy, HeLa 
cells were seeded at 4.5×105/well into 24-well plates or onto glass coverslips respectively. 
For plaque assays, HeLa cells were seeded into 6-well plates and were allowed to grow 
confluent. 
3.4.3 Mutagenesis and DNA manipulation 
S. flexneri 2a ΔipaD or ΔipaB strains were generated using the λ red 
mutagenesis method as described previously (Datsenko & Wanner, 2000). Briefly, primers 
(S2 Table) were designed to PCR amplify the kanamycin cassette flanked with 50 bp of the 
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start and end coding sequences of IpaD or IpaB. The fragments were then electroporated into 
WT S. flexneri 2457T or a ΔicsA knockout strain to generate ΔipaD/ΔipaB or 
ΔipaDΔicsA/ΔipaDΔicsA mutant strains. The kanamycin cassette was then eliminated by the 
introduction of pCP20 to avoid potential polar effects. 
Site-directed mutagenesis was performed on pIcsA plasmid (May & Morona, 
2008) using the QuikChange II® system (Agilent) as per the manufacturers protocol. The 
primers used are listed in S2 Table. 
For alanine scanning of the amino region 138 to 148 in the IcsA passenger 
domain, codons of each amino acid were substituted with a codon of alanine and changed 
via inverse PCR with the primers listed in S2 Table. 
The hyper-adherent mutant library was generated by transforming plasmids 
from the IcsA 5 aa insertion library (May & Morona, 2008) into S. flexneri 2a ΔipaDΔicsA 
via chemical transformation as described by Sambrook and Russell (2006). 
For IcsA production, the IcsA passenger sequence from amino acid 53 to 740 
was amplified using primers MD80/81 (S2 Table) from pIcsA, and cloned into the 
pBADhisB vector (Invitrogen) between the XhoI and KpnI sites, resulting in 
pBADhisB::IcsA53-740. The vector was then optimised for purification by inverse PCR to 
replace the His6 tag with a N-terminus fused His12 tag, resulting in pMDBAD::IcsA53-740. 
For the IcsAΔ138-148 production, the coding sequence of amino acids 138 to 148 in the IcsA 
passenger domain was deleted via inverse PCR, resulting in pMDBAD::IcsA53-740/Δ138-148. 
3.4.4 Protein purification and refolding 
For IcsA passenger domain production, an overnight culture of E. coli 
TOP10 transformed with pMDBAD::IcsA53-740 was sub-cultured 1 in 1000 into auto-
induction 2 L Terrific Broth medium (Tartoff & Hobbs, 1987)  that contained a mixture of 
glucose and arabinose in the ratio of 0.1%:0.3% (w/v), and incubated at 37 °C overnight. 
Cells were then harvested by centrifugation (10,000 ×g, 10 min), resuspended in 80 ml TBS 
[50 mM Tris, 150 mM NaCl, pH 7.0] and lysed using a cell disruptor (30 kpsi, Constant 
Systems Ltd) in the presence of two EDTA-free protease inhibitor tablets (Roche). Inclusion 
bodies (IBs) were recovered by centrifugation of the cell lysates (20,000 ×g, 10 min), and 
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pre-cleaned by detergent wash [50 mM Tris, 1 M NaCl, 2% (v/v) Triton X-100, 4 mM DDM 
and 2% (w/v) DOC, pH 8.0] to exclude membrane fractions. IcsA passenger protein from 
the IBs was then solubilised in 50 ml protein solubilisation buffer [8 M urea, 50 mM NaCl, 
50 mM Tris, 10 mM imidazole, pH 8] for 2 h, followed by centrifugation (185,000 ×g, 1 hr). 
Solubilised IcsA passenger protein was then loaded on a His-trap column, washed and eluted 
with increasing concentration of imidazole. IcsA passenger protein was then further purified 
through an HiLoad 16/600 Superdex 200pg column (GE Healthcare) and eluted fractions 
containing purified protein were confirmed by SDS-PAGE. IcsA passenger domain-
containing fractions were then pooled and subjected to refolding. 
Purified IcsA passenger protein was diluted 1:20 into base buffer [50 mM 
NaCl, 50 mM Tris, pH 8.0] with different screening ingredients or conditions including 10% 
(v/v) glycerol, 1.5 M NaCl, 1% (v/v) NP-40, 0.5 M urea, 10 mM DTT, 1% (w/v) glycine, 
100 mM MgCl2 or pH 7.0. The mixtures were then incubated for 16 h at 4 °C, and 
ultracentrifuged (185,000 ×g, 30 min) to separate the insoluble and soluble fractions. 
Samples of both insoluble and soluble fractions were compared by electrophoresis into a 12% 
polyacrylamide SDS-PAGE gel and subjected to Western transfer and Ponceau S staining. 
Conditions that yielded the least aggregation were then used, and the purified IcsA passenger 
protein was refolded by dialysing against optimised buffer [0.5 M urea, 10% (v/v) glycerol, 
50 mM NaCl and 50 mM Tris-HCl pH 7.0] at room temperature for 48 h. Dialysed IcsA 
passenger protein was then ultracentrifuged (185,000 ×g, 1 h) and the resulting supernatant 
was quantified using the protein BCA assay (Thermo Fisher) and stored at -80 °C. With this 
protocol a yield of IcsA of approximately 10 mg protein was obtained from a 2 L overnight 
culture. 
3.4.5 Proteinase accessibility assay 
Proteinase accessibility assay was performed as described by May and 
Morona (2008) with modifications. Refolded IcsA passenger protein was incubated with 
Human Neutrophil Elastase (hNE, EPC Elastin Products) in dialysis buffer at the molecular 
ratio of 1000:1 at 37 °C for 1.5 h. Aliquots were taken at different time points (0 min, 5 min, 
10 min, 15 min, 30 min, 45 min, 60 min and 90 min) and immediately resuspended with an 
equal volume of SDS-PAGE sample buffer (Lugtenberg et al., 1975) followed by incubation 
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at 100 °C for 10 min. A sample of IcsA passenger protein was also heated at 65 °C for 15 
min, cooled to room temperature, and digested as above to serve as a control. Fractions taken 
from different time points were then analysed by SDS-PAGE and stained with Coomassie 
blue G250 (Sigma). 
3.4.6 Fluorescent labelling 
For protein labelling, refolded IcsA passenger protein (that has three cysteine 
residues available for labelling with Dylight 594 maleimide), mutant IcsA passenger protein 
(IcsAΔ138-148), or bovine serum albumin (BSA) protein (Sigma) were incubated with 
DyLight594 maleimide (Thermo Fisher) at the molecular ratio of 1:2 overnight at room 
temperature, and subsequently dialysed against dialysis buffer to remove excessive dye. 
Successfully labelled protein was analysed via SDS-PAGE and the fluorescence was 
confirmed using a ChemiDoc imaging system (BioRad). 
IcsA immunofluorescent labelling on bacterial surfaces was performed as 
described previously (May et al., 2012). Briefly, Shigella grown to an OD600 of 0.5 was 
collected and fixed in PBS containing 3.7% (v/v) formaldehyde and centrifuged onto poly-
L-lysine-coated coverslips. Bacteria was then incubated with 50 μl of rabbit anti-IcsA 
antibody (1:100) for 1 h, washed with PBS, and labelled with 50 μl of Alexa 488-conjugated 
donkey anti-rabbit antibody (1:100) for another 1 h. Samples were then mounted with 20% 
(v/v) Mowiol 4–88 (Calbiochem), 4 mg ml−1 p-phenylenediamine, and imaged with an 
Olympus fluorescent microscope (IX-70). 
3.4.7 SDS-PAGE and Western blotting 
For SDS-PAGE, samples were resuspended in an equal volume of 2× SDS-
PAGE sample buffer (Lugtenberg et al., 1975), and immediately heated at 100 °C for 10 min. 
A total of 20 μl from each sample was then electrophoresed on Any kDTM gels (BioRad) or 
hand-cast 12% SDS acrylamide (BioRad) gels. For Western immunoblotting, samples were 
then transferred onto a nitrocellulose membrane, blocked with TBST [TBS, 0.05% (v/v) 
Tween-20] containing 5% (w/v) skim milk, and incubated with rabbit anti-IcsA antibody 
(Van Den Bosch et al., 1997), rabbit anti-GST antibody (in house made), or mouse anti-His6 
antibody (Genscript) for 4 h. The membrane was then washed with TBST and incubated with 
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HRP-conjugated goat anti-mouse antibody (Biomediq DPC) or HRP-conjugated goat anti-
rabbit antibody (Biomediq DPC) for 1 h. The membrane was then washed with TBS and 
incubated with Chemiluminescence Substrate (Sigma) for 5 min. Chemiluminescence was 
detected using a ChemiDoc imaging system (BioRad). 
3.4.8 Confocal microscopy 
To visualise the binding of IcsA to host cell surfaces, fluorescently labelled 
wild type IcsA passenger protein (2.8 µM), IcsAΔ138-148 protein (2.8 µM)  or BSA protein (5 
µM) were added onto confluent HeLa cell monolayers grown on coverslips in 24-well trays 
and incubated at 37 °C with 5% CO2 for 15 min followed by washing with PBS. Monolayers 
were then fixed with 3.7% (v/v) formaldehyde in PBS, washed with PBS, incubated with 1% 
(v/v) Triton in PBS for 10 min, and then stained with AlexaFluor 488 phalloidin (Invitrogen) 
diluted to 1:100 in PBS containing 10 % (v/v) FCS. Monolayers were then washed with PBS 
and DNA was stained using 10 μg ml−1 DAPI for 1 min, followed by another PBS wash. 
Coverslips were then mounted with 20% (v/v) Mowiol 4–88 (Calbiochem), 4 mg ml−1 p-
phenylenediamine, and imaged with an Olympus confocal laser scanning microscope 
(FV3000).  
3.4.9 Adherence, invasion and plaque formation assays 
For whole cell adherence assays, Shigella grown to an OD600 of 0.4-0.6 were 
collected, washed with MEM, and inoculated to HeLa cell monolayers at the MOI of 100. 
Centrifugation (500 g, 5 min) was used as outlined in the results. After 15 min of incubation, 
HeLa cell monolayers were washed with PBS and lysed using PBS containing 0.1% (v/v) 
Triton X-100 at 37 °C for 10 min. The remaining Shigella bacteria were enumerated by serial 
dilution plating onto LB agar. 
For invasion assays, Shigella grown to an OD600 of 0.4-0.6 in the presence of 
DOC were used to infect HeLa cell monolayer at the MOI of 100. Gentamycin (40 μg ml-1) 
was added after 45 min post infection and HeLa monolayers were incubated for another 45 
min before being lysed and treated as above.  
Plaque formation was performed as described previously (May et al., 2012). 
Briefly, HeLa cells grown to confluency in six-well trays were washed with PBS and 
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Dulbecco’s modified Eagle’s medium (DMEM) sequentially before infection with of 
Shigella (1.25 105 cfu) grown to an OD600 of 0.5. At 90 min post infection, an overlay 
[DMEM, 5% (v/v) FCS, 20 μg ml-1 gentamycin, 0.5% (w/v) agarose was added to each well. 
The second overlay containing 0.1% (w/v) Neutral Red was added at 48 h post infection and 
images of plaques were taken after another 2 h incubation. 
3.4.10 Adherence blocking assays using purified IcsA or anti-IcsA antibody 
For both adherence blocking assays, HeLa cells grown to confluence were 
washed with PBS, and replenished with culture medium devoid of antibiotics. For the IcsA 
adherence blocking assays, IcsA passenger protein at different concentrations (2.5 µM, 1.25 
µM, 250 nM and 25 nM) along with S. flexneri 2a strains were added onto monolayers at the 
multiplicity of infection (MOI) of 100:1. After an incubation of 15 min at 37 °C with 5% 
CO2, samples were centrifuged (500 ×g, 5 min) and incubated for another 15 min as above.  
For the antibody adherence blocking assays, bacteria were washed with PBS 
and replenished in the culture medium (as above) and incubated with either rabbit anti-IcsA 
pAbs (3.125 µg/ml and 0.3125 µg/ml) or rabbit pre-immune serum (concentration of IgG 
100 μg/ml) for 15 min. Bacteria with antibodies were then added onto cell monolayers at the 
MOI of 100 and incubated for another 15 min at 37 °C with 5% CO2. For both assays, 
unbound Shigella bacteria were washed three times with PBS, and monolayers were lysed 
using 0.1% (v/v) Triton X-100 at 37 °C for 10 min. The remaining Shigella bacteria were 
enumerated by serial dilution plating onto LB agar. 
3.4.11 Statistical analysis 
The statistical analysis on Shigella adherence and invasion assays was 
performed using GraphPad Prism 8.0.0. Data was normalised against the relevant control 
and significance was calculated using either a student t test or one-way ANOVA followed 
by Dunnett’s multiple comparisons test against the control.  
3.4.12 Protein lysates, cell fractionation and far Western blotting 
HeLa cells grown to confluence on 100 mm dishes (approximately 8.8108 
cells) were recovered either by using a cell scraper or trypsin digestion, and washed with 
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PBS followed by centrifugation (4,000 ×g, 5 min, 4 °C). Pellets were lysed using RIPA buffer 
[25 mM Tris-HCl, 150 mM NaCl, 1% (v/v) NP-40, 0.5% (w/v) deoxycholate, 0.1% (w/v) 
SDS, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 µg/ml leupeptin] as 
described previously (Suzuki et al., 1998). Lysates were then ultracentrifuged (185,000 ×g, 
30 min, 4 °C) and resuspended in the same volume of SDS-PAGE sample buffer, incubated 
at 95 °C for 10 min, then electrophoresed into a 4-12% gradient SDS-PAGE gel (Thermo 
Fisher) and transferred onto a nitrocellulose membrane. 
Cell fractionation was performed as described by Laarmann and Schmidt 
(2003). Briefly, HeLa cells were scraped from the 100 mm dishes into PBS containing 1 mM 
Pefabloc and 10 µg ml−1 leupeptin, and then sonicated on ice. The sonicated mix was then 
ultracentrifuged (108,000 ×g, 30 min, 4°C). The supernatant was isolated as the cytosolic 
fraction and the pellet was washed with PBS before resuspension in buffer containing 0.1 M 
Na2CO3/1 M NaCl (pH 11) and incubated on ice for 30 min. The extracted membrane lysate 
was then ultracentrifuged as above, resulting in a membrane associated fraction in the 
supernatant and the integral membrane fraction in the pellet. The pellet was solubilised in 2% 
(w/v) CHAPS in sonication buffer, and ultracentrifuged again, resulting in the detergent 
resistant integral membrane fraction in the pellet. All fractions were solubilised in SDS-
PAGE sample buffer incubated at 95 °C for 10 min, then electrophoresed into a 4-12% 
gradient SDS-PAGE gel (Thermo Fisher), and transferred onto a nitrocellulose membrane.   
For far Western blotting, the membrane was blocked in 5% (w/v) skim milk 
in TBST [50 mM Tris, pH 7.0, 150 mM NaCl, 0.1% Tween 20] and incubated with 12.5 µg 
IcsA53-740 or IcsAΔ138-148 in TBST with 5% (w/v) skim milk overnight at 4 °C. The membrane 
was then washed with TBS three times and the interaction between IcsA53-740 or IcsAΔ138-148 
and host cell proteins was detected with the anti-IcsA antibody as above. 
3.4.13 N-WASP pull down 
For N-WASP pull down experiments, approximately 60 µg mini-N-WASP-
GST protein purified as described previously (Papayannopoulos et al., 2005) was mixed with 
either 12.5 µg IcsA53-740 or IcsA53-740(Δ138-148), and incubated with 200 μl glutathione 
SepharoseTM 4B (GE Healthcare) resin overnight at 4 °C. IcsA53-740 and IcsA53-740(Δ138-148) 
were mixed with or without GST, incubated with glutathione SepharoseTM 4B (GE 
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Healthcare) resin and served as controls. Resins were washed sequentially with PBS; PBS 
containing 1 mM DTT; PBS containing 0.1% (v/v) NP-40; and PBS for three times each. 
Protein was eluted in 50 µl PBS containing 20 mM reduced glutathione.   
3.4.14 IcsA structure prediction 
The structure of IcsA passenger was acquired using I-TASSER (Roy et al., 
2010) and analysed using Chimera (Pettersen et al., 2004).   
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3.5. Article results 
3.5.1 Purification of IcsA passenger protein and refolding 
In order to validate the role of IcsA in Shigella adherence in vitro, the IcsA 
passenger domain (53-740) without the previously described unstructured region (741-758) 
(Kuhnel & Diezmann, 2011) was expressed from a pBAD vector with an N-terminal His12 
tag for purification (Fig S1 A). IcsA53-740 was purified from urea solubilised inclusion bodies 
via nickel affinity purification. Fractions containing IcsA53-740 were pooled and further 
purified by size exclusion chromatography (Fig S1 B) and refolded via dialysis. This 
purification strategy has significant advantages including high yields and reduced 
endogenous degradation of the autotransporter passenger domain, a type of domain family 
that is notoriously difficult to purify in a stable and soluble state.  
Since human neutrophil elastase (hNE) has been reported to specifically 
target Shigella surface virulence factors (Weinrauch et al., 2002) and has previously been 
used to assess the conformation and folding of IcsA (Brotcke-Zumsteg et al., 2014), we 
conducted hNE digestions on the purified IcsA53-740 to assess the success of refolding. The 
purified IcsA53-740 showed several resistant fragments, with sizes of approximately 70 kDa, 
60 kD, 40 kDa, 12 kDa and 5 kDa (Fig S1 D), suggesting that the protein has a compact 
structure which is resistant to hNE proteolysis. Heat denaturation at 65 °C for 5 min resulted 
in IcsA53-740 becoming susceptible to hNE, with complete digestion into fragments less than 
15 kDa within the first 5 min (Fig S1 E). In addition, the refolded IcsA53-740 was able to 
interact with mini-N-WASP protein (Fig S2). Together, these data suggest that the purified 
IcsA53-740 was successfully refolded and was functional after purification from inclusion 
bodies. 
3.5.2 Adherence of hyper-adhesion Shigella mutants is highly IcsA dependent 
While previous data strongly indicated that IcsA has adhesin activity 
(Brotcke-Zumsteg et al., 2014), this has not been directly demonstrated. We hypothesised 
that the passenger domain of IcsA directly binds specifically to host cell surface factors in a 
way that pre-treatment of host cells with purified IcsA53-740 would block the adherence of 
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subsequently added S. flexneri. As expected, an ΔipaD mutant strain exhibited an increased 
adherence phenotype to HeLa cells compared to wild type S. flexneri (Fig 1A). This increase 
in adherence is dependent on the presence of IcsA because deletion of IcsA abolished the 
hyper-adherence (Fig 1A). More importantly, addition of the purified IcsA53-740, but not the 
dialysis buffer or BSA protein, was able to inhibit the adherence of the ΔipaD mutant to 
HeLa cells in a dose dependent manner (Fig 1A). This inhibition was also confirmed for a 
hyper-adherent ΔipaB mutant (Fig S3). Moreover, these data also confirmed that the purified 
IcsA53-740 protein was folded in a functional conformation. To confirm that endogenous IcsA 
on the bacterial surface has a direct contribution to the adherence observed for the ΔipaD 
mutant, an adherence blocking assay using polyclonal anti-IcsA antibodies was also 
conducted (Fig 1B). It was found that pre-treatment of bacteria with anti-IcsA antibodies, 
but not the rabbit pre-immune serum, was able to significantly block the adherence of the 
ΔipaD mutant to host cells (Fig 1B). Collectively, these data confirmed a direct role of IcsA 
in the S. flexneri hyper-adherence activity exhibited by ΔipaD and ΔipaB mutants. 
3.5.3 IcsA binds specifically to the host cells 
Evidence was next generated to determine whether that the IcsA passenger 
domain binds specifically to host cell molecules as potential receptors for adherence. The 
purified IcsA53-740 was fluorescently labelled by reacting with DL594 maleimide (Fig 2A). 
BSA protein labelled with DL594 was used as a control (Fig 2A). Unlike the control BSA- 
DL594, IcsA53-740- DL594 was detected on the surface of the HeLa cells (Fig 2B). To 
investigate whether the interaction between IcsA53-740 and the HeLa cell surface was specified 
by a host cell displayed factor, trypsin treated, or untreated HeLa cells lysates were subjected 
to far Western blotting with IcsA53-740 protein (Fig 3A). Two trypsin sensitive molecules 
(~60 kDa and >200 kDa) were recognised by IcsA53-740 protein (Fig 3A). The anti-IcsA 
antibody showed no cross reaction to the HeLa cell lysate (Fig 3A). To further validate the 
cell surface location of these IcsA targets, HeLa cells were fractionated (Fig 3B), and 
subjected to far Western blotting with purified IcsA53-740. IcsA interacting components from 
integral membrane fractions (Fig 3B, lane 4) were detected and two of which were 
corresponding in size (>200 kDa and ~60 kDa) to the trypsin sensitive molecules from whole 
cell lysate (Fig 3A). Apart from these two molecules, we also detected bands at ~25 kDa and  
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Fig 1. Inhibition of the IcsA-mediated adherence by purified IcsA passenger protein 
and anti-IcsA antibodies. 
A. IcsA adherence blocking assay. Shigella grown to an OD600 of 0.5 were collected and 
used to infect HeLa cell monolayer at the MOI of 100. Purified IcsA53-740 protein at the 
concentration of 2.5 μM (IcsA100), 1.25 μM (IcsA50), 250 nM (IcsA10) and 25 nM (IcsA1) 
were applied at the same time. Refolding buffer and BSA at the concentration of 2.8 μM 
were used as negative controls. After 15 min incubation, the cell monolayers were washed 
and lysed. Lysates were serial diluted before dotting on an agar plate for enumeration. Data 
are normalised against ΔipaD (defined as 100%) and are the mean with SEM of three 
independent experiments. Significance was calculated using one-way ANOVA followed by 
Dunnett’s multiple comparisons test against ΔipaD, and p values are as follows: **, p<0.01; 
***, p<0.001.  B. Antibody adherence blocking assay. Shigella grown to an OD600 of 0.5 
were collected and incubated with 3.125 μg/ml (αIcsA10), 0.3125 μg/ml (αIcsA1) of anti-
IcsA antibodies or rabbit pre-immune serum with 100 μg/ml IgG for 15 min before infecting 
HeLa cell monolayers at the MOI of 100. After an extend 15 min incubation, cell monolayers 
were treated as in A. Data are normalised against the ΔipaD (defined as 100%) and are the 
mean with SEM of three independent experiments. Significance was calculated using a 
student t test, and p values are as follows: **, p<0.01. 
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Fig 2. IcsA binds to the surface of HeLa cells.  
A. Fluorescent labelling of IcsA53-740. IcsA53-740 protein and BSA protein were reacted with 
DL594 maleimide overnight and dialysed against protein solubilisation buffer. Labelled 
fluorescent protein probes were detected at the 650 nm after SDS-PAGE. B. IcsA53-740-DL594 
labelled HeLa cells. IcsA53-740-DL594 at the concentration of 2.8 μM was applied to cells for 
15 min. Samples were then permeabilised and stained with phalloidin and DAPI sequentially. 
Images were acquired by confocal microscopy with the orthogonal view (position as shown 
by the dashed yellow line) of a z stack shown below. Cells were stained in the same way 
with BSA-DL594at 28 μM as a negative control. Scale bars = 10 μm. 
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Fig 3. Interactions between IcsA passenger protein and host cell molecules.  
A. Far Western blotting of HeLa cell lysates with IcsA53-740. Confluent HeLa cells were 
recovered either by trypsinisation or cell scraper and lysed by RIPA buffer. Lysates were 
then separated by SDS-PAGE, transferred onto a nitrocellulose membrane, and probed with 
IcsA53-740 passenger protein or BSA as a negative control. Membranes were subsequently 
probed with anti-IcsA antibody. B. Far Western blotting of HeLa cell fractions with IcsA53-
740. HeLa cells were lysed and cytosolic and membrane fractions were isolated. All fractions 
were subjected to far Western blotting, as in A.  
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20 kDa that interacted with IcsA53-740 (Fig 3B lane 4).  A molecule at ~ 200 kDa was detected 
across the all fractions (Fig 3B, lane 1, 2 & 4). These data suggest that the interactions 
between the IcsA53-740 passenger domain and the host cell surface is specific and complex.  
3.5.4 IcsA amino acid region 138-148 is required for adhesion 
To identify functional regions required in adhesin activity, we utilised our 
previously generated plasmid collection that express IcsA mutants harbouring 5 amino acid 
insertions across the passenger domain (May & Morona, 2008) to screen for defects in S. 
flexneri adherence. These plasmids were introduced into S. flexneri ΔipaDΔicsA and 
transformants were used in adherence assays with HeLa cells. In a preliminary experiment 
attempting to repeat the result of Brotcke-Zumsteg et al. (2014), the IcsAi148 mutant but not 
the IcsAi386 mutant had an adherence defect (Fig S4 A). The screening was then focused on 
the N-terminus of IcsA passenger domain and three sites (i138, i140 and i148) were found 
to result in mutated IcsA protein having significant defect in adherence activity (Fig S4 B). 
To further investigate this region (138-148), the amino acids from 138 to 148 were each 
substituted for alanine and the resulting mutants were screened via HeLa adherence assays 
(Fig S4 C). However, none of these mutants conferred a significant defect in adherence 
indicating that a larger region, rather than individual residues, drives host receptor 
interactions. Subsequently, the adjacent amino acids to the i138, i140 and i148 insertion sites 
(138 and 139, 140 and 141, and 148 and 149 respectively) were randomly substituted and 
screened for the defects in adherence. Two IcsA mutants (IcsAI138P and IcsAQ148C/G149N) were 
found to cause complete loss of IcsA adherence function (Fig 4A). A deletion spanning this 
region (IcsAΔ138-148), was likewise defective in adherence (Fig 4B). To rule out any 
confounding effects caused by centrifugation, adherence assays were also performed with 
passive settling of bacteria (Fig 4C). Compared to the point mutants IcsAI138P and 
IcsAQ148C/G149N, the deletion mutant (IcsAΔ138-148) was found to have the greatest defect in 
adherence (Fig 4C). 
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Fig 4. Identification of IcsA adherence function regions.  
A. Screening for adherence related regions using IcsA point mutants and adherence assays. 
Mid-exponential phase S. flexneri were collected and used to infect HeLa cell monolayers at 
a MOI of 100 for 15 min. Monolayers were washed, lysed, and lysates were serial diluted 
before spotting on an agar plate for enumeration. Data are normalised against ΔipaD (defined 
as 100%) and are the mean with SEM of three independent experiments. Significance was 
calculated using one-way ANOVA followed by Dunnett’s multiple comparisons test against 
ΔipaDΔicsA[pIcsA], and p values are as follows: *, p<0.05. B. Adherence assay of the 
IcsAΔ138-148 mutant. Significance was calculated using a student t test, and p values are as 
follows: *, p<0.05. C. Adherence assay of IcsA adherent defective mutants. Adherence 
assays were performed as above with passive settling of bacteria. Significance was calculated 
using a student t test, and p values are as follows: *, p<0.05. 
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The adherence functional region 138 to 148 is within the glycine repeat 
region (May & Morona, 2008), thus deletion of this region might affect IcsA biogenesis 
and/or its ABM function. To test this, the expression, polar localisation, and ABM function 
of IcsAΔ138-148 were confirmed by Western blotting (Fig S5 A), immunofluorescent staining 
(Fig S5 B), and plaque formation (Fig S5 C) respectively. There was no difference in IcsA 
expression level, its surface localisation, and the size of plaques formed, between IcsA and 
IcsA
Δ138-148. This rules out any major defects in IcsA biogenesis and ABM function for this 
mutant.  
To validate that IcsAΔ138-148 has a defect in adherence in vitro, IcsA53-740(Δ138-
148) was expressed, purified, and refolded in an equivalent manner to IcsA53-740. Refolded 
IcsA53-740(Δ138-148) was able to interact with mini-N-WASP protein in vitro (Fig S2), 
confirming that the region 138-148 is not essential for IcsA’s ABM function, and that 
purified IcsA53-740(Δ138-148) protein was functional. However, relative to IcsA53-740, IcsA53-
740(Δ138-148) was unable to block the adherence of S. flexneri ΔipaD (Fig 5A). Moreover, in far 
Western blotting of HeLa cell lysates, unlike IcsA53-740, IcsA53-740(Δ138-148) had greatly 
reduced interaction with host molecules (Fig 5B), given that the deletion of 138-148 did not 
affect the recognition via anti-IcsA antibody (Fig S2). Fluorescently labelled IcsA53-740(Δ138-
148) (Fig 6A) was prepared and used to label HeLa cells, but no staining was detected (Fig 
6C). These data further supporting the notion that residues 138 to 148 affect IcsA’s adhesin 
function.  
In the human gut, Shigella virulence is activated by, among other stimuli, 
bile salt components such as DOC (Pope et al., 1995).The impact of the aa 138-148 region 
on DOC induced hyper-adherence was investigated. As expected, DOC at the physiological 
concentration 2.5 mM was able to enhance the adherence of Shigella significantly (Fig 7A). 
However, the IcsAΔ138-148 mutant displayed a significant defect in the DOC enhanced 
adherence (Fig 7A), which again confirmed that the region from 138-148 is required for the 
IcsA-mediated adherence. Moreover, invasion of HeLa cells by S. flexneri ΔicsA 
complemented with IcsAΔ138-148 to HeLa cells was also significantly attenuated (Fig 7B), 
indicating that the IcsA-mediated adherence is required for Shigella invasion. 
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Fig 5. Confirmation of the IcsA adherence related region 138-148.  
A. IcsA adherence blocking assay. Shigella grown to an OD600 of 0.5 were collected and 
used to infect HeLa cell monolayer at the MOI of 100. Purified wild type (IcsA53-740) or 
mutant (IcsA53-740(Δ138-148)) IcsA passenger protein at the concentration of 1.25 μM were 
applied at the same time. Refolding buffer was used as a negative control. After 15 min 
incubation, the cell monolayers were washed and lysed. Lysates were serial diluted before 
dotting on an agar plate for enumeration. Data are normalised against the mean of ΔipaD 
(defined as 100%) and are the mean with SEM of three independent experiments. 
Significance was calculated using a student t test, and p values are as follows: **, p<0.01. B. 
Far Western blotting of HeLa cell lysates with wild type (IcsA53-740) or mutant (IcsA53-
740(Δ138-148)) IcsA passenger protein. HeLa cells grown on 100 mm dish were recovered either 
by trypsin or cell scraper, and lysed by RIPA buffer. Lysates were then separated by 12% 
SDS-PAGE, transferred onto a nitrocellulose membrane, and probed by either IcsA53-740 or 
mutant IcsA53-740(Δ138-148) protein (12.5 μg) overnight at 4 °C. The membrane was then 
washed by TBST and subjected to Western blotting with anti-IcsA antibody. Note that B 
contains two membranes (indicated by the dashed line) that were incubated with antibodies 
and imaged together. 
86 | P a g e  
 
 
Fig 6. IcsAΔ138-148 lacks the binding ability to HeLa cells.  
A. Fluorescent labelling of IcsA53-740 and IcsA53-740(Δ138-148). IcsA53-740and IcsA53-740(Δ138-148) 
were reacted with DL594 maleimide overnight and dialysed against protein solubilisation 
buffer. Labelled fluorescent protein probes were detected at the 650 nm after SDS-PAGE. B. 
IcsA53-740 protein labelled HeLa cells. IcsA53-740-DL594 at the concentration of 1.5 μM was 
applied in the assay. After an incubation of 15 min with HeLa monolayers, samples were 
then permeabilised and stained with phalloidin and DAPI sequentially. Image was acquired 
by confocal microscopy. C. IcsA53-740(Δ138-148) protein labelled HeLa cells. IcsA53-740(Δ138-148)-
DL594 at the concentration of 1.5 μM was applied in the assay and samples were treated the 
same as in A. Scale bars = 10 μm.  




Fig 7. The adherence region IcsA 138-148 is required for Shigella adhesion and 
invasion during DOC stimulation.  
A. Adherence assay. Shigella grown to an OD600 of 0.5 in the presence of 2.5 mM DOC were 
collected and used to infect HeLa cell monolayer at the MOI of 100. After 15 min incubation, 
the cell monolayers were washed and lysed. Lysates were serial diluted before dotting on an 
agar plate for enumeration. Data are normalised against 2457T (defined as 100%) and are 
the mean with SEM of three independent experiments. B. Invasion assay. Shigella grown to 
an OD600 of 0.5 in the presence of 2.5 mM DOC were collected and used to infect HeLa cell 
monolayer at the MOI of 100. At the 45 min post-infection, gentamicin was added and 
incubated with the cell monolayers for another 45 min. Cell monolayers were then treated as 
in A. Significance was calculated using a student t test, and p values are as follows: *, p<0.05; 
**, p<0.01.  
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3.6. Article discussion 
In this work we have generated evidence that IcsA directly contributes 
to adherence of Shigella species to host cells. We were able to block the hyper-adherence 
phenotype of S. flexneri ΔipaD strains using either purified IcsA53-740 passenger domain or 
anti-IcsA antibody. Purified IcsA53-740 was able to bind host cell surfaces and recognised a 
multitude of host cell molecules. In addition, IcsA residues 138-148 were shown to be critical 
for adhesin function and purified IcsA53-740(Δ138-148) could no longer block Shigella adherence 
to host cells and was unable to recognise host cell molecules via far Western immunoblotting.  
IcsA does not have detectable adherence activity in wild-type S. 
flexneri unless exposed to environmental stimuli (such as DOC) (Pope et al., 1995), or via 
activation of the T3SS (Brotcke-Zumsteg et al., 2014). IcsA adherence activity is strongly 
associated to a conformational change as detected by proteinase accessibility (Brotcke-
Zumsteg et al., 2014). Nevertheless, in E. coli, heterogeneously expressed IcsA can promote 
bacterial adherence to host cells (Brotcke-Zumsteg et al., 2014), presumably because the 
conformation, stimuli, folding, or modification of IcsA is different to that of the S. flexneri. 
Indeed, through hNE digestion analysis on our refolded IcsA53-740, we detected a resistant 
fragment of ~40 kD similarly to that reported previously for the hNE digestion of IcsA on 
intact S. flexneri bacteria (Brotcke-Zumsteg et al., 2014), where a fragment around 40 kDa 
was more resistant to degradation by hNE in those strains with increased IcsA-mediated 
adherence. It is plausible that in Shigella, IcsA’s function in adherence is carefully 
downregulated by some mechanism governed by the T3SS before it encounters an 
environmental cue, such as DOC, whereas in E. coli, lack of such a regulating system allows 
IcsA to exert its adherence function constitutively.  
The purified and refolded IcsA53-740 passenger domain retains its activity as 
a Shigella adhesin. Due to this, pre-incubation of the HeLa cells with purified IcsA53-
740protein blocks the adherence of S. flexneri ΔipaD and ΔipaB strain. The minimum IcsA 
concentration in our experiments showing significant adherence blocking was 1.25 µM, 
which is approximately 10,000 times to the IcsA molecules expressed per input bacteria, 
assuming that each bacterium expresses approximately 4,000 IcsA molecules on the surface 
(Magdalena & Goldberg, 2002). This is likely because purified IcsA53-740 must bind to many 
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host cell receptors to block adherence. Indeed, comparable concentrations of antigens were 
also used to block virus entry (Tiwari et al., 2011) and bacteria adherence (Rose et al., 2008) 
to host cells. This is also supported by both the fluorescent labelling of HeLa cell surface and 
the far Western immunoblotting with purified IcsA53-740, indicating a specific and complex 
interaction between IcsA and host cells. It was not surprising that IcsA53-740 recognised other 
molecules from both cytosolic and membrane associated fractions, as IcsA is known to 
interact with cytosolic molecules responsible for actin based motility (Teh & Morona, 2013) 
and is recognised by host cell autophagic systems (Ogawa et al., 2005). In our antibody 
blocking assay, the anti-IcsA antibody at 3.125 µg/ml blocked the Shigella adherence 
significantly, which is comparable to the concentrations of antibodies used in other studies 
(Amerighi et al., 2016, Zhao et al., 2018, Perez-Zsolt et al., 2019). Given that our data 
support a model where IcsA may recognise multiple receptors on host cells, and that anti-
IcsA antibodies were able to neutralise Shigella adherence in vitro, this strongly suggests 
that the IcsA passenger domain has excellent vaccine potential.   
The previous study using our IcsA insertion library found insertions at sites 
148 and 386 affected IcsA-mediated Shigella adherence (Brotcke-Zumsteg et al., 2014). 
However, in the present study i138, i140, and i148, but not i386, were found to result in 
decreased IcsA-mediated adherence. The discrepancy at the site 386 is possibly due to the 
differences in the screening system. In the previous study (Brotcke-Zumsteg et al., 2014), 
IcsA mutants with normal ABM function and defects in DOC-enhanced Shigella invasion 
were selected, whereas in this study, the adherence region was screened directly by assessing 
the adherence of Shigella IcsA insertion mutants to HeLa cells. While alanine scanning 
mutagenesis of the region 138-148 showed no significant defect in adherence, it is likely that 
the entire region 138-148 is required for multiple contacts between IcsA and host cell 
receptors such that the overall interface stability between IcsA and receptor cannot be 
significantly reduced by any single alanine substitution. Nevertheless, site-directed 
mutagenesis on the IcsAi-adjacent amino acids revealed substitution mutants (I138P and 
Q148C/G149N) that resulted in significant defects in adherence. Moreover, deletion of the 
entire region (138-148) in the IcsA passenger domain also reproduced the defect of the 5aa 
insertions, and was much more severe compared to the double mutants.  
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We speculate that this 138-148 IcsA region is involved in host cell receptor 
binding events. Indeed, in a predicted IcsA passenger structure (Fig S6), the predicted β-rung 
harbouring aa 138-148 is smaller than the adjacent β-helixes and generates a groove in the 
IcsA passenger domain that might function as a putative receptor binding cleft. The Q148C 
found next to another cysteine (C130) in space located on the adjacent β-strand in the β-helix 
potentially allows the formation of a disulfide bond that might obstruct this binding cleft. 
Furthermore, purified mutant IcsA53-740(Δ138-148) passenger domain was unable to block 
adherence and showed reduced interactions to host cell components further supporting our 
speculations that this region might be a binding cleft for host receptors. Even DOC-
stimulated hyper-adherence of S. flexneri expressing mutant IcsA (IcsAΔ138-148) consistently 
showed a defect in adherence and host cell invasion. IcsA has established functional roles in 
binding of host cell cytosolic factors to nucleate ABM, and the IcsA passenger domain can 
also accommodate further functions in adhesion via a specific binding region. Therefore, 
IcsA is a truly multifunctional virulence factor providing an avenue for Shigella to quickly 
respond to the pathogenic niche for adhesion, invasion, and spreading (Koseoglu & Agaisse, 
2019).  
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3.9. Article supporting information 
S1 Table. Strains and Plasmids 
Strain or 
plasmid 
Characteristics  Source/reference 
Strains   
2457T Wild type S. flexneri 2a (Van Den Bosch et al., 
1997) 
RMA2041 2457TΔicsA::TcR (Morona & Van Den 
Bosch, 2003) 
RMA2090 2457TΔicsA::TcR[pIcsA] (Van den Bosch & Morona, 
2003) 
JQRM9 2457TΔipaD This study 
JQRM10 2457TΔipaB This study 
JQRM11 2457TΔipaDΔicsA::TcR This study 
JQRM12 2457TΔipaBΔicsA::TcR This study 
MDRM190 TOP10[pMDBADIcsA53-740] This study 
JQRM116 TOP10[pMDBAD-icsAΔ138-148] This study 
Shigella IcsA 5aa insertion collection 
JQRM16 2457TΔicsAΔipaD::frt[pIcsA] This study 
JQRM17 2457TΔicsAΔipaD::frt[pBR322] This study 
JQRM22 2457TΔicsAΔipaD::frt[pIcsAi56] This study 
JQEM23 2457TΔicsAΔipaD::frt[pIcsAi81] This study 
JQRM24 2457TΔicsAΔipaD::frt[pIcsAi87] This study 
JQRM25 2457TΔicsAΔipaD::frt[pIcsAi120] This study 
JQRM26 2457TΔicsAΔipaD::frt[pIcsAi122] This study 
JQRM27 2457TΔicsAΔipaD::frt[pIcsAi128] This study 
JQRM28 2457TΔicsAΔipaD::frt[pIcsAi132] This study 
JQRM29 2457TΔicsAΔipaD::frt[pIcsAi137] This study 
JQRM30 2457TΔicsAΔipaD::frt[pIcsAi138] This study 
JQRM31 2457TΔicsAΔipaD::frt[pIcsAi140] This study 
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JQRM32 2457TΔicsAΔipaD::frt[pIcsAi148] This study 
JQRM33 2457TΔicsAΔipaD::frt[pIcsAi185] This study 
JQRM34 2457TΔicsAΔipaD::frt[pIcsAi193] This study 
JQRM35 2457TΔicsAΔipaD::frt[pIcsAi219] This study 
JQRM36 2457TΔicsAΔipaD::frt[pIcsAi226] This study 
JQRM37 2457TΔicsAΔipaD::frt[pIcsAi228] This study 
JQRM38 2457TΔicsAΔipaD::frt[pIcsAi230] This study 
JQRM39 2457TΔicsAΔipaD::frt[pIcsAi244] This study 
JQRM40 2457TΔicsAΔipaD::frt[pIcsAi248] This study 
JQRM41 2457TΔicsAΔipaD::frt[pIcsAi268] This study 
JQRM42 2457TΔicsAΔipaD::frt[pIcsAi271] This study 
JQRM43 2457TΔicsAΔipaD::frt[pIcsAi288] This study 
JQRM44 2457TΔicsAΔipaD::frt[pIcsAi292] This study 
JQRM45 2457TΔicsAΔipaD::frt[pIcsAi297] This study 
JQRM46 2457TΔicsAΔipaD::frt[pIcsAi312] This study 
JQRM47 2457TΔicsAΔipaD::frt[pIcsAi314] This study 
JQRM48 2457TΔicsAΔipaD::frt[pIcsAi322] This study 
JQRM49 2457TΔicsAΔipaD::frt[pIcsAi324] This study 
JQRM50 2457TΔicsAΔipaD::frt[pIcsAi326] This study 
JQRM51 2457TΔicsAΔipaD::frt[pIcsAi330a] This study 
JQRM52 2457TΔicsAΔipaD::frt[pIcsAi330b] This study 
JQRM53 2457TΔicsAΔipaD::frt[pIcsAi342] This study 
JQRM54 2457TΔicsAΔipaD::frt[pIcsAi346] This study 
JQRM55 2457TΔicsAΔipaD::frt[pIcsAi369] This study 
JQRM56 2457TΔicsAΔipaD::frt[pIcsAi381] This study 
JQRM57 2457TΔicsAΔipaD::frt[pIcsAi386] This study 
JQRM58 2457TΔicsAΔipaD::frt[pIcsAi456] This study 
JQRM59 2457TΔicsAΔipaD::frt[pIcsAi502] This study 
JQRM60 2457TΔicsAΔipaD::frt[pIcsAi532] This study 
JQRM61 2457TΔicsAΔipaD::frt[pIcsAi563] This study 
JQRM62 2457TΔicsAΔipaD::frt[pIcsAi595] This study 
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JQRM63 2457TΔicsAΔipaD::frt[pIcsAi598] This study 
JQRM64 2457TΔicsAΔipaD::frt[pIcsAi633] This study 
JQRM65 2457TΔicsAΔipaD::frt[pIcsAi643] This study 
JQRM66 2457TΔicsAΔipaD::frt[pIcsAi677] This study 
JQRM67 2457TΔicsAΔipaD::frt[pIcsAi716] This study 
JQRM68 2457TΔicsAΔipaD::frt[pIcsAi748] This study 
IcsA point mutants 
JQRM85 2457TΔicsAΔipaD::frt[pIcsAI138R/T139L] This study 
JQRM86 2457TΔicsAΔipaD::frt[pIcsAI138P/T139T] This study 
JQRM94 2457TΔicsAΔipaD::frt[pIcsAI138R/T139T] This study 
JQRM96 2457TΔicsAΔipaD::frt[pIcsAG140H/S141P] This study 
JQRM98 2457TΔicsAΔipaD::frt[pIcsAG140L/S141G] This study 
JQRM101 2457TΔicsAΔipaD::frt[pIcsAG140A/S140N] This study 
JQRM102 2457TΔicsAΔipaD::frt[pIcsAG140V/S140V] This study 
JQRM106 2457TΔicsAΔipaD::frt[pIcsAQ148D/G149S] This study 
JQRM107 2457TΔicsAΔipaD::frt[pIcsAQ148K/G149S] This study 
JQRM109 2457TΔicsAΔipaD::frt[pIcsAQ148F/G149Q] This study 
JQRM111 2457TΔicsAΔipaD::frt[pIcsAQ148C/G149N] This study 
Alanine scanning 
JQRM141 2457TΔicsAΔipaD::frt[pIcsA138A] This study 
JQRM142 2457TΔicsAΔipaD::frt[pIcsA139A] This study 
JQRM143 2457TΔicsAΔipaD::frt[pIcsA140A] This study 
JQRM144 2457TΔicsAΔipaD::frt[pIcsA141A] This study 
JQRM145 2457TΔicsAΔipaD::frt[pIcsA142A] This study 
JQRM146 2457TΔicsAΔipaD::frt[pIcsA143A] This study 
JQRM147 2457TΔicsAΔipaD::frt[pIcsA144A] This study 
JQRM148 2457TΔicsAΔipaD::frt[pIcsA145A] This study 
JQRM149 2457TΔicsAΔipaD::frt[pIcsA146A] This study 
JQRM150 2457TΔicsAΔipaD::frt[pIcsA147A] This study 
JQRM151 2457TΔicsAΔipaD::frt[pIcsA148A] This study 
JQRM152 2457TΔicsAΔipaD::frt[pIcsA149A] This study 
102 | P a g e  
 
Plasmids   
pMDBADIcsA53-
740 
IcsA53-740 expression construct This study 
pIcsA pBR322 derivatives with CDS of IcsA (Van den Bosch & Morona, 
2003) 
pJQ9 pIcsAΔ138-148 IcsA mutant This study 
pJQ11 pMDBAD::icsA53-740/Δ138-148 This study 
pKD46 Lambda red plasmid, ApR, 30 °C (Datsenko & Wanner, 
2000) 
pKD4 Vector containing FRT-flanked kanR 
gene 
(Datsenko & Wanner, 
2000) 
pCP20 FLP recombinase, ApR, CmR, 30 °C (Datsenko & Wanner, 
2000) 
References 
1. Van Den Bosch L, Manning PA, Morona R. 1997. Regulation of O-antigen chain 
length is required for Shigella flexneri virulence. Mol Microbiol 23:765-775. 
2. Morona R, Van Den Bosch L. 2003. Multicopy icsA is able to suppress the virulence 
defect caused by wzz(SF) mutation in the Shigella flexneri. FEMS Microbiol Lett 
221:213-219. 
3. Van den Bosch L, Morona R. 2003. The actin-based motility defect of a Shigella 
flexneri rmlD rough LPS mutant is not due to loss of IcsA polarity. Microb Pathog 
35:11-8. 
4. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-5. 
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S2 Table Oligonucleotides 

















MD80 TTTTTTCTCGAGACTCCTCTTTCGGGTACTCAAG XhoI IcsA53 Fwd 
MD81 TTTTTTGGTACCTTATCCATCTGACTAGTTAGAT
ACCAC 
KpnI IcsA740 Rev 



















104 | P a g e  
 
JQ43 AGAGTCACCACCATTACCG Universal primer for 
alanine scanning aa 
138-149 














































# underlined nucleotides are degenerated nucleotides. 
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Fig S1. Expression, purification and refolding of the IcsA passenger protein.  
A. Schematic representation of IcsA passenger expression construct. IcsA passenger from 
amino acid 53 to 740 was fused with a His12 tag; its expression in E. coli Top10 was 
controlled by the pBAD promoter. EK, enterokinase site. B.  Coomassie blue staining of 
purified fractions containing IcsA53-740 protein. IcsA53-740 protein (indicated by the arrow) 
was solubilised from inclusion bodies, purified through nickel affinity chromatography and 
further cleaned by size exclusion gel filtration. Peak fractions were analysed by SDS-PAGE 
and stained by Coomassie blue. C. IcsA passenger refolding buffer screening. IcsA53-
740protein was diluted 1 in 20 into different buffer solutions (as indicated), and after an 
incubation of approximately 16 h at 4 °C, solutions were ultracentrifuged, resulting in the 
soluble fractions in the supernatant (S) and the insoluble fractions in the aggregates (Ag). 
Both fractions were separated by 12% SDS-PAGE and transferred onto nitrocellulose 
membrane and stained with Ponceau S. Buffer solutions are all based on 50 mM NaCl, 50 
mM Tris, pH 8, unless where stated. D. Limited proteolysis of refolded IcsA53-740 protein by 
human neutrophil elastase (hNE). Following purification, IcsA53-740 protein was dialysed and 
digested by hNE in the molecular ratio of 1000:1. Sample from different time points were 
taken and analysed by Coomassie blue stained SDS-polyacrylamide gel. E. Limited 
proteolysis of heat inactivated IcsA53-740 protein by human neutrophil elastase (hNE). 
Refolded IcsA53-740 protein was heated to 65 °C for 15 min and cooled to room temperature 
before being digested by hNE in the molecular ratio of 1000:1. 
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Fig S2. Purified IcsA protein was able to interact with mini-N-WASP.  
IcsA53-740 and IcsA53-740(Δ138-148) were mixed with mini-N-WASP-GST, incubated with 
glutathione resin overnight. IcsA53-740 and IcsA53-740(Δ138-148) were mixed with or without GST, 
incubated with glutathione resin and served as controls. Resin was then washed, and protein 
was eluted and analysed via a 12% SDS-PAGE gel and Western immunoblotting using anti-
IcsA antibody (upper) or anti-GST antibody (lower). 
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Fig S3. Inhibition of the IcsA-mediated adherence of S. flexneri ΔipaB with IcsA 
passenger protein.  
Shigella grown to an OD600 of 0.5 were collected and used to infect HeLa cell monolayer at 
the MOI of 100. Purified IcsA53-740 protein at the concentration of 2.5 μM (IcsA100), 1.25 μM 
(IcsA50), 250 nM (IcsA10) and 25 nM (IcsA1) were applied at the same time. Refolding buffer 
and BSA at the concentration of 2.8 μM were used as negative controls. After 15 min 
incubation, the cell monolayers were washed and lysed. Lysates were serial diluted before 
dotting onto agar plates for enumeration. Data are normalised against the mean of ΔipaB 
(defined as 100%) and are the mean with SEM of four independent experiments. Significance 
was calculated using one-way ANOVA followed by Dunnett’s multiple comparisons test 
against ΔipaB, and p values are as follows: ****, p<0.0001.  
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Fig S4. Screening of the IcsA mutants via adherence assays.  
A. Screening of the putative adherence defective IcsA mutants via adherence assay. Shigella 
ΔipaDΔicsA expressing the indicated IcsA mutant constructs were grown to an OD600 of 0.5 
and used to infect HeLa cell monolayer at the MOI of 100. After 15 min infection, the cell 
monolayers were washed and lysed. Lysates were serial diluted before dotting onto agar 
plates for enumeration. Data are normalised against ΔipaD (defined as 100%) and are the 
mean with SEM of three independent experiments. Significance was calculated using a 
student t test, and p values are as follows: *, p<0.05. B. Screening of the Shigella IcsA 5aa 
insertion mutants via adherence assays performed as in A.  Data represent two independent 
experiments. Significance was calculated using one-way ANOVA followed by Dunnett’s 
multiple comparisons test against ΔipaDΔicsA[pIcsA], and p values are as follows: **, 
p<0.01. C. Alanine scanning of the IcsA adherent region via adherence assays. Shigella 
ΔipaDΔicsA expressing the indicated IcsA mutant constructs were used to infect HeLa cells 
as in A. Data represent two independent experiments. Experiments and statistical analysis 
were performed as above. ns: non-significant.  
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Fig S5. The region 138-148 does not affect IcsA’s expression, localization and ABM 
function.  
A. Western immunoblotting of S. flexneri 2457T, and ΔicsA expressing IcsA or IcsAΔ138-148. 
Shigella strains grown to an OD600 of 0.5 were collected and analysed via a 12% SDS-PAGE 
gel and Western immunoblotting with anti-IcsA. B. Immunofluorescent staining of IcsA with 
whole Shigella bacteria. Bacteria grown to an OD600 of 0.5 were collected and fixed with 
formaldehyde. IcsA was stained with rabbit anti-IcsA, and Alexa Fluor 488 conjugated 
donkey anti-rabbit antibodies. Images were acquired using an Olympus epifluorescence 
microscope (May & Morona, 2008). Scale bar represents 2 µm. C. Plaque formation assay 
with IcsA mutants and their complemented strains. Shigella grown to an OD600 of 0.5 were 
collected to infect HeLa cell monolayers. After 1.5 h infection, the extracellular bacteria was 
killed by adding DMEM supplemented with 0.5% (w/v) agar and 40 µg/ml gentamycin. After 
24 h post-infection, a second layer of DMEM medium containing 0.5% (w/v) agar and 0.1% 
(w/v) Neutral Red was added and images were taken after 72 h post-infection. D. Plaque size 
measurements for plaques formed in C. Data were acquired at least from 20 plaques for each 
strain and significance was calculated using a student t test, and p values are as follow: ns, 
non-significant. Note that ΔicsA and ΔicsA [pBR322] did not form plaques. 
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Fig S6. Structural analysis of the amino group substitution sites in the IcsA passenger 
domain.  
A. Predicted structure of IcsA passenger 55-241 shown in ribbon. B. Side view of the ribbon 
structure of IcsA55-241. C. Surface of the predicted IcsA55-241 structure.  The structure of the 
IcsA passenger (55-241) was acquired from Itasser and annotated using Chimera. The amino 
group adjacent to the insertion sites (i138, i140 and i148) are marked on the structure. The 
IcsA adherent region is shown in green. 
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Chapter 4: The passenger domain of Shigella flexneri IcsA has 
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4.2. Article abstract 
Shigella species cause human bacillary dysentery by colonising the colonic 
mucosa which subsequently aids invasion of the colonic epithelium. IcsA, which has been 
long recognized for its actin-based motility (ABM) function that promotes cell to cell spread 
during the infection, also functions as a Shigella cell adhesin. IcsA’s adhesin activity was 
proposed to be through a conformational change. This study revealed that the conformational 
change is dependent on the adhesin region (aa 138-148) and is likely due to an interaction 
between IcsA’s N-terminal and C-terminal regions. Through the purification of IcsA 
passenger, two IcsA populations were isolated, and one was found to be stabilised via a 
disulfide bond. We propose that IcsA modulates its structure through a head to tail interaction 
and a disulfide bond formation stabilises this conformation. 
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4.3. Article introduction 
Shigella spp. are responsible for approximately 100 million episodes of 
shigellosis and 164,000 death cases annually worldwide, especially among children under 
the age of 5 (Kotloff et al., 2018). Shigella causes diseases in humans by targeting and 
invading human colonic epithelial cells (Labrec et al., 1964, Mathan & Mathan, 1986), which 
triggers a massive inflammatory reaction, and causes severe tissue destruction (Perdomo et 
al., 1994a), resulting in the disease symptoms of blood and mucoid stools. However, the 
mechanisms of how Shigella successfully adheres and colonises the human colon are poorly 
understood, and the IcsA protein is only one of the few surface molecules that have been 
reported to contribute to the attachment of Shigella to host cells (Brotcke-Zumsteg et al., 
2014). 
IcsA has long been known for its role in the inter- and intra-cellular spreading 
(Bernardini et al., 1989, Lett et al., 1989). Inside host cells, IcsA on the old pole of bacteria 
binds to neural Wiskott–Aldrich Syndrome protein (N-WASP) (Suzuki et al., 1998) and 
recruits the Arp2/3 complex (Egile et al., 1999), which results in the polymerisation of actin, 
facilitating the movement of the bacteria. This is known as actin-based motility (ABM). IcsA 
also functions as an adhesin in the presence of a host environmental clue deoxycholate (DOC) 
or in IpaB or IpaD null Shigella mutants (Brotcke-Zumsteg et al., 2014). It has been 
suggested that IcsA might possess two different conformations for its different roles 
(Brotcke-Zumsteg et al., 2014), however the mechanism remains unclear. 
In our previous study, IcsA has been confirmed as an adhesin directly 
contributing to Shigella adherence and a region (aa 138-148) that is responsible for IcsA’s 
adhesin role was identified and characterized (Chapter 3). In this study, it was found that the 
IcsA adhesin region affects conformational change in the IcsA passenger domain. The 
conformational change is independent to LPS O antigen, and is likely to involve a head to 
tail interaction of the IcsA passenger domain. 
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4.4. Article methods and materials 
4.4.1 Ethics statement 
The anti-IcsA antibody were produced under the National Health and 
Medical Research Council (NHMRC) Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes, and was approved by the University of Adelaide Animal 
Ethics Committee (S-2012-90). 
4.4.2 Bacterial maintenance and culture 
Shigella flexneri strains (Table S1) were streaked onto Tryptic Soy Agar with 
0.2% (w/v) Congo Red, and after incubation at 37 °C overnight, red colonies were selected 
and incubated in Lysogeny broth (LB) broth overnight with appropriate antibiotics 
(tetracycline, 10 μg/ml; kanamycin, 50 μg/ml; chloramphenicol, 25 μg/ml, spectinomycin 50 
μg/ml and ampicillin, 100 μg/ml) in the presence or absence of 2.5 mM deoxycholate.  
4.4.3 DNA manipulation 
For proteinase accessibility assays, the coding sequence of FLAG3 tag was 
added at the amino acid (aa) site 737 of the IcsA passenger in either pIcsA (Morona & Van 
Den Bosch, 2003) or pIcsAΔ138-148 (Chapter 3) plasmids using inverse PCR (Fig S1A) with 
primers listed in Table S2, resulting in pIcsAFLAG and pIcsAFLAG/Δ138-148 respectively. 
For IcsA passenger (IcsA54::FLAG×3) production, the sequences of icsA and 
icsP were PCR amplified from S. flexneri 2457T chromosomal DNA, digested with 
NcoI/SalI and NdeI/KpnI, respectively, and then ligated into the MCS1 and MCS2 of the 
pCDFDuet-1 (Novagen) plasmid to generate pCDFDuet-1::icsA-icsP. A FLAG3 tag was 
inserted next to aa 54 of IcsA passenger domain via restriction free cloning. Primers (Table 
S2) were designed to be complement to each other and were used to PCR amplify gene blocks 
containing the coding sequence FLAG3 tag flanked with sequence up- and down-stream of 
the insertion site aa 54 (Fig S1B). Gene blocks were then used as mega primers to PCR clone 
the FLAG3 tag into the pCDFDuet-1::icsA-icsP to generate the co-expression construct 
pCDFDuet-1::icsA54::FLAG-icsP. 
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4.4.4 IcsA passenger purification and size exclusion chromatography  
For IcsA passenger (IcsA54::FLAG3) production, pCDFDuet-1::icsA54::FLAG3-
icsP was introduced into C43(DE3). Bacterial strains were subcultured 1 in 20 into 4 L of 
LB from 18 h cultures and were grown to an OD600 of 0.4-0.6 at 37 °C. Expression of IcsA 
was then induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and cultures 
were incubated at 30 °C for 18 h. The culture supernatant was harvested via centrifugation 
(7,000 g, 25 °C, 15 min), and further cleaned by passing through an asymmetric 
polyethersulfone (aPES) membrane with 0.2 μm pore size (Rapid-flow, Thermo Scientific). 
Proteins in the filtered culture supernatant were then concentrated and exchanged into 50 ml 
of TBS buffer [50 mM Tris, 150 mM NaCl, pH 7.5] using a VivaFlow 200 filtration system 
(Sartorius) with 30,000 MWCO PES membranes. The concentrated protein preparation was 
then loaded onto a TBS pre-equilibrated polypropylene column (Thermo Scientific) 
prepacked with 2 mL of anti-FLAG G1 resin (Genescript). The column was washed with 
TBS, and IcsA passenger was eluted with 10 ml of 100 mM glycine, pH 3.5. IcsA passenger 
was then concentrated to 500 μl using a Vivaspin 6 with 10 kDa MWCO (GE Healthcare). 
For size exclusion chromatography analysis, protein was loaded onto a Superdex 200 
Increase 10/300 column (GE Healthcare) with TBS buffer, and different protein elution 
fractions were pooled and concentrated again as above, which yielded ~0.8 mg from 4 L 
culture supernatant. Sizes were calculated according to the Gel Filtration Makers Kit (for 
protein molecular weight 29 kDa to 700 kDa, Sigma). 
4.4.5 IcsA N-WASP pull down 
For IcsA N-WASP pull down experiments, approximately 60 µg mini-N-
WASP-his protein purified as described previously (Papayannopoulos et al., 2005) was 
mixed with either 38 µg IcsA, and incubated with 100 µL of anti-FLAG affinity resin (anti-
DYKDDDDK G1 resin, GenScript) resin overnight at 4 °C. For mock pull down, 60 µg mini-
N-WASP-his protein was mixed with 100 µL of anti-FLAG affinity resin and processed as 
above. Resins were washed 5 times with 1 mL TBS and beads were resuspended in 50 µL of 
2 SDS PAGE buffer (Lugtenberg et al., 1975) and heated to 100 °C. 
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4.4.6 Native PAGE, SDS-PAGE and Western immunoblotting 
For native PAGE, proteins were mixed with 2 native sample buffer [62.5 
mM Tris pH 6.8, 25% (v/v) glycerol, 1% (w/v) bromophenol blue] at the ratio of 1:1, and 
directly loaded onto a self-cast native gel [315 mM Tris pH 8.5, 0.1% ammonium persulfate 
(APS), 7% acrylamide/bis]. Proteins were electrophoresed with the running buffer [25 mM 
Tris pH 8.5, 192 mM glycine]. For SDS-PAGE, proteins were mixed with 2 SDS-PAGE 
sample buffer and electrophoresed in any-kDa gels (Biorad). Proteins were stained with 
Coomassie blue G250 (Thermo Scientific). 
For Western immunoblotting, proteins from the gel were transferred onto a 
nitrocellulose membrane, and the membrane was blocked with 5% (v/v) skim milk in TTBS 
buffer [TBS,  0.1% (v/v) Tween 20], incubated with either mouse anti-FLAG antibody (anti- 
DYKDDDDK antibody, Genscript), anti-N-WASP antibody (Suzuki et al., 2002) or rabbit 
anti-IcsA antibody (Van Den Bosch et al., 1997) overnight. The membrane was then washed 
with TTBS and incubated with either HRP-conjugated goat anti-mouse antibody (Biomediq 
DPC) or HRP-conjugated goat anti-rabbit antibody (Biomediq DPC) for 1 h. The membrane 
was then washed with TBS and incubated with Chemiluminescence Substrate (Sigma) for 5 
min. Chemiluminescence was detected using a ChemiDoc imaging system (BioRad). 
4.4.7 IcsA self-interaction analysis 
For IcsA self-interaction analysis, purified protein was mixed with either 100 
mM MgCl2 or 10 mM DTT and incubated for 5 min at room temperature and analysed via 
native PAGE. 
4.4.8 Chemical crosslinking 
For chemical crosslinking, purified IcsA passenger protein was mixed with 
0.1 mM, 1 mM or 10 mM DSP (Sigma) in PBS and incubated at room temperature for 30 
min. The reaction was quenched by adding 50 mM Tris (pH 7.0). 10 mM DTT was added to 
reduce the protein crosslink when required. Samples were mixed with 2 SDS-PAGE sample 
buffer without β-ME and subjected to SDS-PAGE.  
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4.4.9 Proteinase accessibility assay 
Protein accessibility assay was described previously (Brotcke-Zumsteg et al., 
2014). Briefly, Shigella strains grown overnight were collected (1109 cells) washed with 
and resuspended into 1 ml PBS. 33 nM human neutrophil elastase (hNE, Elastin Products) 
was added and incubated at 37 °C. At the indicated time points in the figure legends, a 100 
µl of sample was taken, mixed with 2 SDS-PAGE sample buffer and immediately incubated 
at 100 °C for 15 min. Alternatively, digestion fractions at the indicated time point were 
centrifuged (16,000 g, 1 min) to give whole bacterial and supernatant fractions, mixed with 
2 SDS-PAGE sample buffer and immediately incubated at 100 °C for 15 min. Samples 
were then subjected to SDS-PAGE and Western immunoblotting with anti-FLAG antibody. 
4.4.10 LPS O antigen depletion, regeneration and LPS silver staining 
LPS depletion and regeneration were done as described previously (Teh et 
al., 2012). Briefly, 18 h bacterial cultures were subcultured 1 in 20 into LB and grown to an 
OD600 of 0.5 at 37 °C before further dilution 1:20 into LB in the presence of 3 μg/ml
 
polymyxin B nanopeptide (PBMN, Sigma) and 5 μg/ml tunicamycin  (Sigma), and incubated 
for another 3 h at 37 °C to deplete the LPS O antigen. Bacterial cultures were then centrifuged, 
washed twice with fresh LB to remove PMBN and tunicamycin, and further diluted 1:20 into 
LB for another 3 h incubation at 37 °C to regenerate LPS O antigen. Samples were prepared 
for LPS silver staining and proteinase accessibility assays. LPS silver staining was performed 
as described previously (Murray et al., 2003). Briefly, Shigella strains grown to an OD600 of 
0.8 were collected (1109 cells), resuspended in 50 μl lysing buffer and incubated with 2.5 
μg proteinase K (Invitrogen) overnight at 56 °C. The LPS samples were electrophoresed on 
an SDS-15 %-PAGE gel, and the gel was stained with silver nitrate and developed with 
formaldehyde. 
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4.5. Article results 
4.5.1 IcsA’s conformational change is independent to LPS O antigen masking 
It has been shown that IcsA functions as an adhesin in the hyper-adherent 
Shigella flexneri ΔipaD (Brotcke-Zumsteg et al., 2014), and the authors proposed that an 
alternative conformation is required for IcsA to be able to promote Shigella adherence. This 
was demonstrated through in situ bacterial surface protein digestion with hNE. However, as 
Shigella surface LPS O antigen might have masking effects on IcsA (Morona et al., 2003), 
which might influence proteinase accessibility of surface presented IcsA, we considered it is 
important to rule out that the changes in hNE digestion could be attributed to modulation of 
LPS in the Shigella flexneri ΔipaD, such that it might then lead to an altered proteinase 
accessibility of IcsA (Mattock & Blocker, 2017). To examine the impact of LPS O antigen 
on the hNE accessibility of IcsA, we also constructed a C-terminus FLAG tagged IcsAFLAG 
(IcsA737::FLAG3) which is similar to the previously reported construct (Brotcke-Zumsteg et 
al., 2014). Upon the assessment of the accessibility of IcsAFLAG produced in S. flexneri 
ΔicsA[pIcsAFLAG] or ΔicsAΔipaD[pIcsAFLAG] with depleted O antigen (Fig 1A) to hNE 
digestion (Fig 1B), it was found that a ~40 kDa fragment from IcsAFLAG produced in the S. 
flexneri ΔicsAΔipaD[pIcsAFLAG] was more resistant to hNE than that expressed in the S. 
flexneri ΔicsA[pIcsAFLAG], which is in accordance with findings reported by Brotcke-
Zumsteg et al. (2014) using smooth LPS Shigella, suggesting that the altered proteinase 
accessibility is not due to an LPS O antigen masking effect. 
4.5.2 Adhesin region of IcsA affects hNE accessibility of C terminal region 
We have recently identified a region (aa 138-148) within IcsA passenger 
affecting IcsA’s adhesin function (Chapter 3), and hypothesised that the mutant IcsAΔ138-148 
does not have the altered IpaD dependent hNE accessibility compared to the wild type IcsA 
(Fig 1B&C). We digested IcsAFLAG (IcsA737::FLAG3) (Fig 2A&C) and mutant IcsAFLAG/Δ138-
148 (IcsA737::FLAG3/Δ138-148) (Fig 2B&D) produced in S. flexneri ΔicsA [pIcsAFLAG] (Fig 2A); 
S. flexneri ΔicsAΔipaD [pIcsAFLAG] (Fig 2C); S. flexneri ΔicsA [pIcsAFLAG/Δ138-148] (Fig 2B); 
and S. flexneri ΔicsAΔipaD [pIcsAFLAG/Δ138-148] (Fig 2D), respectively, with hNE. Consistent  
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Fig 1. LPS O antigen does not affect the altered hNE accessibility of IcsA. 
(A) Silver staining of Shigella LPS O antigen depletion. S. flexneri ΔicsA [pIcsAFLAG] and S. 
flexneri ΔicsAΔipaD  [pIcsAFLAG] expressing IcsAFLAG were treated without (lane 1&2) or 
with (lane 3&4) tunicamycin/PMBN and were grown for 3 h. Shigella treated with 
tunicamycin/PMBN were then washed and diluted in LB and were grown for another 3 h for 
LPS O antigen regeneration (lane 5&6). S. flexneri ΔicsA [pIcsAFLAG] (A, lane 3) and S. 
flexneri ΔicsAΔipaD [pIcsAFLAG] (A, lane 4) depleted of O antigen by treatment with 
tunicamycin/PMBN (A lane 3&4) were taken for analysis in B and C, respectively. IcsAFLAG 
produced from S. flexneri ΔicsA [pIcsAFLAG] (B) and S. flexneri ΔicsAΔipaD [pIcsAFLAG] (C) 
were digested with hNE in vivo. Samples were taken at indicated time points and were 
immunoblotted with anti-FLAG antibody. Arrow indicates full length IcsA, and the hNE 
resistant fragment (~40 kDa) is indicated by an asterisk. Note that B&C consists two gels 
and were transferred onto the same membrane. 
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Fig 2. Adherence defective IcsAΔ138-148 has an altered hNE accessibility. 
S. flexneri ΔicsA [pIcsAFLAG] (A), S. flexneri ΔicsA [pIcsAFLAG/Δ138-148] (B), S. flexneri 
ΔicsAΔipaD [pIcsAFLAG] (C), and S. flexneri ΔicsAΔipaD [pIcsAFLAG/Δ138-148] (D) were 
digested with hNE in vivo. Samples were taken at the indicated time points and were 
immunoblotted using anti-FLAG. Arrow indicates full length IcsA (~120 kDa), and the hNE 
resistant fragment (~40 kDa) is indicated by an asterisk. Note that A&C and B&D consists 
two gels respectively and were transferred onto the same membrane. 
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with Brotcke-Zumsteg et al. (2014), we detected an ~40 kDa IcsA fragment in the hyper-
adherent strain S. flexneri ΔicsAΔipaD [pIcsAFLAG] (Figure 2C) with increased resistance to 
hNE digestion compared to that produced in S. flexneri ΔicsA [pIcsAFLAG] (Fig 2A). 
Additionally, the digestion patterns of IcsAFLAG (Fig 2A) and the mutant IcsAFLAG/Δ138-148 
(Fig 2B) produced in S. flexneri ΔicsA [pIcsAFLAG] and S. flexneri ΔicsA [pIcsAFLAG/Δ138-148] 
were similar, suggesting that the deletion of the adhesin region did not dramatically alter the 
structure of IcsA. However, unlike the IcsAFLAG (Fig 2C), the mutant IcsAFLAG/Δ138-148 
produced in the S. flexneri ΔicsAΔipaD [pIcsAFLAG/Δ138-148]  (Fig 2D) was much less resistant 
to hNE digestion, suggesting that 138-148 region is required for the wild type IcsAFLAG to 
have an alternative proteinase accessibility as detected in IcsAFLAG produced in the hyper-
adherent S. flexneri ΔipaD background. 
To further investigate the molecular mechanism of how IcsA alters its 
conformation for its adhesin role, we took advantage of our FLAG tagged construct to 
determine the origin of the FLAG×3 tagged 40 kDa fragment from IcsAFLAG. The FLAG3 
tag was engineered to be between the C terminus of IcsA passenger and the β-barrel domain 
(Fig 3C). To determine whether the detected 40 kDa fragment was actually from the IcsA 
passenger domain, the digested samples at each time point were separated into whole bacteria 
and supernatant sub-fractions. We found that the hNE resistant fragment (40 kDa) was 
cleaved off the bacteria surface in the first 5 min and released into the supernatant (Figure 
3B). Therefore, the ~40 kDa hNE resistant fragment is derived from the passenger domain. 
This were also the case for both IcsAFLAG and the mutant IcsAFLAG/Δ138-148 produced by S. 
flexneri ΔicsA [pIcsAFLAG] (Fig S2A), S. flexneri ΔicsAΔipaD [pIcsAFLAG] (Fig S2C), S. 
flexneri ΔicsA [pIcsAFLAG/Δ138-148] (Fig S2B), and S. flexneri ΔicsAΔipaD [pIcsAFLAG/Δ138-148] 
(Fig S2D), respectively. Moreover, at 90 min post-digestion by hNE, the ~40 kDa fragment 
was predominant only in the sample for S. flexneri ΔicsAΔipaD [pIcsAFLAG] (Fig S2C), 
which again confirmed our hypothesis that the region 138-148 is responsible for the altered 
proteinase accessibility associated with IcsA’s hyper-adherence phenotype in S. flexneri 
ΔipaD background. The β-barrel domain (aa 759-1102) of IcsA is embedded into the 
membrane and inaccessible to the hNE, hence the cleavage at the C-terminal of the ~40 kDa 
fragment was between the FLAG×3 and β-barrel domain, which is predicted to be at around  
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Fig 3. The ~40 kDa hNE resistant fragment is from the C terminal region of IcsA 
passenger. 
S. flexneri ΔicsA [pIcsAFLAG] expressing IcsAFLAG were digested with hNE in situ. Samples 
were taken at the indicated time points and were separated into (A) whole cell lysate (WCL) 
and (B) digestion supernatant (Sup), and were immunoblotted with anti-FLAG antibody. The 
hNE resistant fragment (~40 kDa) is indicated by an asterisk. (C) Predicted hNE digestion 
map. 3D structures of IcsA passenger and β-barrel were acquired from I-TASSER. The 
predicted hNE cutting sites are indicated by the scissors and the adhesin region (aa 138-148) 
of IcsA is shown in red. The position of the FLAG×3 is indicated in the orange box. 
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aa 760, given that hNE preferably cleaves alanine, valine and isoleucine (Weinrauch et al., 
2002, Fu et al., 2018). According to the size of the fragment, it can also be estimated that the 
cleavage at the N-terminal of the ~40 kDa fragment is around aa 413. Clearly, the ~40 kDa 
fragment does not contain the adhesin region aa 138-148, yet deletion of this region at N-
terminal of IcsA passenger affected IcsA’s resistance to hNE digestion at the C terminal 
region (Fig 2). Therefore, we hypothesised that IcsA’s N-terminal region may interact with 
C terminal region (414-760) in the hyper-adherent S. flexneri ΔipaD, thereby increasing the 
resistance of C terminal region to hNE. 
4.5.3 Purified IcsA passenger has an intramolecular interaction 
To further investigate the potential head to tail interaction of IcsA at a 
molecular level, we purified IcsA passenger (IcsA54::FLAG3) from the culture supernatant (Fig 
4A) and confirmed its function of interacting with N-WASP protein (Fig S3 A&B). 
Following size exclusion chromatography, the purified IcsA passenger showed two 
populations (Fig 4B) which migrated with the apparent molecular size of 249 kDa (Fig 4B, 
H) and 137 kDa (Fig 4B, L). This was also confirmed by Native PAGE gel (Fig 4D), 
indicating that IcsA passenger has self-association ability. To further analyse the self-
interaction of IcsA, we tested whether these two forms of IcsA were affected by electrostatic 
interactions (Jekow et al., 1999) using 100 mM MgCl2 or disulfide bond formation using 10 
mM DTT (Fig S4). We found that treatment of DTT resulted in a shift in migration of the 
137 kD band up to ~146 kDa in the Native PAGE gel (Fig 5A and Fig S4), indicating that 
the 137 kDa band had a disulfide bond. IcsA adapts an elongated shape (Kuhnel & Diezmann, 
2011, Leupold et al., 2017, Mauricio et al., 2017), similar to other bacterial autotransporter 
adhesins Pertactin (Emsley et al., 1996) and antigen 43 (Heras et al., 2014). Therefore, it was 
not possible to determine the oligomeric status of these sub-populations using standard 
protein markers with globular shape. However, when treated to reduce disulfide bonds, the 
IcsA passenger domain migrated slower in the Native PAGE gel (Fig 5A), suggesting that 
the disulfide bond forms intramolecularly. IcsA has three cysteines in the passenger domain. 
One of the cysteines (aa 130) is located near the adhesin region (138-148), and the other two 
(aa 376 and 380) are closely located in the middle of the passenger. It is likely that the 
disulfide bond forms between 130 to 376 or 380, thereby causing a dramatic change in gel  
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Fig 4. Purification of IcsA passenger protein. 
(A) IcsA passenger (IcsA54::FLAG3) was purified with FLAG affinity resin, and the eluted 
fractions (lane 1-4) were analysed by SDS-PAGE. (B) Purified IcsA passenger was analysed 
via size exclusion chromatography, and protein sizes were calculated using protein standard 
markers. The IcsA populations at the higher (a) apparent molecular weight (249 kD) and the 
lower (b) apparent molecular weight (137 kDa) were analysed by (C) SDS-PAGE and (D) 
Native PAGE. Purified IcsA passenger is indicated by an asterisk. 
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Fig 5. Purified IcsA passenger protein has an intramolecular interaction to promote a 
disulfide bond formation. 
(A) Purified IcsA passenger (IcsA54::FLAG3) separated by size exclusion chromatography 
with higher (H) and lower (L) apparent molecular weight were treated with 10 mM DTT. 
Samples were then analysed via Native PAGE. IcsA with higher apparent molecular weight 
(a), lower apparent molecular weight (b) and DTT reduced lower apparent molecular weight 
population (c) were indicated. (B) DSP crosslinking of purified IcsA protein. Purified IcsA 
passenger was treated with DSP at different concentration and analysed by SDS-PAGE. DSP 
cross-linked IcsA are indicated with asterisks.  
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mobility, as this would be a result from a head to tail interaction which changes the overall 
shape of the IcsA molecule. Indeed, we found that when treated with 0.1 mM DSP (Fig 5B), 
purified IcsA passenger (74 kDa) migrated at ~66 kDa in denaturing conditions (Fig 5B), 
faster than the migration of un-crosslinked IcsA passenger in the gel. In addition, this 
migration change is reversible by the treatment of DTT which reduced the disulfide bond in 
DSP (Fig 5B). Collectively, these data suggested that the purified IcsA passenger has an 
intramolecular interaction between head to tail which allows a disulfide bond to form. This 
supports our observations that a head to tail arrangement of IcsA is impacted by the adhesin 
region. 
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4.6. Discussion 
In this study we found that the IcsA exists in multiple conformations. We 
found that the alternative conformation of IcsA requires the IcsA adhesin region aa 138-148, 
as the adhesin defective mutant IcsAΔ138-148 did not show altered accessibility to hNE when 
expressed in S. flexneri ΔicsAΔipaD (Fig 2B&D). Furthermore, the hNE resistant IcsAFLAG 
fragment at ~40 kDa was found to be derived from the C terminus of passenger, which is the 
region close to the bacterial surface and well separated from the adhesin region (138-148). 
IcsA passenger had been purified as a monomer previously (Mauricio et al., 2017). Using 
the similar approach, we isolated IcsA passenger in two forms and found one with an 
intramolecular interaction which facilitated an intramolecular disulfide bond formation (Fig 
5A). This intramolecular interaction was also revealed by DSP crosslinking of the purified 
IcsA protein (Fig 5B). It has been reported previously that IcsA forms a disulfide bond, which 
increases the resistance to proteinases (Brandon & Goldberg, 2001). Therefore, it is plausible 
that the alternative conformation of IcsA associated with adhesin activity might involve in 
the interaction between the adhesin region and the C terminus region, whereby allowing the 
C terminal region of IcsA to become more resistant to hNE digestion. Interestingly, in 
addition to the region 138-148, 5 aa insertion mutation at 386, which is near the other two 
cysteines (376 and 380), was also reported to affect IcsA’s adhesin activity (Brotcke-
Zumsteg et al., 2014). It is plausible that a disulfide bond could form between 130 and 376 
or 380, as the overall structure of IcsA passenger was found in a “V” shape which has been 
proposed to form a bridging loop between the central region of the protein to interact with 
the N-terminal domain (Mauricio et al., 2017). 
We speculate that the N-terminal domain of IcsA is flexible which could aid 
the conformational change, as the C-terminal of the passenger adapts a compact structure 
(Leupold et al., 2017). In contrast to the N-terminal domain, the C-terminal domain (aa ~414-
760) of IcsA passenger is more resistant to hNE (Fig 3B). This region is almost identical to 
the crystalized IcsA passenger region (419-758) , which was screened out from 18,432 
truncated IcsA constructs and was the only one to succeed in crystallization (Leupold et al., 
2017). 
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IcsA has recently been reported to aid S. flexneri biofilm formation in the 
presence of bile salts by promoting bacterial cell to cell contact and aggregative growth 
(Koseoglu et al., 2019). E. coli bacterial clumping was revealed to be mediated via the head 
to tail interaction of autotransporter antigen 43 (Heras et al., 2014). Therefore, we speculate 
that this head to tail interaction in IcsA is important for its function as an adhesin that 
promotes S. flexneri adherence and biofilm formation. Here we propose a model (Fig 6) 
where IcsA changes its conformation through the interaction between the N-terminal domain 
and its C-terminal domain in the hyper-adherent S. flexneri and this interaction also allows 
the formation of a disulfide bond.  
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Fig 6. Model of IcsA adapting alternative conformations through an intramolecular 
interaction. 
In the wild type strain grown in standard culture conditions, IcsA passenger is adhesin 
inactive (a). The N-terminal region does not interact with its C terminal region. When 
produced in S. flexneri ΔipaD, IcsA is adhesin active (b). The N-terminal region interacts 
with the C terminal region. This interaction allows a disulfide bond formation (c). The 
adhesin region aa 138-148 is indicated with arrows. 
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4.9. Article supporting information 
 
Fig S1. Generation of FLAG-tagged IcsA expression construct. 
(A) Generation of pIcsAFLAG and pIcsAΔ138-148/FLAG. Primers were designed to target the 
adjacent sequence to aa 737 with half of the FLAG×3 sequence each and amplify the whole 
pIcsA or pIcsAΔ138-148 plasmid to generate pIcsAFLAG and pIcsAΔ138-148/FLAG. (B) Construction 
of FLAG-tagged IcsA plasmid for IcsA passenger (IcsA54::FLAG3) purification. Primers were 
designed to be complementary to each other and were used to PCR amplify (1st PCR) gene 
blocks containing the coding sequences of FLAG3 tag and flanked with up- and down-
stream sequences to the insertion site at aa 54. Gene blocks were then used as mega primers 
to PCR clone (2nd PCR) the FLAG3 tag into the pCDFDuet-1::icsA-icsP to generate the co-
expression construct pCDFDuet-1::icsA54::FLAG3-icsP (pIcsA-IcsP). 
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Fig S2. The ~40 kDa hNE resistant fragment is from the C terminal region of IcsA 
passenger. 
S. flexneri ΔicsA [pIcsAFLAG] (A), S. flexneri ΔicsA [pIcsAFLAG/Δ138-148] (B), S. flexneri 
ΔicsAΔipaD [pIcsAFLAG] (C), and S. flexneri ΔicsAΔipaD [pIcsAFLAG/Δ138-148] (D) were 
digested with hNE in vivo. Samples were taken at the indicated time points and were 
separated into whole cell lysate (WCL) and digestion supernatant (Sup), and were 
immunoblotted with anti-FLAG antibody. Arrow indicates full length IcsA, and the hNE 
resistant fragment (~40 kDa) is indicated by an asterisk. 
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Fig S3. Purified FLAG-tagged IcsA is able to interact with N-WASP. 
Purified IcsA passenger (IcsA54::FLAG3) was mixed with both mN-WASP and FLAG resin, 
and were incubated for 18 h. For mock pull down, mN-WASP was mixed with FLAG resin 
only (mock). Resins were washed, and denatured in SDS-PAGE buffer. Samples were 
analysed via (A) SDS-PAGE and (B) immunoblotting with anti-N-WASP. The position of 
IcsA passenger and mN-WASP are indicated. 
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Fig S4. Purified IcsA forms an intramolecular disulfide bond. 
Purified IcsA passenger (unseparated, US) and size exclusion chromatography separated 
IcsA with higher (H) and lower (L) apparent molecular weight were treated with 100 mM 
MgCl2 and 10 mM DTT. Samples were then analysed via Native PAGE and were 
immunoblotted with anti-IcsA. IcsA with higher apparent molecular weight (a), lower 
apparent molecular weight (b) and DTT reduced apparent lower molecular weight population 
(c) are indicated. 
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Table S1. Strains and Plasmids 
Strain or plasmid Characteristics  Source/reference 
Strains   
2457T Wild type S. flexneri 2a (Van Den Bosch et al., 
1997) 
RMA2041 2457TΔicsA::TcR (Morona & Van Den 
Bosch, 2003) 
JQRM11 2457TΔipaDΔicsA::TcR (Chapter 3) 
JQRM115 C43[pCDFDuet-1::icsA54::FLAG3-icsP] This study 
JQRM120 ΔicsA[pIcsAFLAG] This study 
JQRM121 ΔicsA[pIcsAFLAG/Δ138-148] This study 
JQRM122 ΔipaDΔicsA[pIcsAFLAG] This study 
JQRM123 ΔipaDΔicsA[pIcsAFLAG/Δ138-148] This study 
Plasmids   
pIcsA pBR322 derivatives with CDS of IcsA (Van den Bosch & 
Morona, 2003) 
pIcsAΔ138-148 pIcsAΔ138-148 IcsA mutant (Chapter 3) 
pIcsA-IcsP pCDFDuet-1::icsA54::FLAG3-icsP This study 
pIcsAFLAG pIcsA737::FLAG3 This study 
pIcsAFLAG/Δ138-148 pIcsA737::FLAG3/Δ138-148 This study 
References 
Van Den Bosch, L., Manning, P.A. and Morona, R. (1997). Regulation of O-antigen chain 
length is required for Shigella flexneri virulence. Mol Microbiol 23, 765-775. 
Morona, R. and Van Den Bosch, L. (2003). Multicopy icsA is able to suppress the virulence 
defect caused by wzz(SF) mutation in the Shigella flexneri. FEMS Microbiol Lett 221, 
213-219. 
Van den Bosch, L. and Morona, R. (2003). The actin-based motility defect of a Shigella 
flexneri rmlD rough LPS mutant is not due to loss of IcsA polarity. Microb Pathog 
35, 11-8. 
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Table S2 Oligonucleotides 
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ICSA RECEPTOR IDENTIFICATION 
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Chapter 5: IcsA receptor identification 
5.1. Introduction 
IcsA has been confirmed as a S. flexneri adhesin contributing to the polar 
attachment of Shigella to host cells (Brotcke-Zumsteg et al., 2014), thereby facilitating 
subsequent invasion. However, the cellular receptors for IcsA have not yet been revealed. 
Brotcke-Zumsteg et al. (2014) suggested that the receptors for IcsA are expressed in multiple 
cell types, given that the IcsA-dependent hyper-adherence can be demonstrated in HeLa cells, 
polymorphonuclear leukocytes (PMN) cells, and mouse Bone-marrow-derived macrophage 
(BMDM) cells. In Chapter 3, the purified IcsA passenger IcsA53-740 showed ability to bind 
to HeLa cell surfaces by interacting with several trypsin sensitive molecules from the 
membrane fraction, which demonstrated a potential use as a bait protein to investigate the 
host cellular receptors. The aim of this Chapter was to attempt to use the purified IcsA53-740 
protein to identify receptors in HeLa cells.  
5.2. IcsA receptor identification 
To identify the receptors for IcsA, HeLa cells grown to confluence from four 
100 mm dishes were lysed and incubated with His-tagged IcsA53-740, and the IcsA53-740 
interacting complexes was immunoprecipitated using protein A resin preloaded with either 
anti-IcsA or anti-His6 antibody (Section 2.7.17). Samples were then prepared and 
electrophoresed in an SDS-PAGE gel as described in Section 2.7.17.  
Several HeLa cell molecules with apparent molecular sizes around 15 kDa, 
40 kDa, 65 kDa, 180 kDa, 200 kDa and over 200 kDa were pulled down by IcsA53-740 (Figure 
5.1, lane 2&3) compared to the mock co-immunoprecipitation (co-IP) (Figure 5.1, lane 1). 
To investigate the cell surface receptors for IcsA, it was decided to select only the bands 
(Figure 5.1, lane 2&3, a) that correlated to the trypsin sensitive molecules from the HeLa 
membrane fraction detected via far Western blotting (Section 3.5.3), and these were excised 
out for mass spectrometry analysis (Section 2.7.19.1). The same region in the mock co-IP 
(Figure 5.1, lane 1) was excised and analysed by mass spectrometry to determine non-
specifically bound proteins. 
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Figure 5.1. Co-immunoprecipitation of IcsA-interacting molecules from HeLa cells. 
HeLa cell lysates were incubated with either dialysis buffer (lane 1) or IcsA53-740 (lane 2 and 
3), and IcsA interacting complexes were precipitated with anti-IcsA (lane 1 and 2) or anti-
His6 (lane 3) (Section 2.7.17), separated by SDS-PAGE (Section 2.7.9.1), and stained with 
Colloidal blue (Section 2.7.10.2). The IcsA interacting molecules detected in both far 
Western blotting (Section 3.5.3) and in co-IPs are indicated by an arrow. a: bands excised 
for MS analysis; b: IcsA53-740. 
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Upon the mass spectrometry analysis of samples (Figure 5.1, a) from both 
anti-IcsA and anti-His6 immunoprecipitations, Nonmuscle Myosin Heavy Chain IIA (NM-
Myosin IIA, MYH9) and NM-Myosin IIA (MYH10) (~220 kDa) were identified with unique 
peptides matched to 31.7% and 23.1% of the sequences, respectively (Table 5.1). These were 
not present in samples from the mock co-IP. This implicates these proteins as potential host 
cell surface displayed receptors for the IcsA passenger domain. These co-IP samples were 
also analysed via Western immunoblotting (Section 2.7.11) with anti-Myosin IIA antibodies. 
However, Myosin IIA was undetectable in both the co-IPs done with anti-IcsA and anti-His6 
antibodies, but was detected in HeLa cell lysates (see Figure 5.3). 
5.3. Investigation of the interaction between IcsA and Myosin 
IIA/IIB 
To investigate whether Myosin IIA and Myosin IIB are the host cell 
molecules that are recognised by S. flexneri IcsA, thereby allowing the attachment of the 
hyper-adherent S. flexneri ΔipaD, anti-Myosin IIA and anti-Myosin IIB antibodies (Section 
2.3.1) were used in Shigella adherence blocking assays (Section 2.9.2.2).  
It was found that neither anti-Myosin IIA nor anti-Myosin IIB antibodies 
significantly blocked the adherence of S. flexneri ΔipaD to HeLa cells (Figure 5.2), although 
it showed an decrease in adherence rate when treated with 15 μg/ml anti-Myosin IIA 
antibodies compared to the S. flexneri ΔipaD treated with lower concentrations of anti-
Myosin IIA.  
Since the preincubation of HeLa monolayers with 15 μg/ml of anti-Myosin 
IIA antibody showed a slight decrease in the adherence of S. flexneri ΔipaD (Figure 5.2), the 
role of Myosin IIA in HeLa cells for S. flexneri ΔipaD adherence was investigated in COS-
7 cells. COS-7 cells are African Green Monkey kidney cells and do not express Myosin IIA 
(Bao et al., 2005). 
To confirm that COS-7 does not express Myosin IIA, whole cell lysate 
sample (Section 2.7.14) of both COS-7 cells and HeLa cells were prepared and analysed via 
Western immunoblotting (Section 2.7.11.3) with anti-Myosin IIA antibodies (Section 2.3.1). 
Indeed, compared to HeLa cell lysate, anti-Myosin IIA antibody does not recognise any  
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Table 5.1. Mass spectrometry identified Myosin IIA/IIB unique peptides 
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Figure 5.2. Shigella adherence blocking assay by anti-Myosin IIA and anti-Myosin 
IIB 
Antibody adherence blocking assay. HeLa cells grown to confluence were incubated with 
either anti-Myosin IIA or anti-Myosin IIB at the concentrations of 15 μg/ml (10), 1.5 μg/ml 
(1), and 0.15 μg/ml (0.1) for 15 min. Shigella grown to an OD600 of 0.5 were collected and 
infected HeLa cell monolayers at the MOI of 100. After an extended 15 min incubation, cell 
monolayers were washed with PBS and lysed in PBS containing 1% (v/v) Triton X-100 
before serial dilution plating on LB agar plates (Section 2.9.2.2).  Data is normalised against 
the mean of ΔipaD (defined as 100%) and is the mean with SEM of three independent 
experiments. Significance was calculated (Section 2.9.4) using a student t test, and p values 
are as follows: ns, non-significant. 
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molecules from COS-7 cell lysate (Figure 5.3), which confirmed the absence of Myosin IIA 
in COS-7 cells. 
To assess the IcsA-dependent adherence of S. flexneri ΔipaD in the absence 
of Myosin IIA, COS-7 cells grown to confluence were used to perform Shigella adherence 
assays (Section 2.9.1) with WT Shigella flexneri 2a (2457T), S. flexneri ΔipaD, S. flexneri 
ΔipaDΔicsA, S. flexneri ΔipaDΔicsA [pIcsA],  and S. flexneri ΔipaDΔicsA [pBR322]. It was 
found that the expression of IcsA in S. flexneri ΔipaDΔicsA [pIcsA] significantly increased 
the adherence to COS-7 cells compared to that in S. flexneri ΔipaDΔicsA [pBR322] (Figure 
5.4). This suggested that although Myosin IIA was absent in COS-7 cells, S. flexneri ΔipaD 
was still able to adhere to cells. Furthermore, both the adherence levels of S. flexneri ΔipaD 
and S. flexneri ΔipaDΔicsA [pIcsA] were not significantly different between HeLa cells and 
COS-7 cells (Figure 5.4). Collectively, this indicated that there might be other IcsA receptors 
existing in COS-7 cells.  
To assess whether COS-7 cells express molecules that can be recognised by 
IcsA, COS-7 cells were lysed (Section 2.7.14) and analysed via far Western blotting (Section 
2.7.11.5) with both purified IcsA53-740 (Figure 5.5, lane 1&2) and the adherence defective 
mutant IcsA53-740(Δ138-148) (Figure 5.5, lane 3&4). A HeLa cell lysate was used as a control 
(Figure 5.5, lane 1&3). 
As expected, unlike the purified mutant IcsA53-740(Δ138-148) (Figure 5.5, lane 
3), IcsA53-740 (Figure 5.5, lane 1) was able to recognise molecules from HeLa cells. However, 
there are molecules from COS-7 cells recognised by IcsA53-740 (Figure 5.5, lane 2) but not 
by IcsA53-740(Δ138-148) (Figure 5.5, lane 4), which indicated that other IcsA-interacting 
molecules are present in COS-7 that contribute to the IcsA-dependent adherence observed 
for S. flexneri ΔipaD (Figure 5.4). 
Myosin IIA has been reported to be essential for S. flexneri spread 
intercellularly in HeLa cells (Lum & Morona, 2014b). Therefore, to test whether this is also 
the case in COS-7 cells, S. flexneri WT (2457T), S. flexneri ΔicsA [pBR322], and S. flexneri 
ΔicsA [pIcsA] grown to the mid-exponential phase (Section 2.1.3.2) were used in plaque 
formation assays (Section 2.9.5) with both HeLa and COS-7 cells.  
 






Figure 5.3. Western immunoblotting confirming the absence of Myosin IIA in COS-7 
cells 
HeLa cells and COS-7 cells (Section 2.2.1) grown to confluence were recovered by cell 
scraper and prepared into whole cell lysate sample (Section 2.7.14). Samples were then 
analysed via SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 2.7.11.3) 
with anti-Myosin IIA antibody (Section 2.3.1). Full length Myosin IIA (~220 kDa) is 
indicated with an arrow. 
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Figure 5.4. Adherence assay of S. flexneri with HeLa and COS-7 cells 
Shigella grown to an OD600 of 0.5 were collected and used to infect HeLa cell monolayer at 
the MOI of 100 (Section 2.9.1). After 15 min incubation, the cell monolayers were washed 
and lysed. Lysates were serial diluted before dotting onto agar plates for enumeration 
(Section 2.9.1). Data is normalised against the mean of ΔipaD (defined as 100%) and is the 
mean with SEM of three independent experiments. Significance was calculated (Section 
2.9.4) using a student t test, and p values are as follows: ****, p<0.0001; ns, non-significant. 
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Figure 5.5. Far Western immunoblotting detecting IcsA-interacting molecules from 
COS-7 cells 
HeLa cells and COS-7 cells grown to confluence were recovered either by cell scraper and 
lysed by RIPA buffer (Section 2.7.14). Lysates were then separated by SDS-PAGE (Section 
2.7.9.1), transferred onto a nitrocellulose membrane (Section 2.7.11.1), and probed with 
IcsA53-740 passenger protein or IcsA53-740(Δ138-148) as a negative control (Section 2.7.11.5). 
Membranes were subsequently probed with anti-IcsA antibody (Section 2.7.11.5). 
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As expected, S. flexneri ΔicsA [pIcsA] generated plaques (Figure 5.6 A, 
upper panel) in a similar size to the WT S. flexneri 2457T (Figure 5.6 B) in HeLa cells. 
However, in COS-7 cells (Figure 5.6 A, lower panel), S. flexneri ΔicsA [pIcsA] also 
generated plaques (Figure 5.6 A, lower panel) as the similar size to the WT S. flexneri 2457T 
(Figure 5.6 B). Interestingly, the size of the plaques on COS-7 cells were significantly larger 
(~2×) than those generated in HeLa cells (Figure 5.6 B). Together, these data indicated that 
Myosin IIA is not the limiting factor for IcsA’s ABM function in COS-7 cells.  
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Figure 5.6. Myosin IIA is not essential for intercellular spread in COS-7 cells 
(A) Plaque formation assay (Section 2.9.5) using S. flexneri WT (2457T), S. flexneri ΔicsA 
[pBR322], and S. flexneri ΔicsA [pIcsA] with HeLa cells (upper panel) and COS-7 cells 
(lower panel). Strains grown to mid-exponential phase were collected and used to infect cell 
monolayers for 1.5 h. The extracellular bacteria was killed by adding DMEM supplemented 
with 0.5% (w/v) agar and 40 µg/ml gentamycin. After 24 h post-infection, a second layer of 
DMEM medium containing 0.5% (w/v) agar and 0.1% (w/v) Neutral Red was added and 
images were taken after 72 h post-infection. Scale bar represents 5 mm. (B) Plaque size 
measurements for plaques formed in A (Section 2.9.5). Data were acquired at least from 10 
plaques for each strain and significant was calculated using a student t test (Section 2.9.4), 
and p values are as follow: ****, p<0.0001. Note that S. flexneri ΔicsA [pBR322] did not 
form plaques on HeLa and COS-7 cells. 
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5.4. Discussion 
This Chapter attempted to identify the receptors for the S. flexneri adhesin 
IcsA in HeLa cells. Using the purified IcsA53-740, several IcsA-interacting molecules from a 
HeLa whole cell lysate were co-immunoprecipitated with protein A preloaded with either 
anti-IcsA or anti-His6 antibodies. The molecules at the molecular sizes corresponding to 
those trypsin sensitive IcsA-interacting components (~220 kDa) shown by far Western 
blotting in Chapter 3 (Section 3.5.3) were excised and identified as Myosin IIA and Myosin 
IIB via mass spectrometry. This implicates these proteins as potential host cell surface 
displayed receptors for IcsA passenger domain adhesin activity. However, neither anti-
Myosin IIA nor anti-Myosin IIB antibody significantly blocked the hyper-adherence of S. 
flexneri ΔipaD to HeLa cells, though anti-Myosin IIA showed slight inhibition at the 
concentration of 15 µg/ml. The anti-Myosin IIA and anti-Myosin IIB antibodies used in the 
adherence blocking assay were developed against synthetic peptides corresponding to amino 
acid residues 1949-1960 of Myosin IIA and 1965-1976 of Myosin IIB, respectively, hence 
they might have limited ability to block the IcsA interacting sites. In HeLa cells, Myosin IIA 
might not be the only nor the major receptor for IcsA to target. This is supported by the far 
Western immunoblotting (Chapter 3, Section 3.5.3), where multiple HeLa cell molecules 
were recognized by IcsA53-740. Hence it might be difficult to validate the role of Myosin IIA 
in acting as a receptor for IcsA in S. flexneri adherence. In addition, Western immunoblotting 
on the co-IP samples with anti-Myosin IIA antibody failed to detect Myosin IIA. This is 
likely to due to the low expression level of Myosin IIA on HeLa cell surfaces (Sun et al., 
2014). 
Although Myosin IIA is not present in COS-7 cells, S. flexneri ΔipaD still 
demonstrated the hyper-adherence phenotype in an IcsA-dependent manner. The adherence 
level was comparable to that observed with HeLa cells. This data indicated that other cellular 
molecules may play a role as IcsA receptors. Indeed, using far Western immunoblotting, 
IcsA-interacting molecules were also detected in COS-7 cell lysates.  
Myosin IIA was reported to be essential in S. flexneri cell to cell spread in 
HeLa cells (Lum & Morona, 2014b), yet it was not required for S. flexneri to generate plaques 
in COS-7 monolayers. In fact, S. flexneri generated plaques twice the size as those on HeLa 
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cells. The size of the plaques generated in cell monolayers positively correlated to IcsA’s 
cell to cell spread function. This highlighted an intrinsic difference between cell lines in that 
S. flexneri IcsA could utilise different cellular components and mechanisms in different cells 
for its cell to cell spread function. This could also be the case in the IcsA mediated hyper-
adherence seen in S. flexneri ΔipaD, where incubation of IcsA passenger detected different 
interacting molecules in COS-7 cells compared to HeLa cells. 
While Myosin IIA is an intracellular molecule (Shutova & Svitkina, 2018), 
in the human intestinal mucosa it was found on the villous surface of the epithelial lining and 
colonic crypt epithelium (Babbin et al., 2009) which are the primary infection sites reported 
in the Guinea pig and humans (Arena et al., 2015). Myosin IIA has been reported as a 
receptor for Thrombocytopenia syndrome virus (Sun et al., 2014) and as a cellular entry 
receptor for herpes simplex virus 1 (HSV-1) (Arii et al., 2010). Currently, it cannot be 
concluded that interaction between IcsA and myosin IIA is essential for Shigella adherence 
but remains intriguing for future investigation. A cell line with increased surface expression 
of Myosin IIA would greatly aid the investigation of how Myosin IIA contributes to the IcsA-
mediated S. flexneri adherence. 
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Chapter 6: Investigation of the role of deoxycholate in Shigella 
flexneri hyper-adherence 
6.1. Introduction 
S. flexneri grown in the presence of deoxycholate (DOC) exhibited a hyper-
adherence phenotype (Pope et al., 1995), and this phenotype is depend on the presence of 
the adhesin IcsA and is controlled by the T3SS (Brotcke-Zumsteg et al., 2014). Incubation 
of S. flexneri WT with DOC at 4 °C did not increase the adherence to HeLa cells (Pope et 
al., 1995), hence the DOC induction signal cascade is likely to be through the expression of 
some unknown factors. The molecular mechanism of this induction process remains to be 
investigated. Similar to this, S. flexneri ΔipaD which has a defective T3SS also had increased 
adherence to host cells compared to that of WT S. flexneri (Menard et al., 1993). In a previous 
study (Brotcke-Zumsteg et al., 2014), it was found that the hNE accessibility of IcsA 
produced in DOC induced S. flexneri WT or S. flexneri ΔipaD was altered compared to that 
produced in S. flexneri WT in the absence of DOC, yet the mechanism of how IcsA changed 
its hNE accessibility remains unclear. 
The aim of this Chapter is to characterise the hyper-adherence of S. flexneri 
WT grown in the presence of DOC, and attempt to determine the molecular mechanism of 
DOC induced IcsA-dependent hyper-adherence. 
6.2. DOC triggers the release of IpaD into the culture supernatant 
The impact of DOC on the expression and secretion of IpaD in S. flexneri 
WT, and the expression levels of IcsA in both the DOC induced hyper-adherent S. flexneri 
and S. flexneri ΔipaD were investigated. Whole cell samples (Section 2.7.1) and 
corresponding culture supernatant samples (Section 2.7.2) of S. flexneri WT and S. flexneri 
ΔipaD grown in the presence and absence of DOC for 2 h were prepared and analysed via 
SDS-PAGE (Section 2.7.9.1) followed by Western immunoblotting (2.7.11.3)  with anti-
IcsA and anti-IpaD antibodies (Section 2.3.1). 
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It was found that the cellular expression level of IcsA was not changed in S. 
flexneri ΔipaD (Figure 6.1, lane 3) compared to the S. flexneri WT (Figure 6.1, lane 1). This 
was in accordance with the results reported by Brotcke-Zumsteg et al. (2014).This was also 
the case for the DOC treated S. flexneri WT (Figure 6.1, lane 2). Moreover, the secretion 
level of the IcsA passenger was also similar in both S. flexneri WT (Figure 6.1, lane 5&6) 
and S. flexneri ΔipaD (Figure 6.1, lane 7&8) regardless of DOC treatment. Collectively, these 
data suggested DOC does not affect the expression and secretion of IcsA. 
In contrast to IcsA, the expression level of IpaD in the DOC treated S. flexneri 
WT (Figure 6.1, lane 2) was dramatically decreased compared to that expressed in the 
untreated S. flexneri WT (Figure 6.1, lane 1). It was also found that the level of IpaD in the 
culture supernatant was increased in the DOC treated S. flexneri WT (Figure 6.1, lane 6) 
compared to the untreated S. flexneri WT (Figure 6.1, lane 5). These data suggested that 
DOC triggers the release of IpaD from bacteria and enhances the secretion of IpaD into the 
culture supernatant. 
6.3. DOC alters the IcsA’s hNE accessibility 
DOC does not affect the expression of IcsA (Figure 6.1), yet its hyper-
adherence phenotype also requires the presence of IcsA (Chapter 3). Therefore, it was 
hypothesised that the IcsA expressed in the presence of DOC may have an altered hNE 
proteinase accessibility, which could be attributed to an alternative conformation required 
for its adhesin activity. To this end, S. flexneri ΔicsA [pIcsAFLAG] producing IcsAFLAG in the 
absence or presence of DOC was digested with hNE (Sectrion 2.7.13), and whole cell 
samples (Section 2.7.1) were collected at the indicated digestion time points and analysed by 
SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 2.7.11.3) with anti-
FLAG antibodies (Section 2.3.1).  
In the absence of DOC, IcsAFLAG was digested into fragments around ~80 
kDa, ~50 kDa and ~40 kDa at 90 min post-digestion (Figure 6.2 A), with the ~40 kDa 
fragment being most resistant to hNE. This was the same as reported in Chapter 4. However, 
in the presence of DOC, IcsAFLAG was digested into fragments around ~60 kDa and ~50 kDa 
at 90 min post-digestion (Figure 6.2 B), with a ~50 kDa fragment being the most resistant to  
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Figure 6.1. DOC triggers the release of IpaD into culture supernatant 
Intra- and extra-cellular protein expression of IpaD and IcsA in S. flexneri WT and S. flexneri 
ΔipaD grown in the absence (lane 1, 3, 5 and 7) and presence (lane 2, 4, 6 and 8) of 2.5 mM 
DOC for 2 h. Whole cell protein samples (WCL) (Section 2.7.1) and cultured supernatant 
protein samples (Sup) (Section 2.7.2) were prepared and analysed via SDS-PAGE (Section 
2.7.9.1) followed Western immunoblotting with both anti-IcsA and anti-IpaD antibodies. 
IcsAα, IcsA passenger domain. 
  




Figure 6.2. DOC alters the hNE accessibility of IcsA 
S. flexneri ΔicsA [pIcsAFLAG] grown in the absence (A) or presence (B) of 2.5 mM DOC were 
collected and analysed via proteolysis assay by hNE (Section 2.7.13). Digested whole cell 
samples collected at the indicated time points were analysed via SDS-PAGE (Section 2.7.9.1) 
and Western immunoblotting (Section 2.7.11.3) with anti-FLAG antibody (Section 2.3.1). 
Arrow indicates full length IcsA and the apparent molecular sizes of the hNE resistant 
fragments was as indicated. 
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hNE. Clearly, the altered hNE accessibility of IcsA produced in the S. flexneri ΔicsA 
[pIcsAFLAG] grown in the presence of DOC is different to that produced in the absence of 
DOC.  
6.4. The adhesin region aa 138-148 does not affect the altered hNE 
proteinase accessibility of IcsA induced by DOC 
It was shown that aa 138-148 was the adhesin region of IcsA and was 
required for the IcsA-mediated hyper-adherence in the S. flexneri ΔipaD (Chapter 3). 
Furthermore, deletion of this region abolished both the hyper-adherence of S. flexneri ΔipaD 
(Chapter 3) and the altered hNE accessibility (Chapter 4) of IcsA produced in S. flexneri 
ΔipaD background. As the adhesin region aa 138-148 was also found essential for the DOC 
induced hyper-adherence phenotype of S. flexneri WT (Chapter 3), it was therefore decided 
to assess whether the adhesin region aa 138-148 also affected the altered proteinase 
accessibility of IcsA in S. flexneri WT upon the DOC treatment. To this end, IcsAFLAG and 
IcsAFLAG/Δ138-148 produced in S. flexneri ΔicsA [pIcsAFLAG] and S. flexneri ΔicsA 
[IcsAFLAG/Δ138-148], respectively, in the absence or presence of DOC were digested with hNE 
(Sectrion 2.7.13), and whole cell samples (Section 2.7.1) collected at the indicated digestion 
time points were analysed by SDS-PAGE (Section 2.7.9.1) and Western immunoblotting 
(Section 2.7.11.3) with anti-FLAG antibodies (Section 2.3.1).  
As expected, IcsAFLAG produced from S. flexneri ΔicsA [pIcsAFLAG] had an 
altered hNE proteinase accessibility in the presence of DOC compared to that produced in 
the absence of DOC (Figure 6.3 A). However, IcsAFLAG/Δ138-148 produced from S. flexneri 
ΔicsA [IcsAFLAG/Δ138-148] in the presence of DOC also had an altered hNE proteinase 
accessibility profile (Figure 6.3 B), which was the same to that of IcsAFLAG produced from 
S. flexneri ΔicsA [pIcsAFLAG] grown in the presence of DOC (Figure 6.3 A). This data 
suggested that the adhesin region aa 138-148 does not affect the altered hNE accessibility 
profile of IcsA grown in the presence of DOC. 
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Figure 6.3. The adhesin region aa 138-148 does not affect the altered proteinase 
accessibility induced by DOC 
S. flexneri ΔicsA [pIcsAFLAG] (A) and S. flexneri ΔicsA [IcsAFLAG/Δ138-148] (B) grown in the 
absence or presence of 2.5 mM DOC were collected and analysed via proteolysis assay by 
hNE (Section 2.7.13). Digested whole cell samples collected at the indicated time points 
were analysed via SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 
2.7.11.3) with anti-FLAG antibody (Section 2.3.1). The apparent molecular size of the hNE 
resistant fragments was as indicated. 
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6.5. The C-terminal of IcsA was inaccessible in the presence of 
DOC 
To analyse the origin of the ~50 kDa IcsA fragment with resistance to hNE 
produced in the presence of DOC, S. flexneri ΔicsA [pIcsAFLAG] grown in the presence or 
absence of DOC were digested with hNE (Section 2.7.13). These digested samples were then 
separated into whole cell fractions (WCL) and digestion supernatant fractions (Sup) via 
centrifugation (Section 2.7.13). Samples of both whole cell fractions and digestion 
supernatant fractions were then analysed via SDS-PAGE (Section 2.7.9.1) and Western 
immunoblotting (Section 2.7.11.3) with anti-FLAG antibodies (Section 2.3.1). 
In the absence of DOC, the ~40 kDa IcsA fragment with resistant to hNE 
was absent in the digested whole cell fractions (Figure 6.4 A) and appeared in the digested 
supernatant from 5 min post digestion (Figure 6.4 B), suggesting that the ~40 kDa IcsA 
fragment was cleaved from the bacteria surface in the first 5 min of digestion and 
accumulated in the digestion supernatant at 90 min post digestion (Figure 6.4 B). This is in 
accordance with the results described in Chapter 4, where the ~40 kDa IcsA fragment was 
predicted to be cleaved at aa 413 and 760 by hNE (Figure 6.4 C). However, when grown in 
the presence of DOC, the ~50 kDa resistant IcsA fragment was absent in the supernatant of 
hNE treated cells (Figure 6.4 B), but was present in the whole cell fractions up to 90 min 
post digestion (Figure 6.4 A). This indicated that the ~50 kDa IcsA fragment remained on 
the bacteria surface with the IcsA β-barrel domain (aa 759-1102) which is inaccessible to 
hNE (Figure 6.4 C). Therefore, according to the molecular size of the fragment (~50 kDa), 
the hNE cleavage site is predicted to be at around aa 667, and the fragment is estimated to 
be consist of aa 668-1102 (Figure 6.4 C). Unlike the ~40 kDa hNE resistant IcsA fragment 
digested from IcsAFLAG produced from S. flexneri ΔicsA [pIcsAFLAG] in the absence of DOC, 
the ~50 kDa fragment digested from IcsAFLAG produced from S. flexneri ΔicsA [pIcsAFLAG] 
in the presence of DOC does not contain aa 414-667 (Figure 6.4 C).  
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Figure 6.4. The C-terminal of IcsA was inaccessible in the presence of DOC 
S. flexneri ΔicsA [pIcsAFLAG] grown in the absence or presence of 2.5 mM DOC were 
collected and analysed via proteolysis assay by hNE (Section 2.7.13). Digested samples 
collected at the indicated time points were separated into whole cell fractions (A, WCL) and 
digestion supernatant fractions (B, Sup) via centrifugation (Section 2.7.13) and analysed via 
SDS-PAGE (Section 2.7.9.1) and Western immunoblotting (Section 2.7.11.3) with anti-
FLAG antibody (Section 2.3.1). The appeared molecular size of the hNE resistant fragments 
was as indicated. (C) Schemetic representation of the aa prediction on the ~50 kDa and ~40 
kDa hNE resistant fragments observed in A and B respectively. The insertion site of the 
FLAG3 tag (aa 737) is indicated by a red arrow. 
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6.6. The altered hNE proteinase accessibility induced by DOC is 
independent to bacterial growth 
It was reported that the growth of WT S. flexneri in the presence of DOC at 
4 °C did not activate the hyper-adherence phenotype (Pope et al., 1995), and the authors 
proposed that the DOC induced hyper-adherence phenotype of S. flexneri requires bacterial 
growth. To examine whether the altered proteinase accessibility induced by DOC also 
requires bacterial growth, the growth of S. flexneri ΔicsA [pIcsAFLAG] at the mid-exponential 
phase was inhibited by adding chloramphenicol (Section 2.7.13). The bacterial cultures were 
then incubated in the presence or absence of DOC for another 2 h before being digested with 
hNE (Section 2.7.13). Digested samples were then analysed via SDS-PAGE (Section 2.7.9.1) 
and Western immunoblotting (Section 2.7.11.3) with anti-FLAG antibody (Section 2.3.1). 
After the growth inhibition by chloramphenicol in the absence of DOC and 
following hNE digestion of S. flexneri ΔicsA [pIcsAFLAG], bands of around ~80 kDa, ~50 
kDa and ~40 kDa at 90 min post-digestion were detected (Figure 6.5), which is similar as 
shown in Figure 6.3 (A). Moreover, in the presence of both chloramphenicol and DOC, 
IcsAFLAG produced from S. flexneri ΔicsA [pIcsAFLAG] was digested into fragments around 
~90 kDa, ~60 kDa and ~50 kDa at 90 min post-digestion (Figure 6.5), which is similar as 
shown in Figure 6.3 (A). These data suggested that inhibition of S. flexneri growth by 
chloramphenicol does not abolish the altered proteinase accessibility of IcsA induced by 
DOC, and indicating that DOC may act directly on IcsA to affect its conformation. 
6.7. DOC promotes the intermolecular interaction of IcsA 
IcsA was recently reported to be responsible for the biofilm formation in the 
presence of DOC (Koseoglu et al., 2019) by promoting cell to cell contacts and aggregative 
growth. This correlated with the IcsA self-association activity (May et al., 2012). Therefore, 
it is hypothesised that DOC may have an impact on the IcsA self-association activity. To 
examine this, and to test whether the adhesin region aa 138-148 is required for the IcsA self-
association activity. S. flexneri ΔicsA [pIcsAFLAG] and S. flexneri ΔicsA [IcsAFLAG/Δ138-148] 
were grown in the absence or presence of DOC, and were cross-linked with DSP (Section  
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Figure 6.5. Chloramphenicol treatment does not abolish the altered hNE accessibility 
of IcsA induced by DOC 
S. flexneri ΔicsA [pIcsAFLAG] grown to mid-exponential phase were collected via 
centrifugation, resuspended in LB containing chloramphenicol, and were incubated at 37 °C 
for 30 min (Section 2.7.13). The bacterial growth inhibition by chloramphenicol was 
confirmed by measuring the Optical Desntity of cultures at 600 nm (Section  2.7.13). S. 
flexneri ΔicsA [pIcsAFLAG] were then continued to be incubated at 37 °C in the absence or 
presence of 2.5 mM DOC for 2 h, before being digested with hNE in 1 mL PBS in the 
presence of chloramphenicol (Section 2.7.13). Digested whole cell samples collected at the 
indicated time points were analysed via SDS-PAGE (Section 2.7.9.1) and Western 
immunoblotting (Section 2.7.11.3) with anti-FLAG antibody (Section 2.3.1). The apparent 
molecular sizes of the hNE resistant fragments are as indicated. 
  
165 | P a g e  
 
2.7.8.1). Cross-linked samples were collected, solubilised and treated with or without DTT 
(Section 2.7.8.1) and analysed via SDS-PAGE (Section 2.7.9.1) and Western 
immunoblotting (Section 2.7.11.3) with anti-IcsA antibody (Section 2.3.1). 
When grown in the absence of DOC, both IcsAFLAG and IcsAFLAG/Δ138-148 
(~120 kDa) produced in S. flexneri ΔicsA [pIcsAFLAG] and S. flexneri ΔicsA [IcsAFLAG/Δ138-
148], respectively, were cross-linked to complexes with an apparent molecular size over 260 
kDa (Figure 6.6 A, lane 1&3). This is consistent to the results reported by May et al. (2012). 
In addition, cross-linked complexes were detected with apparent molecular sizes of ~90 kDa 
(Figure 6.6 A, lane 1&3, *), which are smaller than the reduced full-length IcsA (Figure 6.6 
A, lane 2&4, arrow). These observations were in accordance with the results described in 
Chapter 4, where the DSP cross-linked purified IcsA passenger migrated faster than the 
uncrosslinked IcsA. In the presence of DOC, the quantity of the cross-linked complexes of 
IcsAFLAG and IcsAFLAG/Δ138-148 (~120 kDa) produced in S. flexneri ΔicsA [pIcsAFLAG] and S. 
flexneri ΔicsA [IcsAFLAG/Δ138-148] with the molecular size around ~90 kDa were dramatically 
reduced (Figure 6.6 B, lane 1&3, *) compared to samples of cells grown in the absence of 
DOC (Figure 6.6 A, lane 1&3, *). The quantity of the cross-linked complexes with the 
apparent molecular size of over 260 kDa were dramatically increased (Figure 6.6 B, lane 
1&3), compared to that from cells grown in the absence of DOC (Figure 6.6 A, lane 1&3). 
There were no detectable differences between the crosslinked IcsAFLAG and IcsAFLAG/Δ138-
produced in S. flexneri ΔicsA [pIcsAFLAG] and S. flexneri ΔicsA [IcsAFLAG/Δ138-148] either in 
the presence or absence of DOC. Together, these data suggested that DOC promotes the 
intermolecular interaction of IcsA independent of the adhesin region aa 138-148. 
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Figure 6.6. DOC promotes the intermolecular interaction of IcsA  
S. flexneri ΔicsA [pIcsAFLAG] (lane 1&2) and S. flexneri ΔicsA [IcsAFLAG/Δ138-148] (lane 3&4) 
grown in the absence (A) or presence (B) of 2.5 mM DOC were collected and either left 
untreated or treated with DSP (Section 2.7.8.1). Cross-linked samples were then treated with 
or without DTT (Section 2.7.8.1) and analysed via SDS-PAGE (Section 2.7.9.1) and Western 
immunoblotting (Section 2.7.11.3) with anti-IcsA antibody (Section 2.3.1). Full length IcsA 
is indicated by an arrow. 
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6.8. Discussion 
It was known that the hyper-adherence phenotype of S. flexneri can be 
experimentally induced either by incubation of S. flexneri WT with DOC (Pope et al., 1995) 
or knocking out ipaD (Brotcke-Zumsteg et al., 2014). IpaD has been known to be located at 
the needle tip of the T3SS extracellularly before DOC induction (Olive et al., 2007, Cheung 
et al., 2015), and is the protein to sense DOC in the environment (Veenendaal et al., 2007, 
Barta et al., 2012). Indeed, mutagenesis on the region that is responsible for the 
conformational change caused by the binding of DOC abolished the hyper-adherence 
phenotype induced by DOC (Bernard et al., 2017). This chapter showed that DOC reduced 
the cellular IpaD levels but increased the level of IpaD secretion into culture supernatant. 
Therefore, it is likely that upon the binding of DOC, IpaD changes its conformation and is 
destabilised from the T3SS needle tip, thereby being released into culture supernatant. This 
reaction triggers an unknown signal cascade to activate the hyper-adherence phenotype. The 
absence of IpaD by mutation could partially mimic this reaction, leading to a hyper-
adherence phenotype in S. flexneri ΔipaD. These hyper-adherence phenotype depends on the 
presence of the S. flexneri adhesin IcsA (Chapter 3) and was not due to changes in either 
IcsA expression or secretion level. 
In the presence of DOC, IcsA produced from S. flexneri WT had an altered 
hNE accessibility compared to that produced in the absence of DOC. However, unlike the 
altered hNE accessibility of IcsA produced in S. flexneri ΔipaD (Chapter 4), the adhesin 
region aa 138-148 did not have any effects on the altered hNE accessibility of IcsA produced 
in S. flexneri WT in the presence of DOC. Following the fractionation of digestion samples, 
it was predicted that the most hNE resistant fragment (~50 kDa) of IcsA produced from S. 
flexneri WT in the presence of DOC consisted of aa 668-1102, which is different to the most 
resistant fragment (~40 kDa) of IcsA produced from S. flexneri ΔipaD (predicted to be 
consist of aa 414-760) (Chapter 4). However, aa 138-148 of IcsA are required for the hyper-
adherence phenotype of S. flexneri WT induced by DOC (Chapter 4), hence it is plausible 
that the altered proteinase accessibility associated with aa 138-148 might be within aa 414-
667 of the IcsA passenger. As this region (aa 414-667) does not have a FLAG tag, it was 
undetectable in the hNE digestions of the IcsAFLAG produced from S. flexneri WT grown in 
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the presence of DOC, hence the hNE digestion of IcsAFLAG/Δ138-148 could not show any 
difference to that of IcsAFLAG. 
DOC induces the production and secretion of multiple virulence factors in S. 
flexneri (Faherty et al., 2012). However, the altered hNE accessibility of IcsA is independent 
of bacterial growth and protein production, as the incubation of S. flexneri ΔicsA [IcsAFLAG] 
in the presence of chloramphenicol did not abolish the altered hNE accessibility of IcsAFLAG 
caused by DOC. However, the growth inhibition by incubation of S. flexneri with DOC at 
4 °C failed to activate the hyper-adherence phenotype (Pope et al., 1995). Therefore, we 
speculate that the altered hNE accessibility of IcsA induced by DOC and observed in this 
Chapter is possibly unrelated to the hyper-adherence phenotype.   
Through DPS cross-linking, it was found that DOC dramatically promoted 
the intermolecular interaction of IcsA. This observation supports the results of Koseoglu et 
al. (2019), where IcsA was found to be responsible for S. flexneri biofilm formation in the 
presence of DOC by promoting cell to cell contacts and aggregative growth. Therefore, it is 
likely that DOC enhances the intermolecular interaction of IcsA, thereby promoting polar 
aggregation of S. flexneri and facilitating biofilm formation. Such intermolecular interaction 
could have made the C-terminal of IcsA passenger inaccessible to hNE, thereby producing a 
different hNE digestion pattern.   
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Chapter 7: Conclusion 
7.1. IcsA adhesin region 
IcsA was found to be an adhesin in S. flexneri (Brotcke-Zumsteg et al., 2014) 
and S. sonnei (Mahmoud et al., 2016) contributing to Shigella colonisation of the human 
colon, thereby facilitating subsequent invasion. The adhesin activity is activated by the 
growth of S. flexneri with DOC, or by knocking out ipaD or ipaB. What regions are required 
for IcsA’s adhesin activity? Investigation has already been conducted and reported that 
insertions of 5 aa at sites i148 and i386 affected IcsA’s adhesin function (Brotcke-Zumsteg 
et al., 2014). This was done by screening for invasion defects with S. flexneri expressing 
IcsA 5aa insertion mutants (May & Morona, 2008) grown in the presence of DOC. In Chapter 
3, the IcsA 5 aa insertion mutants were expressed in S. flexneri ΔipaD, and was screened 
directly for defects in IcsA adhesin activity. This led to finding of three insertions (i138, i140 
and i148), but not the i386, with significant impact on IcsA’s adhesin function. By 
substitutions (I138P, and Q148C/G149N) of amino residues adjacent to these inserted sites, 
and the deletion of residues from aa 138 to aa 148 in the IcsA passenger domain, the region 
aa 138-148 was found to be essential for IcsA’s adhesin activity. The discrepancy of this 
work to the previously published data (Brotcke-Zumsteg et al., 2014) is probably due to the 
screening methods, i.e. adherence defect verses invasion defect. Given that surface localised 
IcsA passenger on S. flexneri remains uncleaved and adapts an elongated shape (Mauricio et 
al., 2017) with its N-terminal region exposed to the environment for binding to host receptors, 
it is more likely that the region required for its adhesin activity resides proximal to the N-
terminal end. The insertion at i386 might have affected other aspects of IcsA’s structure, 
which will be discussed below. Indeed, in Chapter 3, it was also found that unlike the purified 
IcsA53-740 passenger, the purified mutant IcsA53-740(Δ138-148) did not inhibit the hyper-
adherence of S. flexneri ΔipaD to HeLa cells. Moreover, fluorescently labelled IcsA53-740(Δ138-
148) did not bind to HeLa cell surfaces and had reduced binding affinity to molecules from 
HeLa cells compared to that of WT IcsA53-740. Overall, these results revealed a subregion (aa 
138-148) within IcsA passenger domain important for its adhesin function. In Chapter 3, it 
was also demonstrated that loss of the adhesin region aa 138-148 in IcsA passenger also 
171 | P a g e  
 
impairs the invasion ability of S. flexneri, highlighting the importance of this region and 
adherence in the early stage of Shigella pathogenesis. 
It remains to be investigated as to which specific amino residues within this 
region (aa 138-148) are essential for IcsA’s adhesin function. In Chapter 3, the results of 
alanine scanning on the region aa 138-148 suggested that multiple residues are likely to 
contribute to IcsA’s adhesin function. However, due to the time constraint, this remains to 
be investigated in the future. The residues required for the adhesin function can be 
investigated by assessing IcsA mutants with substitutions of more than one residue at a time 
within this region. Such information will be valuable for understanding the molecular 
mechanisms of IcsA’s adhesin activity and will pave the way for understanding the 
interactions between IcsA and its receptors. Nevertheless, the work in Chapter 3 has localised 
the IcsA’s adhesin region to aa 138-148. 
7.2. The multiple conformations of IcsA 
In Chapter 4, the expression level of IcsA was found to be the same in hyper-
adherent strains compared to S. flexneri WT, yet IcsA’s adhesin function is only active in 
those hyper-adherent strains. How does IcsA function as adhesin in those hyper-adherence 
strains? By using hNE that targets Shigella surface virulence factors (Weinrauch et al., 2002) 
including IcsA (Brotcke-Zumsteg et al., 2014), the conformations of IcsA produced from 
non-hyper-adherence S. flexneri WT and hyper-adherent S. flexneri ΔipaD were revealed to 
be different (Brotcke-Zumsteg et al., 2014). It was found that the hNE accessibility of 
IcsAFLAG expressed from S. flexneri ΔipaD was altered compared to that produced from WT 
S. flexneri, and this altered hNE accessibility is independent of the presence of LPS O antigen 
and is depend on the presence of the adhesin region aa 138-148. These data suggested that 
the adhesin region is also required for IcsA adapting the conformation that is associated with 
the hyper-adherence of S. flexneri ΔipaD. Through the analysis of the hNE digested IcsA 
fragments using FLAG3 tagged IcsA reporter, it was found that the adhesin region affected 
the hNE resistance of a C-terminal region which is estimated to be consists of aa ~414-760. 
This highlighted a role of IcsA self-association in an alternative conformation. Using the 
native IcsA purified from the culture supernatant, IcsA was found with two forms. Analysis 
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of these populations revealed that one form of the purified IcsA was stabilised via an 
intramolecular disulfide bond. It is likely that the disulfide bond forms between C130 and aa 
C376 or C380 as a result of the interaction between the N-terminal of IcsA passenger 
containing the adhesin region aa 138-148 and the C-terminal region of IcsA passenger near 
aa ~414-760. The previously reported invasion defects caused by the insertion at i386 
(Brotcke-Zumsteg et al., 2014) could also be due to the disruption of the spatial localization 
of C376 and C380 by the 5 aa insertion, which abolished the formation of the disulfide bond. 
However, the importance of this disulfide bond formation within IcsA passenger to IcsA’s 
function is beyond the scope of this work and remains to be investigated in the future, such 
as mutation of C130, C376 and C380 and examination of their impact on the IcsA-mediated 
S. flexneri hyper-adherence and subsequent invasion. Nevertheless, this work is the first to 
describe multiple conformations of IcsA and highlighted a potential self-interaction between 
the N-terminal region of IcsA to its C-terminal region. 
7.3. The interaction between IcsA and host cell surface 
What host molecules does IcsA bind to as receptors? In Chapter 3, the 
purified IcsA was made as a fluorescent probe and revealed to bind to the HeLa cell surfaces. 
In addition, the purified IcsA also recognised several host molecules sensitive to surface 
trypsin shaving through indirect probing. These data suggested that the purified IcsA 
passenger produced form E. coli also maintains its adhesin function, similar to when 
expressed in E. coli (Brotcke-Zumsteg et al., 2014). Moreover, this provided a tool to identify 
the potential receptors of IcsA on HeLa cells. In Chapter 5, the purified IcsA was used as a 
bait to isolate putative receptors from HeLa cell lysate, and Myosin IIA and Myosin IIB were 
identified as putative host IcsA-interacting molecules. However, the indirect probing of 
HeLa lysate with purified IcsA suggested that there might be multiple receptors other than 
Myosin IIA and Myosin IIB for IcsA on HeLa cells. Therefore, it is difficult to examine the 
effects of Myosin IIA and Myosin IIB on the IcsA-mediated Shigella hyper-adherence at the 
cellular level. Due to the time constraint, this remains to be investigated in the future. Either 
a Myosin IIA or Myosin IIB knock-out cell line can be made to examine the effects on the 
IcsA-mediated S. flexneri adherence. Nevertheless, this work has identified Myosin IIA and 
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Myosin IIB as putative receptor for IcsA and paved way for future IcsA receptor 
identification studies. 
7.4. The effect of DOC on IcsA 
How does DOC affect IcsA’s adhesin function? In Chapter 6, it was found 
that DOC does not affect the expression and secretion of IcsA. Growth of S. flexneri in the 
presence of DOC altered the hNE accessibility of IcsA. The altered hNE accessibility profile 
of IcsA produced from S. flexneri in the presence of DOC is different to that of produced 
from S. flexneri ΔipaD, yet IcsA was also found to be essential for the DOC induced hyper-
adherence in Chapter 3. The analysis of conformations of IcsA and IcsAΔ138-148 produced 
from S. flexneri grown in the presence of DOC revealed no difference. This was probably 
because that the IcsA C-terminal regions interacting with the adhesin region aa 138-148 
shown in S. flexneri ΔipaD background were undetectable in the DOC treated S. flexneri 
background. Therefore, it was not possible to completely assess the effect of the adhesin 
region aa 138-148 had on the DOC induced conformational change in IcsA. Nevertheless, it 
is likely that the altered hNE accessibility detected in Chapter 6 is independent to IcsA’s 
adhesin function. This is because the incubation of S. flexneri in the presence of DOC at 4 °C 
did not activate the hyper-adherence phenotype (Pope et al., 1995), yet the incubation of S. 
flexneri with the growth inhibition using chloramphenicol in the presence of DOC altered 
the IcsA’s hNE accessibility. The exact effect of DOC on IcsA’s conformation might require 
future re-design of epitopes at other sites within IcsA and/or digestion with different 
proteinases.  
The results in Chapter 6 for the first time reveal that DOC enhances the self-
association of IcsA in S. flexneri. It has been reported that DOC promotes Shigella biofilm 
formation and aggregative bacterial growth, and this requires the presence of IcsA (Koseoglu 
et al., 2019). The results in Chapter 6 supports this notion, and highlighted for the first time 
a molecular mechanism of which DOC enhances the Shigella cell to cell contact by 
promoting IcsA inter-molecular association. 
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7.5. IcsA as a vaccine potential and therapeutic target 
In Chapter 3, it was found that both the purified IcsA passenger and anti-
IcsA antibody were able to block the hyper-adherence of S. flexneri ΔipaD. This highlighted 
a vaccine potential for IcsA, in that antibody raised against IcsA might protect against 
Shigella pathogens from the early stage of the infection, i.e. colonisation. For this, IcsA must 
be purified in its native and functional form with high solubility and stability. However, it is 
notoriously difficult to purify the full length IcsA passenger in its native form in a large 
quantity (Kuhnel and Diezmann, 2011, Leupold et al., 2017). Therefore, the work in Chapter 
4 developed IcsA purification protocol. Using this protocol, functional IcsA was purified in 
a high purity and may be of use in vaccine studies. Such a protocol can be also beneficial in 
determining full length IcsA’s structure. It has been determined that by using this protocol, 
IcsA can be purified and concentrated to ~10 mg/ml, which is the common protein 
concentration required for primary screening of crysallisation conditions. As this work 
revealed the adhesin region of IcsA, it is therefore important to include the structure 
determination of the mutant IcsAΔ138-148 in the future. Such information will greatly aid our 
understanding in not only the IcsA-mediated adherence, but also the overall Shigella 
pathogenesis. Moreover, the knowledge in the molecular basis of IcsA adhesin could also 
aid the future design of therapeutics targeting IcsA. Such therapeutics would have advantages 
in avoiding the resistance developed within Shigella species, as targeting IcsA’s adhesin 
function does not impact the overall Shigella fitness but would disarm the virulence of 
Shigella. 
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Appendix A: Bacterial strains 
Strains Notes 
Lab strains 
DH5α F-, Φ80dlacZ△M15, △(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17 
(rk-,mk+), phoA, supE44, λ- , thi-1, gyrA96, relA1 (NEB) 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 
araD139 Δ(ara-leu)7697 galK rpsL(StrR) endA1 λ- (ThermoFisher 
Scientific) 
C43(DE3) F- ompT gal dcm hsdSB(rB- mB-) λ(DE3) (NEB) 
XL10-Gold endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte Δ(mcrA)183 Δ(mcrCB-
hsdSMR-mrr)173 tetR F'[proAB lacIqZΔM15 Tn10(TetR Amy CmlR)] 
(Agilent) 
2457T RMA4258, Shigella flexneri 2a (Laboratory stock) 
2457TΔrlmD RMA723 (Van Den Bosch et al., 1997) 
2457TΔicsA RMA2041 (Van den Bosch & Morona, 2003) 
2457TΔicsAΔrmlD RMA2043 (Van den Bosch & Morona, 2003) 
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Strains Parent[Plasmids] Description 
Strains generated in this thesis 
JQRM1 2457T[pKD46] AmpR, mutagenesis strain, 30 °C 
JQRM2 2457TΔicsA[pKD46] TetR, AmpR, mutagenesis strain, 30 °C 
JQRM3 DH5α[pGEM-Teasy::ipaD] AmpR, complementation construct storage 
JQRM4 DH5α[pGEM-Teasy::ipaB] AmpR, complementation construct, no 
expression 
JQRM5 2457TΔipaD::kan KanR, ipaD knock-out strain, kanamycin 
cassette 
JQRM6 2457TΔipaB::kan KanR, ipaB knock-out strain, polar effect 
JQRM7 2457TΔicsAΔipaD::kan TetR, KanR, ipaD icsA knock-out strain 
JQRM8 2457TΔicsAΔipaB::kan TetR, KanR, ipaB icsA knock-out strain, polar 
JQRM9 2457TΔipaD::frt ipaD knock-out strain 
JQRM10 2457TΔipaB::frt ipaB knock-out strain 
JQRM11 2457TΔicsAΔipaD::frt TetR, ipaD icsA knock-out strain 
JQRM12 2457TΔicsAΔipaB::frt TetR, ipaB icsA knock-out strain, polar 
JQRM13 2457TΔipaD::frt[pGEM-Teasy::ipaD] AmpR, IpaD complementation strain 
JQRM14 2457TΔicsAΔipaD::frt[pGEM-Teasy::ipaD] TetR, AmpR, IpaD complementation strain 
JQRM15 2457TΔipaD::frt[pGEM-Teasy::90nts] AmpR, vector control.  
JQRM16 2457TΔicsAΔipaD::frt[pIcsA] TetR, AmpR, icsA complementation strain 
JQRM17 2457TΔicsAΔipaD::frt[pBR322] TetR, AmpR, vector control 
JQRM18 2457TΔipaD::frt[pIcsAi148] TetR, AmpR, IcsA insertion library 
JQRM19 2457TΔipaD::frt[pIcsAi386] TetR, AmpR, IcsA insertion library 
JQRM20 2457TΔipaD::frt[pIcsAi148-386] TetR, AmpR, IcsA insertion library, combined 
JQRM21 2457TΔipaD::frt[pGEM-
Teasy::ipaD][pIcsA-GFP] 
TetR, AmpR, KanR, IpaD IcsA 
complementation 
JQRM22 2457TΔicsAΔipaD::frt[pIcsAi56] TetR, AmpR, IcsA insertion library 
JQEM23 2457TΔicsAΔipaD::frt[pIcsAi81] TetR, AmpR, IcsA insertion library 
JQRM24 2457TΔicsAΔipaD::frt[pIcsAi87] TetR, AmpR, IcsA insertion library 
JQRM25 2457TΔicsAΔipaD::frt[pIcsAi120] TetR, AmpR, IcsA insertion library 
JQRM26 2457TΔicsAΔipaD::frt[pIcsAi122] TetR, AmpR, IcsA insertion library 
JQRM27 2457TΔicsAΔipaD::frt[pIcsAi128] TetR, AmpR, IcsA insertion library 
JQRM28 2457TΔicsAΔipaD::frt[pIcsAi132] TetR, AmpR, IcsA insertion library 
JQRM29 2457TΔicsAΔipaD::frt[pIcsAi137] TetR, AmpR, IcsA insertion library 
JQRM30 2457TΔicsAΔipaD::frt[pIcsAi138] TetR, AmpR, IcsA insertion library 
JQRM31 2457TΔicsAΔipaD::frt[pIcsAi140] TetR, AmpR, IcsA insertion library 
JQRM32 2457TΔicsAΔipaD::frt[pIcsAi148] TetR, AmpR, IcsA insertion library 
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JQRM33 2457TΔicsAΔipaD::frt[pIcsAi185] TetR, AmpR, IcsA insertion library 
JQRM34 2457TΔicsAΔipaD::frt[pIcsAi193] TetR, AmpR, IcsA insertion library 
JQRM35 2457TΔicsAΔipaD::frt[pIcsAi219] TetR, AmpR, IcsA insertion library 
JQRM36 2457TΔicsAΔipaD::frt[pIcsAi226] TetR, AmpR, IcsA insertion library 
JQRM37 2457TΔicsAΔipaD::frt[pIcsAi228] TetR, AmpR, IcsA insertion library 
JQRM38 2457TΔicsAΔipaD::frt[pIcsAi230] TetR, AmpR, IcsA insertion library 
JQRM39 2457TΔicsAΔipaD::frt[pIcsAi244] TetR, AmpR, IcsA insertion library 
JQRM40 2457TΔicsAΔipaD::frt[pIcsAi248] TetR, AmpR, IcsA insertion library 
JQRM41 2457TΔicsAΔipaD::frt[pIcsAi268] TetR, AmpR, IcsA insertion library 
JQRM42 2457TΔicsAΔipaD::frt[pIcsAi271] TetR, AmpR, IcsA insertion library 
JQRM43 2457TΔicsAΔipaD::frt[pIcsAi288] TetR, AmpR, IcsA insertion library 
JQRM44 2457TΔicsAΔipaD::frt[pIcsAi292] TetR, AmpR, IcsA insertion library 
JQRM45 2457TΔicsAΔipaD::frt[pIcsAi297] TetR, AmpR, IcsA insertion library 
JQRM46 2457TΔicsAΔipaD::frt[pIcsAi312] TetR, AmpR, IcsA insertion library 
JQRM47 2457TΔicsAΔipaD::frt[pIcsAi314] TetR, AmpR, IcsA insertion library 
JQRM48 2457TΔicsAΔipaD::frt[pIcsAi322] TetR, AmpR, IcsA insertion library 
JQRM49 2457TΔicsAΔipaD::frt[pIcsAi324] TetR, AmpR, IcsA insertion library 
JQRM50 2457TΔicsAΔipaD::frt[pIcsAi326] TetR, AmpR, IcsA insertion library 
JQRM51 2457TΔicsAΔipaD::frt[pIcsAi330a] TetR, AmpR, IcsA insertion library 
JQRM52 2457TΔicsAΔipaD::frt[pIcsAi330b] TetR, AmpR, IcsA insertion library 
JQRM53 2457TΔicsAΔipaD::frt[pIcsAi342] TetR, AmpR, IcsA insertion library 
JQRM54 2457TΔicsAΔipaD::frt[pIcsAi346] TetR, AmpR, IcsA insertion library 
JQRM55 2457TΔicsAΔipaD::frt[pIcsAi369] TetR, AmpR, IcsA insertion library 
JQRM56 2457TΔicsAΔipaD::frt[pIcsAi381] TetR, AmpR, IcsA insertion library 
JQRM57 2457TΔicsAΔipaD::frt[pIcsAi386] TetR, AmpR, IcsA insertion library 
JQRM58 2457TΔicsAΔipaD::frt[pIcsAi456] TetR, AmpR, IcsA insertion library 
JQRM59 2457TΔicsAΔipaD::frt[pIcsAi502] TetR, AmpR, IcsA insertion library 
JQRM60 2457TΔicsAΔipaD::frt[pIcsAi532] TetR, AmpR, IcsA insertion library 
JQRM61 2457TΔicsAΔipaD::frt[pIcsAi563] TetR, AmpR, IcsA insertion library 
JQRM62 2457TΔicsAΔipaD::frt[pIcsAi595] TetR, AmpR, IcsA insertion library 
JQRM63 2457TΔicsAΔipaD::frt[pIcsAi598] TetR, AmpR, IcsA insertion library 
JQRM64 2457TΔicsAΔipaD::frt[pIcsAi633] TetR, AmpR, IcsA insertion library 
JQRM65 2457TΔicsAΔipaD::frt[pIcsAi643] TetR, AmpR, IcsA insertion library 
JQRM66 2457TΔicsAΔipaD::frt[pIcsAi677] TetR, AmpR, IcsA insertion library 
JQRM67 2457TΔicsAΔipaD::frt[pIcsAi716] TetR, AmpR, IcsA insertion library 
JQRM68 2457TΔicsAΔipaD::frt[pIcsAi748] TetR, AmpR, IcsA insertion library 




TetR, AmpR, SpecR, IpaD IcsA 
complementation 
JQRM70 DH5α[pIcsA54::his6] AmpR, IcsA construct with N terminal tag 
JQRM71 DH5α[pCDF-Duet::IcsA54::his6] SpecR, IcsA expression construct 
JQRM72 DH5α[pCDF-Duet::IcsA54::his6-IcsP] SpecR, IcsA IcsP co-expression construct 
JQRM73 BL21(DE3) Codon plus [pCDF-
Duet::IcsA54::his6-IcsP] 
SpecR, CmlR, IcsA IcsP co-expression strain 
JQRM74 C43(DE3)[pCDF-Duet::IcsA54::his6-IcsP] SpecR, IcsA IcsP co-expression strain 
JQRM75 LEMO(DE3) [pCDF-Duet::IcsA54::his6-IcsP] SpecR, CmlR, IcsA IcsP co-expression strain 
JQRM76 DH5α[pGEX-2T::IcsA111-170] AmpR, IcsA peptide construct 
JQRM77 DH5α[pGEX-2T::IcsA351-410] AmpR, IcsA peptide construct 
JQRM78 C43(DE3)[pGEX-2T::IcsA111-170] AmpR, IcsA peptide expression strain 
JQRM79 C43(DE3)[pGEX-2T::IcsA351-410] AmpR, IcsA peptide expression strain 
JQRM80 DH5α[pCDF-Duet::IcsA54::his6-Δ138-148-IcsP] SpecR, IcsAΔ138-148 IcsP construct 
JQRM81 DH5α[pIcsAΔ138-148] AmpR, IcsAΔ138-148 construct 
JQRM82 C43(DE3)[pCDF-Duet::IcsA54::his6-Δ138-148-
IcsP] 
SpecR, IcsAΔ138-148 IcsP conexpression strain 
JQRM83 2457TΔicsA[pIcsAΔ138-148] TetR, AmpR, IcsAΔ138-148 complementation 
strain 
JQRM84 2457TΔicsAΔipaD::frt[pIcsAΔ138-148] TetR, AmpR, IcsAΔ138-148 complementation 
strain 
JQRM85 2457TΔicsAΔipaD::frt[pIcsAI138R/T139L] TetR, AmpR, IcsA point mutant  
JQRM86 2457TΔicsAΔipaD::frt[pIcsAI138P] TetR, AmpR, IcsA point mutant 
JQRM87 2457TΔicsAΔipaD::frt[pIcsAm138-139-3] TetR, AmpR, IcsA point mutant 
JQRM88 2457TΔicsAΔipaD::frt[pIcsA] TetR, AmpR, IcsA point mutant 
JQRM89 2457TΔicsAΔipaD::frt[pIcsAm138-139-5] TetR, AmpR, IcsA point mutant 
JQRM90 2457TΔicsAΔipaD::frt[pIcsAm138-139-6] TetR, AmpR, IcsA point mutant 
JQRM91 2457TΔicsAΔipaD::frt[pIcsAm138-139-7] TetR, AmpR, IcsA point mutant 
JQRM92 2457TΔicsAΔipaD::frt[pIcsAm138-139-8] TetR, AmpR, IcsA point mutant 
JQRM93 2457TΔicsAΔipaD::frt[pIcsAm138-139-9] TetR, AmpR, IcsA point mutant 
JQRM94 2457TΔicsAΔipaD::frt[pIcsAI138R/T139T] TetR, AmpR, IcsA point mutant 
JQRM95 2457TΔicsAΔipaD::frt[pIcsAm140-141-1] TetR, AmpR, IcsA point mutant 
JQRM96 2457TΔicsAΔipaD::frt[pIcsAG140H/S141P] TetR, AmpR, IcsA point mutant 
JQRM97 2457TΔicsAΔipaD::frt[pIcsAm140-141-3] TetR, AmpR, IcsA point mutant 
JQRM98 2457TΔicsAΔipaD::frt[pIcsAG140L/S141G] TetR, AmpR, IcsA point mutant 
JQRM99 2457TΔicsAΔipaD::frt[pIcsAm140-141-5] TetR, AmpR, IcsA point mutant 
JQRM100 2457TΔicsAΔipaD::frt[pIcsAm140-141-6] TetR, AmpR, IcsA point mutant 
JQRM101 2457TΔicsAΔipaD::frt[pIcsAG140A/S140N] TetR, AmpR, IcsA point mutant 
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JQRM102 2457TΔicsAΔipaD::frt[pIcsAG140V/S140V] TetR, AmpR, IcsA point mutant 
JQRM103 2457TΔicsAΔipaD::frt[pIcsAm140-141-9] TetR, AmpR, IcsA point mutant 
JQRM104 2457TΔicsAΔipaD::frt[pIcsAm140-141-10] TetR, AmpR, IcsA point mutant 
JQRM105 2457TΔicsAΔipaD::frt[pIcsAm140-141-10-2] TetR, AmpR, IcsA point mutant 
JQRM106 2457TΔicsAΔipaD::frt[pIcsAQ148D/G149S] TetR, AmpR, IcsA point mutant 
JQRM107 2457TΔicsAΔipaD::frt[pIcsAQ148K/G149S] TetR, AmpR, IcsA point mutant 
JQRM108 2457TΔicsAΔipaD::frt[pIcsAm148-149-3] TetR, AmpR, IcsA point mutant 
JQRM109 2457TΔicsAΔipaD::frt[pIcsAQ148F/G149Q] TetR, AmpR, IcsA point mutant 
JQRM110 2457TΔicsAΔipaD::frt[pIcsAm148-149-5] TetR, AmpR, IcsA point mutant 
JQRM111 2457TΔicsAΔipaD::frt[pIcsAQ148C/G149N] TetR, AmpR, IcsA point mutant 
JQRM112 2457TΔicsAΔipaD::frt[pIcsAm148-149-7] TetR, AmpR, IcsA point mutant 
JQRM113 2457TΔicsAΔipaD::frt[pIcsAm148-149-8] TetR, AmpR, IcsA point mutant 
JQRM114 DH5α[pCDF-Duet::IcsA54::FLAG×3-IcsP] SpecR, IcsA expression construct 
JQRM115 C43(DE3)[pCDF-Duet::IcsA54::FLAG×3-IcsP] SpecR, IcsA expression strain 
JQRM116 TOP10[pMDBAD-icsAΔ138-148] AmpR, IcsAΔ138-148 expression strain 
JQRM117 DH5α[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag construct 
JQRM118 2457TΔicsAΔipaD::frt[pIcsA737::FLAG×3] TetR, AmpR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM119 DH5α[pIcsA Δ138-148/737::FLAG×3] AmpR, IcsAΔ138-148 C-terminal tag construct 
JQRM120 2457TΔicsA[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag complementation 
JQRM121 2457TΔicsA[pIcsA Δ138-148/737::FLAG×3] Amp
R, IcsAΔ138-148 C-terminal tag 
complementation 




TetR, AmpR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM124 2457TΔicsAΔrmlD[pIcsA737::FLAG×3] AmpR, KanR, IcsA C-terminal tag 
complementation 
JQRM125 2457TΔicsAΔrmlD[pIcsAΔ138-148/737::FLAG×3] AmpR, KanR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM126 2457T(VP-)[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag complementation 
JQRM127 2457T(VP-)[pIcsAΔ138-148/737::FLAG×3] AmpR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM128 S. flexneri Y(VP-)[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag complementation 
JQRM129 S. flexneri Y(VP-)[pIcsAΔ138-148/737::FLAG×3] AmpR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM130 S. flexneri YΔicsA[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag complementation 
JQRM131 S. flexneri YΔicsA[pIcsAΔ138-148/737::FLAG×3] AmpR, IcsAΔ138-148 C-terminal tag 
complementation 
JQRM132 2457TΔrmlD[pKD46] AmpR, KanR, mutagenesis strain, 30 °C 
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JQRM133 2457TΔicsAΔrmlD[pKD46] AmpR, KanR, mutagenesis strain, 30 °C 
JQRM134 2457TΔgtrII[pIcsA737::FLAG×3] AmpR, IcsA C-terminal tag complementation 
JQRM135 2457TΔgtrII[pIcsAΔ138-148/737::FLAG×3] AmpR, IcsAΔ138-148 C-terminal tag 
complementation 










TetR, AmpR, IcsAQ148C/G149N C-terminal tag 
complementation 
JQRM139 BL21[pIcsA] AmpR, IcsA expressing strain for glycan 
array 
JQRM140 BL21[pBR322] AmpR, Vector contaol strain for glycan array 
JQRM141 2457TΔicsAΔipaD::frt[pIcsA138A] TetR, AmpR, IcsA alanine scanning strain 
JQRM142 2457TΔicsAΔipaD::frt[pIcsA139A] TetR, AmpR, IcsA alanine scanning strain 
JQRM143 2457TΔicsAΔipaD::frt[pIcsA140A] TetR, AmpR, IcsA alanine scanning strain 
JQRM144 2457TΔicsAΔipaD::frt[pIcsA141A] TetR, AmpR, IcsA alanine scanning strain 
JQRM145 2457TΔicsAΔipaD::frt[pIcsA142A] TetR, AmpR, IcsA alanine scanning strain 
JQRM146 2457TΔicsAΔipaD::frt[pIcsA143A] TetR, AmpR, IcsA alanine scanning strain 
JQRM147 2457TΔicsAΔipaD::frt[pIcsA144A] TetR, AmpR, IcsA alanine scanning strain 
JQRM148 2457TΔicsAΔipaD::frt[pIcsA145A] TetR, AmpR, IcsA alanine scanning strain 
JQRM149 2457TΔicsAΔipaD::frt[pIcsA146A] TetR, AmpR, IcsA alanine scanning strain 
JQRM150 2457TΔicsAΔipaD::frt[pIcsA147A] TetR, AmpR, IcsA alanine scanning strain 
JQRM151 2457TΔicsAΔipaD::frt[pIcsA148A] TetR, AmpR, IcsA alanine scanning strain 
JQRM152 2457TΔicsAΔipaD::frt[pIcsA149A] TetR, AmpR, IcsA alanine scanning strain 
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Appendix B: Plasmids 
Plamids Description 
Lab plasmids used in this thesis  
pKD4 Kanamycin cassette for mutagenesis, (Datsenko & Wanner, 2000) 
pKD13 Kanamycin cassette for mutagenesis, (Datsenko & Wanner, 2000) 
pKD46 Lambda red recombinase construct, (Datsenko & Wanner, 2000) 
pCP20 Yeast recombinase recognising frt sequences, (Datsenko & Wanner, 2000) 
pIcsA IcsA expression construct, (Morona & Van Den Bosch, 2003) 
pBR322 Vector control (Van den Bosch & Morona, 2003) 
pSU23::icsA IcsA expression construct, (Teh & Morona, 2013) 
pCDF-Duet Duet expression vector (Novagen) 
pGEM-Teasy Cloning vector for white and blue screening (Promega) 
pGEM-Teasy::90nts Vector control with 90 nucleotides insertion, blue colony (Laboratory stock) 
pMDBAD::icsAhis12-52-740 IcsA passenger expression construct (Dr Matthew Doyle) 
Plasmids generated in this thesis 
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Appendix C: Oligonucleotides 
Oligos Sequences (5’-3’) Description 
JQ1 TATATCCAAGAGCCATAATAATATATGGCTCTTCCTGTAAGGAAATAACCGT
GTAGGCTGGAGCTGCTTC 
Mutagenesis of ipaD, pKD4 
JQ2 GCCTTATATAAGAATGTTGGCGCTTGAGTATTATTTACATTATGCATGGCGCA
CCGCCATGGTCCATATGAATATCCTCC 
Mutagenesis of ipaD, pKD4 
JQ3 AAAGCACAATCATACTTGGACGCAATTCAGGATATCAAGGAGTAATTATTGT
GTAGGCTGGAGCTGCTTC 
Mutagenesis of ipaB, pKD4 
JQ4 TATAAAATCTGGGTTGGTTTTGTGTTTTGAATTTCCATAACATTCTCCTTATTT
GTAGCCATGGTCCATATGAATATCCTCC 
Mutagenesis of ipaB, pKD4 
JQ5 ATCCCAAGTATCTAAAGAAGCATCCC Primer amplifying ipaD 
JQ6 GAAGTTTGCGAACTATGGATATCGG Primer amplifying ipaD 
JQ7 AGTTCCAACAAGCAGCAGACC Primer amplifying ipaB 
JQ8 GTGGTTGTTAATACGGGATTTTTACCG Primer amplifying ipaB 
JQ9 GCCTTATATAAGAATGTTGGCGCTTGAGTATTATTTACATTATGCATGGCGCA
CCATGGGAATTAGCCATGGTCC 
Replacement of JQ2 
JQ10 TATAAAATCTGGGTTGGTTTTGTGTTTTGAATTTCCATAACATTCTCCTTATTT
GTAATGGGAATTAGCCATGGTCC 
Replacement of JQ4 
JQ11 ATCCAAGAGCCATAATAATATATGGCTCTTCCTGTAAGGAAATAACCATGAT
TCCGGGGATCCGTCGACC 
Mutagenesis of ipaD, pKD13 
JQ12 AGTATTATTTACATTATGCATGGCGCACCTCAGAAATGGAGAAAAAGTTTTG
TAGGCTGGAGCTGCTTCG 
Mutagenesis of ipaD, pKD13 
JQ13 GCACAATCATACTTGGACGCAATTCAGGATATCAAGGAGTAATTATTATGAT
TCCGGGGATCCGTCGACC 
Mutagenesis of ipaB, pKD13 
JQ14 GAATTTCCATAACATTCTCCTTATTTGTATCAAGCAGTAGTTTGTTGCAATGT
AGGCTGGAGCTGCTTCG 
Mutagenesis of ipaB, pKD13 
JQ15 GGGCCAATAGCTTTTGCTACTCCTCATCACCATCATCACCACC His6 insertion in IcsA54 
JQ16 TCTGAAAAATGAAGTTCTTGAGTACCCGAAAGGTGGTGATGATGGTGATGA His6 insertion in IcsA54 
JQ17 CTACGACCATGGCTATGAATCAAATTCACAAATTTTTTTGTAATATGACCC NcoI-ATG-IcsA 
JQ18 CTACGAGTCGACTCAGAAGGTATATTTCACACCCAAAATACC IcsA-SalI 
JQ19 CTACGACATATGATGAAATTAAAATTCTTTGTACTTGCAC NdeI-IcsP 















JQ25 GGGCTGGCAAGCCACGTTTGGTG pGEX sequencing primer 
JQ26 CCGGGAGCTGCATGTGTCAGAGG pGEX sequencing primer 
JQ27 AATAGTTGTGGCGGTAATGGTGGTGACTCTNNNNNNGGATCTGACTTGTCTA
TAATCAATCAAGG 
Site-directed mutagenesis primer targeting IcsA138-139 
JQ28 TGTGGCGGTAATGGTGGTGACTCTATTACCNNNNNNGACTTGTCTATAATCA
ATCAAGGCATG 
Site-directed mutagenesis primer targeting IcsA140-141 
JQ29 CATGCCTTGATTGATTATAGACAAGTC Reverse primer of JQ27 & JQ28 
JQ30 CGCTACCGCCGCTACCACCAAGAATCAT Reverse primer of mutagenesis primer 148NNS 
JQ31 GGAGTCACCACCATTACCG IcsAΔ138-148 deletion, alternative codon to have BspEI 




GBlock Gene for IcsA737::FLAG×3 
JQ34 CTGAATACCAATAAGTGGTATCTAACTAGTGACTACAAAGACCATGACGGTG
ATTATAAAGATCATGACATCGATTACAAGGATGACG 
















IcsA54::FLAG×3 FLAG tag addition, reverse PCR 
JQ39 ATCTTTATAATCACCGTCATGGTCTTTGTAGTCAGGAGTAGCAAAAGCTATTG
G 
IcsA54::FLAG×3 FLAG tag addition, reverse PCR 
JQ40 CATGACATCGATTACAAGGATGACGATGACAAGCAGATGGATAATCAAGAA
TCAAAACAG 
IcsA737::FLAG×3 FLAG tag addition, reverse PCR 
JQ41 ATCTTTATAATCACCGTCATGGTCTTTGTAGTCACTAGTTAGATACCACTTAT
TGGTATTC 
IcsA737::FLAG×3 FLAG tag addition, reverse PCR 
JQ43 AGAGTCACCACCATTACCG Universal primer for alanine scanning aa 138-149 
JQ44 GCTACCGGATCTGACTTGTCTATAATC Mutagenesis primer, I138A 
JQ45 ATTGCTGGATCTGACTTGTCTATAATCAATCAAG Mutagenesis primer, T139A 
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JQ46 ATTACCGCTTCTGACTTGTCTATAATCAATCAAGG Mutagenesis primer, G140A 
JQ47 ATTACCGGAGCTGACTTGTCTATAATCAATCAAGGCATG Mutagenesis primer, S141A 
JQ48 ATTACCGGATCTGCTTTGTCTATAATCAATCAAGGCATGATTC Mutagenesis primer, D142A 
JQ49 ATTACCGGATCTGACGCTTCTATAATCAATCAAGGCATGATTCTTG Mutagenesis primer, L143A 
JQ50 ATTACCGGATCTGACTTGGCTATAATCAATCAAGGCATGATTCTTGG Mutagenesis primer, S144A 
JQ51 ATTACCGGATCTGACTTGTCTGCTATCAATCAAGGCATGATTCTTGG Mutagenesis primer, I145A 
JQ52 ATTACCGGATCTGACTTGTCTATAGCTAATCAAGGCATGATTCTTGGTG Mutagenesis primer, I146A 
JQ53 ATTACCGGATCTGACTTGTCTATAATCGCTCAAGGCATGATTCTTGGTGG Mutagenesis primer, N147A 
JQ54 ATTACCGGATCTGACTTGTCTATAATCAATGCTGGCATGATTCTTGGTGGTAG Mutagenesis primer, Q148A 
JQ55 ATTACCGGATCTGACTTGTCTATAATCAATCAAGCTATGATTCTTGGTGGTAG
CGG 
Mutagenesis primer, G149A 
148NNS ATTACCGGATCTGACTTGTCTATAATCAATNNSNNSATGATTCTTGGTGGTAG
CGGCGGTAGCG 
Site-directed mutagenesis primer targeting IcsA148-149 
(Dr Min Teh) 
MD80 TTTTTTCTCGAGGACTCCTCTTTCGGGTACTCAAG XhoI IcsA53 Forward (Dr Matthew Doyle) 
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